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ABSTRACT 
This work aimed at the development of monolithic chromatographic platforms for antibody 
purification. A sustainable strategy, comprising the use of natural polymers such as chitosan, 
agarose and dextran, was employed to create 3D porous structures. In order to improve the 
mechanical properties and biodegradability of monoliths, natural polymers were physically 
blended with synthetic ones. All supports were, in a first stage, produced by freeze-drying 
methods while in a second attempt were prepared by an integrated approach involving gelation 
process, water-acetone substitution and scCO2 drying. A further optimization for opening the 
porous network was evaluated involving swelling and freeze-drying procedures. To optimize the 
efficacy of monoliths, magnetic nanoparticles were embedded in monoliths structure to confer 
them a magnetic responsive behaviour. This additional feature improved antibody recovery 
when performing a magnetically-assisted elution (93% recovery of bound IgG) complemented to 
less time processing. The selectivity of monoliths for antibody, IgG, was guaranteed by the 
immobilization of ligand 22/8 (artificial Protein A) and a new triazine-based ligand (TPN-BM) 
onto their surfaces. The functionalization strategy of TPN-BM, which synthesis followed the 
principles of green chemistry, was induced by plasma technology. This alternative strategy 
allowed the reduction of time and solvents consumption while maximizing the functionalization 
yield of supports (2-fold, comparing to the traditional procedures). Moreover, the binding/elution 
mechanism between TPN-BM and IgG at a molecular level was validated through molecular 
docking studies and dynamic simulations.  
Overall, TPN-BM functionalized natural-based monoliths revealed values of pore size diameter, 
porosity, and flux between 1-96 µm, 28-88 % and 3-220 (L m
-2
 h
-1
). Chitosan/poly(vinyl alcohol)-
based monoliths revealed the best binding and elution capacities, 160 mg IgG g
-1
 support and 
97%, respectively, at least over four consecutive cycles.  Moreover, tested with crude samples, 
supports exhibited a good specificity for mAbs, recovering them with 96-98% of purity. 
 
 
 
 
KEYWORDS: Biopolymers, monoliths, affinity ligand, plasma technology, supercritical carbon 
dioxide, green chemistry, antibody purification. 
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RESUMO 
 
Este trabalho teve como objectivo o desenvolvimento de suportes monolíticos para a 
purificação de anticorpos por cromatografia de afinidade. Para tal, utilizou-se uma estratégia 
sustentável para produzir essas estruturas porosas 3D (monólitos), envolvendo polímeros 
naturais tais como quitosano, dextrano e agarose. Para melhorar as propriedades mecânicas e 
biodegradáveis dos monólitos, os polímeros naturais foram misturados fisicamente com 
polímeros sintéticos. Primeiramente, todos os suportes foram produzidos por liofilização, e 
numa segunda fase por processos de gelificação, substituição de água por acetona e secagem 
por scCO2. A optimização da abertura da rede porosa foi efectuada recorrendo à capacidade 
de inchamento dos suportes e subsequente liofilização. Para melhorar a performance dos 
monólitos, incorporaram-se nanopartículas magnéticas nas redes monolíticas por forma a 
conferir-lhes a capacidade de resposta magnética e consequente deformação quando sob 
acção de um campo magnético. Realizaram-se assim eluições assistidas por campo magnétco 
o que permitiu o aumento do rendimento de recuperação de anticorpo (IgG) ligado (93%) e 
diminuir o tempo do passo de eluição. A selectividade dos monólitos para o anticorpo foi 
garantida através da imobilização de dois ligandos sintéticos mimetizando a Proteína A (ligando 
22/8 e o novo ligando TPN-BM) na superfície dos suportes. A estratégia de funcionalização do 
TPN-BM, cuja síntese seguiu os princípios da química verde, foi feita utilizando a tecnologia de 
plasma. Esta estratégia permitiu reduzir tempo e uso de solventes bem como maximizar todo o 
processo (em 2 vezes) comparativamente aos procedimentos tradicionais. O mecanismo de 
ligação/eluição do TPN-BM e IgG foi validado através de estudos de acoplamento molecular e 
simulações dinâmicas. 
Em geral, todos os monólitos TPN-BM-funcionalizados exibiram valores de diâmetro de poro, 
porosidade e fluxo entre 1-96 µm, 28-88 % e 3-220 (L m
-2
h
-1
), respectivamente. Os monólitos 
de quitosano/poli(vinil álcool) revelaram as melhores capacidades de ligação e de eluição, 160 
mg IgG g
-1
 suporte e 97%, respectivamente, pelo menos durante quatro ciclos consecutivos. 
Adicionalmente, quando testados com extractos brutos, exibiram uma boa especificidade para 
mAbs, recuperando-os com 96-98% de pureza. 
. 
 
 
 
 
PALAVRAS-CHAVE - Biopolímeros, monólitos, ligandos de afinidade, tecnologia de plasma, 
dióxido de carbono supercrítico, química verde, purificação de anticorpos. 
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BACKGROUND 
 
The European market for therapeutic monoclonal antibodies (mAbs) is one of the fastest 
growing in the pharmaceutical sector.
1,2
 Currently, about 25% of commercial pharmaceuticals 
are biopharmaceuticals and about half of the worldwide sales are referred to mAbs, 
representing the majority. Therefore, these values translate greatly the importance of these 
proteins.
2
 
Nowadays, the high value of mAbs as therapeutic drugs is possible due to established synergy 
between the development of hybridoma technology and subsequent advancements in molecular 
biology and genetic engineering.
3
 Presently, mAbs are employed on the treatment of several 
diseases being cancer and autoimmune disorders the most common targets. Thus, mAbs with 
high purity level are required and thus, considerable efforts have been made to restructure the 
purification process in terms of specificity, selectivity, reproducibility, economy, product 
recovery, storage and maintenance.
3,4,5
 Although different downstream processes have been 
established for mAbs, affinity chromatography is still the most widely used technique.
4,6,7
 This 
process relies on a chromatographic matrix which has covalently immobilized an affinity ligand 
able to establish highly specific and selective interactions to the target.  
Up to now, different chromatographic supports and affinity ligands have been explored in order 
to improve antibody purification processes.
8
 The most common affinity ligand used is the 
biological ligand Protein A. Although the biological ligands present highly biding and selectivity, 
their use presents several drawbacks such as: high associated costs, low stability and re-
usability.
9
 In order to overcome this, biomimetic ligands have emerged based on triazine and 
boronic molecules, and Ugi reactions based products.
9,10,11,12
 An artificial protein A has been 
developed based on the triazine scaffold which showed great affinity and stability towards 
mAbs.
10
 On the other side, also chromatographic matrices have been target of exhaustive 
optimization studies in order to reduce or eliminate mass diffusion and pressure drop problems 
associated to traditional chromatographic fillings (agarose beads or other polymeric 
particles).
13,14
 Thus, membranes and more recently monoliths have been developed as the most 
attractive generation of chromatographic platforms able to overcome chromatography 
drawbacks.
15
 Monoliths are 3D porous structures known by presenting an outstanding porous 
networks with well-defined and interconnected pores that enable to process faster, by 
convection transport, different viscous fluids, than typical chromatographic platforms that 
operate mainly by diffusion.
16
  
Currently, monoliths have been produced from polymerization of different acrylate monomers 
and by chemical modifications of natural or synthetic polymers combining sol-gel, gelation, and 
freeze-drying methods.
17,18,19,20
 Although powerful, these strategies are time consuming and 
involve the use of organic solvents. Therefore, in order to reverse the negative publicity 
associated to chemistry based processes, regarding ecological and social points of view, 
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chemists and engineers have made a strong effort to start to find out greener alternatives to 
processes and products design and development, respectively.
21
 As an example of this is the 
use of supercritical fluids (SCF) in the preparation of 3D porous platforms. SCF-based 
processes offer significant environmental benefits, the drying steps are energy intensive and 
pores structure collapse is avoided.
22
 
Once established, is essential that the support should be uniform, macroporous, hydrophilic, 
chemically and mechanically stable, selective and insoluble in the solvent used in purification.
14
 
Additionally, it must exhibit minimum non-specific absorption and ideal flow characteristics, and 
provide a large surface area for ligand attachment. Different methods for ligand coupling have 
been frequently used based on chemical approaches (e.g. epoxyactivation followed by 
amination procedures or aldehyde functionalization processes), to facilitate further ligand 
attachment.
23
 Since these sequential methods also involve large time and solvent 
consumptions, it is required novel, sustainable and robust methods for ligand coupling, able to 
avoid ligand leaching, and reduce costs.  
To date, there is no purification alternative that combines a sustainable approach with the most 
attractive features of a chromatographic support and affinity ligand. More important than 
creating something totally new, it is the redesign of processes already established using natural 
resources and minimizing the waste, the energy and solvents feedings. The regulatory laws call 
for a business strategy regarding environment, health, safety and social issues. This has been 
working as the most important driving force to change mentality in academy and industry to 
reinvent greener and sustainable processes and products. Based on this, herein it is intended to 
prepare, through greener methods, monoliths based on natural polymers, with well-defined 
pores architecture, tuneable mechanical properties and able to operate over a wide range of 
chemical conditions (e.g. pH and solution compositions) for antibody purification. Also the 
redesign, following green metrics, of a biomimetic synthetic ligand is envisioned as well as its 
study at atom level to predict the promising binding sites with the antibody. Moreover, the 
strategy of ligand attachment to the chromatographic matrices pretends to be optimized 
regarding time saving and the reduction of organic species involved. Thus, this greener and 
integrated strategy aims to offer a sustainable solution for antibody purification 
processes, that can also be extended to other applications such as drug or cells delivery 
and tissue engineering. 
 
 
 
 
 
 
 
CHAPTER 1: FUNCTIONAL MONOLITHIC PLATFORMS: CHROMATOGRAFIC TOOLS FOR 
ANTIBODY PURIFICATION 
1 
  
 
 
 
CHAPTER 1 
FUNCTIONAL MONOLITHIC PLATFORMS: CHROMATOGRAPHIC TOOLS FOR 
ANTIBODY PURIFICATION 
 
 
 
 
SUMMARY 
 
Polymer monoliths are an efficient platform for antibody purification. The use of monoclonal 
antibodies (mAbs) and engineered antibody structures as therapeutics has increased 
exponentially over the past few decades. Several approaches use polymer monoliths to purify 
large quantities of antibody with defined clinical and performance requirements. Functional 
monolithic supports have attracted a great deal of attention as they offer practical advantages 
for antibody purification, such as faster analysis, smaller sample volume requirements and the 
opportunity for a greater target molecule enrichment. This chapter focuses on the development 
of synthetic and natural polymer-based monoliths for antibody purification. The materials and 
methods employed in monolith production are discussed, highlighting the properties of each 
system. It is also presented the structural characterization techniques available using monolithic 
systems and their performance under different chromatographic approaches to antibody capture 
and release. Finally, a summary of monolithic platforms developed for antibody separation is 
offered, as well as expected trends in research to solve current and future challenges in this 
field.  
 
 
 
 
 
Article published: Telma Barroso, Abid Hussain, Ana C. A. Roque and Ana Aguiar-Ricardo, Functional 
monolithic platforms: Chromatographic tools for antibody purification. Biotechnol. J. 2013, 8, 1-11. 
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1.1 INTRODUCTION 
In recent decades, the use of antibodies, monoclonal antibodies (mAbs) and engineered 
antibody structures for cancer, autoimmune, inflammation and infectious disease therapy has 
increased exponentially, with an overall annual market worth tens of billions of US dollars.
7,23,24
 
Therefore, innovative platforms for large scale antibody production and purification are 
required.
25
 Current research is aimed at developing more selective isolation methods for 
antibody purification, rather than relying on traditional chromatographic techniques.
7,23,24
 A 
chromatographic process can be defined as a separation process which allows the isolation of a 
target molecule from a complex mixture. This is enabled through the different chemical 
interactions between a specific ligand immobilized onto a chromatographic support and the 
target molecule. Presently, chromatographic methods such as hydrophobic interaction 
chromatography (HIC), ion exchange chromatography (IEC) and affinity chromatography (AC) 
dominate the manufacturing of biopharmaceuticals.
16,26
 Numerous biological (antibodies, 
peptides, proteins, lectins) and non-biological (synthetic dyes, ion exchangers, metal chelates) 
ligands, materials and geometries (agarose beads, polymeric membranes, monoliths) may be 
incorporated into chromatographic separation matrices. The plethora of options available make 
chromatography the most commonly used technique for antibody purification.
9,26
 
 
 
Figure 1.1 - Schematic representation of opportunity window for polymer monolith incorporation into 
chromatographic bioseparation processing technology on the basis of target molecule size. 
 
Thus, the ideal bioseparation matrix must fulfill the following criteria: (i) high selectivity and high 
binding capacity for the target molecule; (ii) good mechanical, morphological and chemical 
stability; (iii) inhibition of non-specific molecular adsorption; (iv) high stability under cleaning in 
place (CIP) and sterilization in place (SIP) conditions; and (v) facilitation of short processing 
times for high volumes.
26
 To date, materials typically employed in chromatographic processes 
are beads or gels manufactured from such raw materials as agarose and polymeric 
membranes.
7
 These materials, while readily available, present certain shortcomings such as 
limitations with the mass transfer, gel compressibility and poor pore diffusion leading to high 
pressure drops and low flow rates – all of which incur process time and cost. These 
weaknesses have led to an investment on alternative chromatographic supports which maintain 
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the efficiency of the established processes while improving their associated limitations. One of 
these new generation of alternatives are monolithic supports, herein referred to as monoliths,
27
 
which were introduced in the early 1990’s.
26
 
 
1.2 MONOLITHIC PLATFORMS 
We define monolith here as a porous, single-unit material introduced into a chromatographic 
device.
28
 Individual monoliths are characterized by a network of large interconnected pores (or 
channels) which allow high operational fluxes and consequently lead to rapid processing times.
7
 
Due to their excellent morphological and mechanical properties, monoliths have attracted 
attention for use in antibody purification
14
 (Fig. 1.1) both at research and industrial scale (table 
1). Incorporation of monoliths into chromatography stationary phase also avoids a high-shear 
fractionation atmosphere, which is crucial for optimal recovery of shear-sensitive molecules 
such as viruses, sensitive proteins, DNA and cells.
27
 A vital requirement for implementation 
within the pharmaceutical industry is translation to large-scale operation. High-throughput 
processing must be enabled at moderate pressure drops without sacrificing the product purity. 
In this respect, the main advantages associated with monoliths (convention dominated mass 
transport, high porosity, low cost preparation and simple column filling) has encouraged several 
manufacturers to examine monoliths as potential supports.
29
 Nowadays there are several 
commercially available polymeric monolith based supports, for both small scale and analytical 
purposes, offering a wide range of pore diameters. These allow the purification of a large 
number of biomolecules ranging in size and features in a simple and effective way (Fig. 1.1 and 
Table 1.1). 
Monoliths employed in antibody purification have been prepared using inorganic materials as 
well as natural and synthetic polymers. Recently, Arrua et al.
30
 reviewed current developments 
and future possibilities for polymeric monolithic structures. Depending on the material, different 
manufacturing routes can be followed, including polymerization initiated by different stimuli,
31
 
sol-gel
32
 and cryogelation,
19
 creating porous networks with distinguishing structural properties. 
Since these polymers and materials adopt the format of the mould used, monolithic materials 
can be prepared in different formats, such as large rod polymers (used in standard 
HPLC/capillary columns), monolithic disks, cylinders and flat sheet polymers.
30
 A classification 
according to the morphological features of different monolithic supports is indicated in Table 1.2 
agreeing to the commonly defined literature criteria.
33
 
Since the optimal performance of monoliths depends on the balance between morphological, 
mechanical and physicochemical properties, it is difficult to single out any specific parameter 
range to be set as the “gold standard”. It is crucial to establish first whether the monolith will be  
for analytical or large scale applications. For analytical purposes, pore size diameter can be 
designed according to the target antibody. In contrast, at large scale pore size must be 
considered in light of the contaminants which also residing in the load solution, so that all 
components are able to permeate freely through the support. Hence, in general, a monolith for 
antibody purification must have a range of pore size diameter between 1 and 50 μm, a porosity 
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of around 60±10%, a surface area within 10–400 m
2
 cm
-3
 with a permeability and a binding 
capacity of up to 100 L m
-2
h
-1
atm
-1
 and 50 mg mL
-1
, respectively.
34,35
 This range of values can 
be tuned according to the components of the load solution by the methods selected to prepare 
the monoliths. Thus, different types of monoliths can be generated and customized to ensure 
maximum efficiency in the capture of the target antibody. 
 
Table 1.1 - Overview of commercially available monoliths for applications in bioseparation.
29
 
 
Trade name Manufacturer Material 
Separation 
modes 
Macro pore 
size (µm) 
CIM BIA Separations Polymethacrylate 
Ion exchange 
Hydrophobic 
interaction 
Reverse phase 
Bioaffinity 
0.03-1.5 
UNO Bio-Rad Polyacrylamide Ion exchange 1 
SWIFT Isco Polymethacrylate 
Ion exchange 
Reversed phase 
1.5 
SepraSorb Sepragen Modified cellulose Ion exchange 50-300 
Chromolith Merck Silica Reversed phase ≥ 2 
 
 
Table 1.2 - Morphological features of different types of porous structure.
33
 
 
 Micropore Mesopore Macropore 
Pore Diameter (nm) <  2 2-50 > 50 
Porosity (%) ≤ 25 25-65 ≥ 65 
Surface Area (m
2
cm
-3
)  ≥ 1000 1000-350 ≤ 350 
 
1.2.1. SYNTHETIC POLYMER MONOLITHS 
Polymer monoliths produced by organic synthesis were first used in chromatography columns in 
the late 1980’s and the early 1990s, and so far, its production continues to 
grow.
14,19,29,30,31,32,33,34,35,36,37,38
 Monolithic columns were prepared by radical polymerization of 
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monovinyl monomer in the presence of a crosslinker, radical initiator and porogen (responsible 
for pore formation) (Fig. 1.2 A). Inspired by this straightforward strategy of monolith production, 
different monomers such as acrylamide (AAm), methacrylate and styrene were then employed 
to create rigid monoliths with desired morphological properties and dimensions.
14,39,40,41,42,43,44
 
 
 
 
Figure 1.2 - Preparation of GMA-EDMA monoliths (A) and of AA-AGE cryogels (B) and their chemical 
structures. 
 
In particular, glycidyl methacrylate (GMA) and ethylene glycol dimethacrylate (EDMA) have 
become the most commonly employed monomers for the preparation of synthesized 
monoliths.
31,45
 The great advantages of using these monomers is that GMA, which carries the 
very reactive epoxy group, facilitates further functionalization for target molecule capture; while 
EDMA, as an excellent crosslinker, confers mechanical stability to the final monolith. As an 
example, Hahn et al.
46
 developed an affinity poly(GMA-co-EDMA) monolith using a simple 
strategy for ligand immobilization. The model peptide (or ligand) was directly immobilized by 
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reaction with the epoxy groups on the GMA chains incorporated into the matrix of monolith. 
Spacer arms can be introduced between the ligand and the support to promote the accessibility 
of the ligand functional groups to interact with the target biomolecule. As an example, reactive 
macroporous monoliths of poly(GMA-co-EDMA) were prepared by in situ copolymerization of 
GMA and EDMA in the presence of porogenic agents, followed by Protein A and L-histidine 
linkage to the monoliths either directly or through the use of a spacer arm. The IgG adsorption 
capacity of the monolith functionalized with Protein A was greatly increased with the introduction 
of the spacer.
47
 Poly(GMA-co-EDMA) monoliths have also been functionalized with Protein L 
and Protein G with promising results,
48,49,50
 sufficient to justify their commercialization.
51,52
 
To evaluate the application of synthetic monoliths for antibody purification, several studies have 
been performed. Lokman et al.
53
 developed a novel porous monolithic system for effective IgG 
purification from human plasma based on the preparation of porous monoliths through the bulk 
polymerization of (hydroxyethyl) methacrylate HEMA and N-methacryloyl-(L)-histidine -
methylester (MAH). An upper adsorption value (>96.5 mg g
–1
) was achieved from human 
plasma with an associated purity value of 95.3%. Moreover, the authors verified that IgG could 
be reversibly adsorbed using poly(HEMA-MAH) monolith. Another strategy from the same 
group
54
 involved the preparation of imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-
tyrosine methyl ester) particles using hepatitis B antibody as the surface template. These 
particles demonstrated spectacular binding specificity, adsorbing an amount of hepatitis B 
antibody 18.3 times greater than anti-hepatitis A antibody, and 2-fold greater than 
immunoglobulin E. The self-polymerization of poly(glycerol poly(glycidyl ether) (PGPGE) using 
methyl tert-butyl ether as a porogenic agent resulted in the formation of a particularly rigid 
monolith where the epoxy groups of the poly(glycerol polyglycidyl ether) served a dual purpose: 
firstly, to provide functional groups for the polymerization reaction, and secondly to allow direct 
binding of Protein A to the monolith surface. Capillary columns loaded with this monolith allowed 
the isolation of IgG (5.3±0.9 μg) and presented a capacity of 0.44±0.08 mg mL
-1
 within a 
capillary volume of 12 μL.
50
 In addition to affinity-based monoliths, anion-exchange 
methacrylate monolithic systems constituted by a monolithic macroporous convective interaction 
media (CIM) were tested and proved to be effective in the isolation of anti-glycophorin-A IgG1 
mouse mAbs from cell culture supernatant. Also, CIM-iminodiacetate (IDA) disks with four 
different metal ions (Zn
2+
, Cu
2+
, Co
2+
 and Ni
2+
) immobilized were employed for mAb isolation 
from cell culture supernatant, achieving a maximum recovery of 85.4% of purified antibody.
55
 
Synthetic polymer monoliths have also been employed in complex IgM purification systems. 
Recently, an epoxy-activated monolith CIM disc functionalized with an affinity peptide
56
 was 
developed for IgM, IgG and mAb isolation from embryonic stem cells. With this approach, it was 
possible to recover 67%, 83% and 95% of IgG, IgM and mAbs, respectively. In addition, the 
binding capacity was reproducible over two thousand cycles. Recently, ammonium quaternized 
monolith CIM disks (CIM –QA (quaternary amine) and –EDA from Bia Separations) have also 
been used to purify IgM from mammalian cell cultures, with recovery yields up to 85%.
57,58
 CIM-
QA and CIM-EDA discs can separate IgM from human plasma and can fractionate low 
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abundance plasma proteins.
59
 Other approaches regarding IgM isolation have also been 
developed
31,60,61
 using synthetic polymer monoliths. 
1.2.1.1. Hydrogels and cryogels 
Cryogels and hydrogels are synthetic polymer monoliths which can be defined as 
supermacroporous gels.
19
 In cryogels, networks are formed by the cryogelation of monomers 
(e.g. GMA, allyl glycidyl ether (AGE)) at sub-zero temperatures using ammonium persulfate 
(APS) as an initiator and N,N,N’,N’-tetramethylene diamine (TEMED) as the catalyst (Fig. 1.2 
B). Hydrogels are formed by the polymerization of acrylamide (AAm), N’,N’-
methylenebisacrylamide (MBA) and AGE in an aqueous buffer which works as a porogen, just 
as in the formation of acrylamide gels for gel electrophoresis assays.
26
 The use of GMA and 
AGE allows a direct introduction of epoxy groups enabling further functionalization with ligands 
or other synthetic and natural species.  
The macroporous network of hydrogels and cryogels makes them very attractive for cell and 
antibody separation,
61
 due to their higher porosity (up to 90%) and larger pore size (0.1–200 
μm).
26,62,63,64
 Unlike methacrylate or silica monoliths, cryogels and hydrogels have poor 
mechanical behaviour. Low material rigidity can be minimized through crosslinking procedures, 
physical blends or the addition of stiff polymers to the initial casting solution.
30
 
Over the past decade, different polymeric cryogel systems such as AAm and MBA grafted with 
N,N-dimethylaminoethyl methacrylate (DMAEMA) and poly(methacrylic acid (MAA)-co-
polyethylene glycoldiacrylate) embedded with polystyrene or poly(EDMA) nanoparticles have 
been prepared at sub-zero temperatures. Due to the large porous network, efficient separation 
of highly purification antibody from fermentation broth was achieved using affinity 
supermacroporous monolithic cryogels functionalized with Protein A.
64,65,66
  
Poly(AAm-AGE) cryogels functionalized with concanavalin A (Con A) were able to capture IgG 
from pure aqueous solutions and human plasma, with high capacity (up to 25.6 mg g
-1
) and 
eluent purity (85%).
67
 Similar approaches were developed to purify IgM using polyHEMA 
cryogels activated with cyanogen bromide for further functionalization with Protein A. Due to 
their hemocompatibility, these systems enabled IgM and IgG isolation from human plasma with 
high reproducibility over repeated cycles.
68,69
 In related work, Cibacron Blue F3GA and (IDA)-
Cu
2+
 covering PGMA particles incorporated into the polyHEMA cryogel allowed IgG and albumin 
isolation from human serum with efficiency of 93.6 and 89.4%, respectively.
70
 N-methacryloyl-
(L)-histidine methyl ester (MAH) was selected to function as a pseudospecific ligand and as co-
monomer simultaneously to prepare polyhydroxyethyl methacrylate-N-methacryloyl-(L)-
histidinemethylester cryogel.
71
 The MAH incorporation into the support elevated the specific 
surface area up to one hundred times and allowed the highest registered quantity of IgG 
adsorbed from human plasma (97.3 mg g
-1
 of cryogel) with an associated purity of 94.6%. 
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1.2.2. MONOLITHS BASED ON NATURALLY OCCURRING POLYMERS 
Societal, environmental, and regulatory drivers are pressing industry to design engineered 
products from “cradle to grave”.
71
 This has been a driving force for the use of natural and 
biodegradable polymers at an industrial level. The most widespread natural polymers are 
polysaccharides, such as cellulose, chitosan and agarose.
71
 The popularity of agarose beads as 
first-choice supports for traditional affinity chromatography stems from bead hydrophilicity and 
good chemical stability, even under extremes of pH.
9
 Thus, it is not surprising that agarose has 
been used for monolith preparation.
72
 Unfortunately, agarose based monolith supports exhibit 
poor mechanical properties, and at the time of writing they are only known as porous particles 
confined in a mold or as a macroporous gel.
72,73
 
Chitosan (CHT) is also a natural polymer obtained by deacetylation of chitin originated from the 
xoskeleteon of crustaceans.
74
 Chitosan has been extensively investigated in diverse fields of 
work
73,75
 due to its nontoxic, antimicrobial, biocompatible, and biodegradable properties and 
sensitivity towards changes in pH.
76
 Due to its high molecular weight, chitosan yields viscous 
solutions can be utilized to produce porous gels and structures through methodologies such as 
freeze drying and supercritical fluid technology.
20,75,77,78,79,80
 Sun et al.
81
 prepared chitosan-
agarose cryogels in situ through cryopolymerization and linked 2-mercaptopyridine onto 
divinylsulfone-activated matrix, producing cryogels used to purify IgG. Cryogels presented 
interconnected pores of 10-100 μm size, a specific surface area of 350 m
2 
g
-1
 and a high 
adsorption and elution capacity for IgG of 71.4 mg g
-1
 and 90%, respectively. These supports 
proved to be stable and reusable for more 10 cycles without substantial loss in their 
performance. More recently, Barroso et al.
82
 prepared chitosan-based monoliths for IgG 
purification by combining freezing and lyophilization methods. The authors were able to improve 
the mechanical properties of chitosan through blending with poly(vinyl alcohol )(PVA) and by 
cryopolymerizing with GMA at sub-zero temperatures (Fig. 1.3). The supports were 
functionalized with a Protein A biomimetic ligand, through plasma technology, a free solvent 
technique. This sustainable and faster approach allowed high binding capacities (150±10 mg 
IgG g
-1
 support), and 90±5% recovery of the bound protein with 98% purity directly from cell-
culture extracts. 
Cellulose has also been employed in chromatographic procedures using cellulose derivatives in 
the form of discs/membranes retaining the possibility for further functionalization with different 
type of molecules for protein separation, and evaluation of affinity interactions.
83,84,85,86,87
 
Recently, Barroso et al.
88
 prepared cellulose membranes/discs using an alternative approach to 
generate cellulose porous structures for different applications, namely that of human IgG 
purification. 
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Figure 1.3 - (A) Schematic preparation of chitosan-based monoliths. (B1, B2) SEM micrographs of 
chitosan monoliths and chitosan cryopolymerized with glycidyl methacrylate (GMA) respectively,
82
 adapted 
with the permission of The Royal Society of Chemistry. 
 
Presently, the use of natural polymers for the preparation of chromatographic supports is still 
low, but this trend needs to be reversed in view of stricter chemical legislation regarding health 
and safety, thus pushing the industry towards greener and more sustainable processes. Table 
1.3 provides a summary of the key supports, targets and separation criteria for the processes 
discussed above. 
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Table 1.3 - Monolithic materials for antibody purification. 
Material Mode Ligand Target 
Surface area 
(m
2
 g
-1
) 
Flow rate 
(mL min
-1
) 
Capacity 
Recovery 
(%) 
Purity Ref’s 
GMA-EDMA 
Affinity 
Protein A IgG, IgM, IgA 89.1 0.05; 1.0 20 (IgG) mg g
-1
 99 High 
[47] [49] 
Protein L IgG n.a. 1×10
-5
 n.a. n.a. High 
[45] 
Protein G IgG n.a. 0.05; 2.5 20 mg g
-1
 n.a. High 
[49] [50] 
L-histidine IgG 89.1 1.0 22.0 mg g
-1
 n.a. n.a. 
[47] 
Anion 
Exchange 
DEAE 
MAbs 
n.a. 1.0 n.a. 95.0 High 
[51] 
EDA n.a. 1.0 n.a. 91.4 High 
[51] 
Ion Exchange MAA IgG 57.1 1.0-2.0 n.a. 98.8 Good 
[48] 
PG-PGE Affinity Protein A IgG from rabbit serum n.a. n.a. 0.44 mg mL
-1
 n.a. n.a. 
[49] 
HEMA-MAH 
Pseudo-
affinity 
(MAH) IgG 145.8 1.0 96.5 mg g
-1
 n.a. 95.3% 
[53] 
CIM-IDA IMAC Cu
2+
/Ni
2+
/Zn
2+
/Co
2+
 IgG/ Mab’s n.a. 2.0 n.a. 63/41/85/40 n.a. 
[55] 
IMAC Cu
2+
/Ni
2+
/Zn
2
 IgG and Mab’s n.a. 3.0 0.5 mg mL
-1
 82.4 n.a. 
[89] 
CIM 
Pseudo-
affinity 
Peptide IgM/IgG/ Mab’s n.a. 1.0-10 n.a. 83/67/95 n.a. 
[56] 
Ion Exchange QA/DEAE/EDA 
IgM/IgG n.a. 1.0-2.0 ≈ 20 mg g
-1
 n.a. n.a. 
[90] 
IgM n.a. n.a. 16-36 mg g
-1
 n.a. n.a. 
[57] 
DMAA-AGE 
cryogel 
IMAC IDA-Cu
2+
 
Fv antibody fragments from 
E. Coli cell culture 
n.a. n.a. n.a. 84-96 High 
[91] 
Affinity Protein A Cells bearing IgG antibodies 20.2 0.5 
1.6×10
6
 cells mL
-1
 
adsorbent 
60-70 High 
[68] 
AAm-AGE cryogel 
Affinity Conc A IgG n.a. 1.0 25.6 mg g
-1
 94 85% 
[67] 
Afinity Protein A IgG labeled inclusion bodies n.a. 0.5 n.a n.a. n.a. 
[92] 
HEMA-cryogel 
Affinity Protein A 
IgM 
20.2 0.5 42.7 mg g
-1
 ≥ 90 - 
[68] 
IMAC PGMA-IDA-Cu
2+
 n.a. 0.5-2.0 257 mg g
-1
 89.4 - 
[93] 
Affinity 
PGMA-Cibracron Blue 
F3GA IgG 
n.a. 0.5-2.0 342 mg g
-1
 93.6 - 
[93] 
Affinity Protein A n.a. 0.5-3.0 83.2 mg g
-1
 85 85% 
[69] 
HEMA-MAH 
cryogel 
Pseudo- 
affinity 
(MAH) IgG n.a. 0.5-3.0 97.3 mg g
-1
 80.7 94,6% 
[93] 
Chitosan-agarose Affinity 2-mercaptopyridine IgG 350 1.0 71.4 mg g
-1
 90 High 
[81] 
Chitosan-PVA Affinity 
Artificial Protein A  
(Ligand 22/8) 
IgG and MAbs 2.3 1.0 150 mg g
-1
 90 98% 
[82] 
 
n.a
: not available 
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1.3 STRUCTURAL CHARACTERIZATION OF MONOLITHS 
Ensuring optimal performance of a monolith based chromatographic medium requires accurate 
characterization to determine whether the monolith’s morphological properties fall within the 
range of desired values. Thus, depending on the application, the best balance between 
porosity, pore size and surface area must be attained.
27
 Larger pores decrease the available 
surface area and reduce the mechanical strength of the support. Conversely, smaller pores 
allow larger surface area and impart better mechanical integrity, albeit at the expense of lower 
fluxes and slower processes. One of the most critical issues is the pore size distribution. Various 
authors allude to the difficulty in producing monoliths with an acceptable degree of 
homogeneity.
94,95
 Therefore, a number of methods have been described for evaluating the 
porosity within monolithic networks. These include scanning and transmission electron 
microscopy (SEM/TEM), mercury intrusion porosimetry (MIP), adsorption or desorption of 
nitrogen (AN/DN), and inverse size inclusion chromatography (ISEC).
30,96,97
 However, all these 
techniques require a significant quantity (of the order of milligrams) of monolith sample to obtain 
representative results. Additionally, these analyses are often destructive. Electron microscopy 
samples require heavy metal sputter coating for analysis, while MIP requires samples to be 
impregnated with mercury. In case of studies evaluating adsorption or desorption of nitrogen, 
the samples may be destroyed through the degasification procedures and pressures employed 
during the analysis.  
Developing non-invasive methods for characterizing monolith morphology has become a great 
challenge for some researchers. Petter et al.
98
  utilized near-infrared spectroscopy to determine 
pore size, pore volume, total porosity and surface area in a single analysis. Although this 
technique is not destructive, it still does not provide comprehensive morphological detail such 
as potential wall defects and the degree of radial heterogeneity, both particularly important in 
evaluating monoliths as chromatographic devices. 
The introduction of other recent techniques, such as scanning coupled contactless conductivity 
(sC4D) methods, confocal laser scanning microscopy, magnetic resonance imaging and small 
angle neutron scattering, offers innovative options to complement the aforementioned 
techniques in order to attain a thorough understanding of monolith structural features.
99,100,101
  
 
1.4 PERFORMANCE EVALUATION OF MONOLITHIC PLATFORMS 
Important key parameters that must be studied when developing new monoliths include static 
and dynamic binding capacity, scale up potential and resistance to cleaning and sterilization 
procedures. 
An adsorption isotherm is a useful tool for estimating the maximum binding capacity to the 
target molecule as well as evaluating the level of non-specific adsorption.
102
 By taking into 
account parameters describing the porous network, material and monolith surface area, 
different adsorption isotherms can be applied to achieve the best fit to the experimental data 
obtained through static studies. 
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To assess the monolith dynamic binding features and mass transfer, breakthrough curves 
obtained by frontal analysis are usually estimated. If breakthrough curves do not alter with feed 
concentration, or molecular dimension and velocity, it indicates that the adsorption is not 
restricted by mass transfer phenomena.
16
 To obtain an effective mass transfer, the pores have 
to be sufficiently wide. For this reason, monoliths are ideal for the separation of antibodies and 
other biomolecules with diameters above ~5 nm, since it is technically difficult to produce 
particles with a pore size wide enough to allow permeation of these larger molecules.
25,27,103
 
Regarding the cleaning and regeneration issues of monoliths, different protocols can be 
adopted according to the stability of the immobilized ligand and of the polymeric composition. 
Thus, cleaning and regeneration regimes need to be optimized for individual situations. 
However, the most common procedures employed involve the use of alkaline (0.1–1 M NaOH) 
and salt solutions (1–2 M NaCl) which contain competitor agents that force the removal of 
antibody and proteins from the monolithic supports. Alcohol solutions such as ethanol (up to 
20%) and isopropyl alcohol (up to 30%) can also be used.
34,104
 Moreover, the use of detergents 
(e.g. Tween 80) or organic solvents (acetone, ethanol, and isopropanol) may be required for 
sanitization of chromatographic media after use with particular feedstocks. 
The pressure drop across monolith based media is typically lower than traditional beads or 
membranes. Monoliths used in biomolecules separation field should have a porosity higher than 
50% allowing a pressure drop reduction of 50% compared with beads or membranes.
27
 
An additional and also fundamental concern associated with monolith-based media is its scale 
up capability. This issue still needs to be addressed; however the preparation of monolithic 
devices capable of operating over multiple cycles without capacity loss is within the grasp of 
existing manufacturing processes.
105
 Attachment of monolith to the column wall can also be 
challenging. Monoliths can be attached to a column with a flexible wall, though this set-up would 
prove cumbersome when working with high pressure gradients and high flow rates.
16,105
  
Concerns over column attachment may explain why silica monoliths are not yet available as 
industrial scale chromatography media. In marked contrast, the scale-up of CIM disks and tubes 
made from polymethacrylate has been widespread, since the preparation of these supports 
results in superior mechanical behaviour and resilience to aggressive regeneration conditions 
(e.g. 1 M NaOH). Thus, scale up is straightforward and amenable to biopharmaceutical process 
development strategies.
106
 
At present, intermediate scale purification has been performed by linking monolith columns in 
parallel,
107
 creating an array system with a volume capacity up to 1000 L. Effective scale-up 
from a 0.34 mL disk to 8 L radial columns and tubes is well established.
16
 However, the 
incorporation of monoliths in industrial processes is still a challenge that deserves attention. In 
the near future it is expected that monoliths could increase processing capacity to directly 
compete with traditional chromatographic resins that are able to process hundreds of liters with 
high resolution. At the time of writing, 8 mL of a CIM monolith functionalized with Protein A is 
able to purify 10 mg IgG g
-1
 wet support, while 2 mL of Protein A agarose resin purifies 20 mg 
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IgG g
-1
 wet support. Thus, an improvement in monolith purification capacity is still required 
before large scale comparisons are attempted. 
 
1.5 SUMMARY, CONCLUDING REMARKS AND FUTURE TRENDS 
Interest in high-value biomolecules in medicine, pharmacology, biochemistry and diagnostics 
has resulted in the development of alternative systems for antibody isolation and purification. 
Monolithic support technology, though nascent, requires further maturation before its full 
potential can be exploited. The advantages and disadvantages of synthetic, cryogel and natural 
polymer monoliths are summarized in Table 1.4. 
Up to now, silica-based monoliths have not been extended to antibody purification and therefore 
were not here included and discussed. However, silica-based monoliths have been applied to 
drug and chiral separations and for immunochromatography.
108,109
 
The technologic transition in purification processes has already begun. There is a substantial 
amount of literature highlighting the virtues of monolithic supports. Commercially available 
monolith based chromatography media have demonstrated efficient biomolecule separation 
across a number of applications. Particularly, the successful technology may find a niche in the 
purification of antibodies of various formats. Additional work is needed to expand the range of 
ligands available, fine tune their immobilization and optimize the scale up of monolithic 
platforms. 
 
Table 1.4 - Summary of monolithic platforms in antibody separation: pros and cons. 
 
Monolith Base Pros Cons 
Organic 
High mechanical stability 
Easy preparation 
Numerous monomers available 
Easy scale up 
Easy ligands attachment 
Some difficulties in processing 
biomolecules with high 
molecular weight  (≥ 100 kDa) 
Cryogels 
High performance to process 
viscous fluids (e.g. blood and 
cells) 
Easy preparation 
Low purification efficiencies for 
biomolecules with low molecular 
weight  (< 100 kDa) 
Low mechanical properties 
Low surface area 
Natural polymers 
Easy preparation 
Tunable mechanical properties 
Biocompatible 
Biodegradable 
Lack of processing methods 
 
 
Protein A was known to biochemists long before its true potential as an antibody purification 
ligand was fully realized. This recognition resulted in a paradigm shift in biomolecular 
separations technologies. The recent advances in proteomics have led to the identification and 
classification of multitudes of new proteins with vital roles in living organisms. The call for 
technology to assist the efficient purification of large proteins from complex mixtures has never 
been greater. To meet this burgeoning demand, the time is ripe for the next leap in affinity 
supports. Monoliths may well prove to be the ideal bespoke chromatographic medium that takes 
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complex bioseparations from the research bench to sustainable large-scale industrial 
processes.
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SUMMARY 
 
Chitosan-based monoliths activated by plasma technology induced the coupling of a robust 
biomimetic ligand, previously reported as an artificial Protein A, with high yields while minimizing 
the environmental impact of the procedure. Due to the high porosity, good mechanical and 
tuneable physicochemical properties of the affinity chitosan-based monoliths, it was possible to 
achieve high binding capacities (150 ±10 mg antibody per gram support), and to recover 90 ± 
5% of the bound protein with 98% purity directly from cell-culture extracts. Therefore, the 
chitosan-based monoliths prepared by clean processes exhibited a remarkable performance for 
the one-step capture and recovery of pure antibodies.  
 
 
 
 
 
 
 
 
Article published: Telma Barroso, Ana C. A. Roque and Ana Aguiar-Ricardo, Bioinspired and sustainable 
chitosan-based monoliths for antibody capture and release. RSC Advances, 2012, 2, 11285–11294. 
 
Attended conference (poster apresentation): Telma Barroso, Ana C. A. Roque and Ana Aguiar-Ricardo, 
“Affinity porous structures for antibody purification” in Affinity, 2011, Tavira-Portugal. 
 
Attended conference (oral apresentation, key note): Telma Barroso, Ana C. A. Roque and Ana Aguiar-
Ricardo, “Bioinspired affinity monoliths: a fast and efficient alternative system for antibody purification” in 
European Society of Biochemical Engineering Sciences (ESBES), 2012, Istanbul-Turkey. 
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2.1. INTRODUCTION 
Antibody-based biopharmaceuticals will be a major source of new therapies for at least the next 
10 years.
4,110
 The large number of antibody products in development certainly supports the case 
for optimized antibody manufacturing approaches. However, the large quantities in which some 
antibody products are required put considerable pressure on current manufacturing 
facilities.
69,111,112
 
In particular, current purification processes are struggling to equal the high productivities 
already obtained in upstream antibody production. Affinity chromatography using Protein A from 
Staphylococcus aureus is the method of choice for antibody capture during the purification 
process.
4,110
 However, protein A resins utilized in chromatography are expensive adsorbents 
with low stability, often causing the leaching of the affinity ligand together with the antibody 
product.
4,16,69
 Thus, synthetic affinity ligands mimicking biological receptors have been 
developed in an attempt to overcome Protein A drawbacks.
113
 Ligands based on a triazine 
scaffold, in particular ligand 22/8 or artificial protein A, are known to be low cost and highly 
resistant to the harsh conditions employed during CIP and SIP. 
10,113
 Ligand 22/8 has been 
immobilized on agarose,
113
 cellulose membranes,
88
 and magnetic particles,
114
 and shown to 
selectively bind to hIgG when employed in chromatographic processes.  
With the need to treat large volumes of concentrated antibody solutions, fast processes with 
high selectivity are desired.
18,40,115
 Monoliths are porous materials cast in a single block and 
inserted into a chromatography housing. These porous supports have been successfully 
employed in the purification of biological species.
16,116,117,118,119
 As convective transport is 
prevalent when using monoliths, faster volumetric throughput rates are achieved thus increasing 
the process speed and productivity.
40
  
The aim of this work was to combine the robustness of synthetic affinity ligands, namely ligand 
22/8, with monolith blocks prepared from biopolymeric materials, in particular chitosan (CHT). In 
addition, sustainable chemistry options have been adopted for the preparation and 
functionalization of the materials based on freeze-drying method
120,121
 and plasma 
technology,
122,123,124 
respectively. In particular, freeze drying processes work by freezing the 
casting solution and then reducing the surrounding pressure to allow the frozen water in the 
material to sublimate directly from the solid phase to the gas phase, resulting in attractive 
porous structures.
125
 On the other hand, plasma technology is a fast and solvent free technique 
which allows surface modification through the introduction of chemical species.
122,123,124,125,126
 
Recently, plasma surface activation was combined for the first time with supercritical fluid 
technology to surface-graft stimuli-responsive hydrogels on differently shaped devices.
127
 
Herein, plasma surface activation was extended to introduce radicals on monolith surfaces for 
further coupling with the affinity ligand. The materials produced have been characterized in 
terms of morphological, mechanical and physicochemical properties, and have shown to 
recover antibodies directly from crude cell samples. CHT has been selected due to its nontoxic, 
antimicrobial, biocompatible, and biodegradable properties, as well as its pH sensitive 
behavior.
128
 Owing to a high molecular weight, CHT forms viscous solutions in dilute aqueous 
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acetic acid that can be used to produce porous structures. The tensile strength of these 
structures can be improved through crosslinking with epichlorohydrin
129
 or glutaraldehyde,
77,78
 
copolymerization with other monomers, or via blending.
130,131
 In this work CHT was 
copolymerized (cryo-polymerization) with GMA at low temperatures in order to produce well 
defined porous monoliths with good tensile strength. PVA was also blended with CHT as an 
alternative strategy to improve the mechanical performance of CHT monoliths. The processing 
of these renewable materials into 3D structures with tuneable and controlled morphological and 
mechanical properties, and their subsequent functionalization with a low cost affinity ligand 
through green methodologies will offer a great contribution in materials design for bioseparation 
processes. This integrated process aims to replace traditional practices of monolith preparation 
and functionalization by new ones where the integrity of the support is maintained from its 
conception to its application even at industrial scale. 
 
2.2. EXPERIMENTAL AND METHODS 
2.2.1. MATERIALS 
Ammonium peroxodisulphate (APS, purity≥98%), citric acid (purity≥99%), disodium hydrogen 
phosphate monodibasic (pro analysis), disodium hydrogen phosphate dibasic (pro analysis), 
disodium tetraborate, ethanol absolute and sodium citrate dihydrate were purchased from 
Merck. Isopropanol and sodium bicarbonate were purchased from Riedel-de-Haen. Acetone 
(purity≥99%), and ethyl acetate were supplied by Roth. Acetic acid (purity≥99%), Aminocaproic 
acid, 3-aminophenol, 4-amino-1-naphthol hydrochloride, cyanuric chloride (purity≥98%), 1,6-
hexanediamine (purity≥98%), N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), 
glycine, ninhydrin, potassium cyanide, pyridine, sodium hydroxide (purity≥99%) were purchased 
from Sigma Aldrich. Chitosan (75≈85% deacetylated, medium molecular weight), poly(vinyl 
alcohol) (purity≥99%), N,N-methylenebisacrylamide (MBAm, purity≥85%), N,N,N’,N’-
tetramethylethylenediamine (TEMED, purity≥99%), bicinchoninic acid (BCA) kit, bovine serum 
albumin (BSA) (purity≥98%) were supplied by Sigma Aldrich. Human IgG was purchased by 
Octapharma (Gammanorm, purity≥99%). 
 
2.2.2. MONOLITHS PREPARATION 
Chitosan-based monoliths were prepared blending different ratios of chitosan (0–100% (wt per 
wt)) with PVA (0–50%) and GMA (10%) in acetic acid aqueous solution (1% v per v). The 
crosslinker agent, MBA, was also added (2% (wt per wt)) and different casting solutions were 
placed in glass tubes and stirred until homogeneous casting solutions were obtained. After the 
initiator and catalyst, TEMED (23 µL) and APS (40 µL) respectively, were added to promote the 
crosslinking process that occurred at 0 ºC during 30 min under stirring.  
The casting solutions were frozen at -80 ºC during 12 h and were lyophilized (Telstar cryodos-
50) until dry.
132,133,134,135
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2.2.3. MONOLITHS CHARACTERIZATION 
Chitosan-based monoliths morphology was investigated using scanning electron microscopy 
(SEM) in Hitachi S 2400 equipment with an accelerating voltage set to 15 kV. The samples 
were frozen and fractured in liquid nitrogen for cross-sectional analysis and gold coated before 
analysis. Chitosan-based monoliths porosity, average pore size diameter and surface area were 
determined by MIP (Micromeritics, autopore IV). Water fluxes were determined at 25 ºC and by 
varying the applied hydrostatic pressure (within 0–0.4 MPa) using a stainless steel high-
pressure cell (with an effective volume of 1.2 cm
3
). At least three measurements of distilled 
water flux were performed for each monolith. The permeability (Lp) of chitosan-based monoliths 
was obtained by the slope of linear relation between flux (F) and pressure (p), and is given by 
Darcy Law,
88
 represented by: 
 
        
          (Equation 2.1) 
 
The wet and dry densities were determined through the ratio of wet weight as well as dry weight 
of the chitosan-based monoliths with respect to their volume. The apparent density in g cm
-3
 
was calculated by the equation below as described by Tripathi et al.
118,119
  
 
  
 
 
 
  
 
   
          (Equation 2.2.) 
 
where W is the weight of monolith sample in grams, D is the diameter of the sample in cm and 
H is the thickness of the sample in cm. 
Uniaxial compression was used to determine the mechanical properties of the monoliths using 
tensile testing equipment (MINIMAT firmware v.3.1) at room temperature. Samples were 
prepared in a cylindrical shape (10 mm in diameter thickness). The length between clamps was 
set at 5 mm, the speed set to 1 mm min
-1
, a full scale load of 20 N and maximum extension of 
90 mm was used. The compression modulus was calculated from the slope of the linear portion 
of the stress-strain curve:
88
 
 
         
 
 
 
          (Equation 2.3) 
         
  
 
 
(Equation 2.4) 
 
where F is the applied force, A the cross sectional area, Δl is the change in length and L is the 
length between clamps. All samples were tested in dry state at room temperature. 
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2.2.4. MONOLITHS FUNCTIONALIZATION 
The chitosan-based monoliths followed two different activation strategies for ligand 22/8 
immobilization. The first one involved the introduction of reactive epoxy groups on monoliths by 
epoxy activation. CP (chitosan-poly(vinyl alcohol) monolith) and CG (chitosan-glycidyl 
methacrylate monolith) monoliths were covered with distilled water (10 mL), NaOH (72 µL, 0.1 
M) and epichlorohydrin (0.83 mL) and then incubated for 3 h at 35 ºC on a rotary shaker (140 
rpm). After incubation, the epoxy-activated chitosan-based monoliths were washed with distilled 
water (200 mL). The epoxy activation content was determined by adding sodium thiosulfate (3 
mL, 1.3 M) to 1 gram of epoxy-activated chitosan-based monoliths and incubating them at room 
temperature for 20 min. This mixture was neutralized with HCl (0.1 M) and the amount of HCl 
was registered. The volume of HCl added corresponded to the amount of hydroxyl ions 
released. The second strategy (Fig. 2.1) involved the use of plasma treatment which was 
carried out in a radio frequency plasma reactor (Plasma system FEMTO, version 5). Native 
chitosan-based monoliths were introduced in a plasma chamber which was thoroughly purged 
with a continuous flow of argon to reduce trace amounts of air and moisture. During the 
treatment, the argon flow was adjusted in order to keep a constant pressure of 0.3 Torr inside 
the chamber.
122
 A power of 60 W was applied over 5 min. At the end of the experiment the 
plasma chamber was ventilated and the activated samples were immediately introduced in an 
aqueous solution of 1 6-hexanediamine to be aminated. Activated chitosan-based monoliths 
reacted with an excess of 1 6-hexanediamine in water for 24 h at 45 ºC, and then thoroughly 
washed with water in order to remove residues of 1 6-hexanediamine which did not react. The 
extent of amination was determined using the Kaiser test.
88
 This test is a colorimetric assay to 
quantify free amine groups and is based on the reaction of ninhydrin with primary amines, which 
gives a characteristic dark blue color. To perform the Kaiser test, each following reagents i) 80% 
crystalline phenol in ethanol (w/v), ii) 2% aqueous solution of potassium cyanide (0.001 M) in 
pyridine (v/v) and iii) 5% ninhydrin in ethanol (w/v) were added (50 µl of each one) to the 
aminated chitosan-based monolith samples (1 mL). The samples were then placed in a water-
bath at 100 ºC during 5 min. The calibration curve was represented by standard solutions of 
glycine (0–5 µmol mL
-1
) and the absorbance measurements of the samples (diluted 1:18) were 
performed at 560 nm. For ligand 22/8 immobilization, an excess of ligand 22/8 (3 equiv. to the 
amination content, 530 µmol, 200 mg), was added to the aminated chitosan-based monolith 
samples (approximately 60 mg) in water–DMF (1:2). The volume of solvent used was sufficient 
to cover the chitosan-based monoliths, and the solution was incubated on a rotary shaker (140 
rpm) for 72 h at 85 ºC. The synthesis of ligand 22/8 followed the procedure described by Teng 
et al.
113
 and Barroso et.al.
88
 The synthesis of ligand 22/8 was confirmed by 
1
H and C-NMR and 
FT-IR. Functionalized chitosan-based monolith samples were then washed with water–DMF 
(1:2) until the absorbance at 270 nm was zero. 
In order to assure a complete exclusion of non-absorbed ligands into and onto chitosan-based 
monoliths, functionalized samples were introduced in a Varian column (a reservoir with 3 mL of 
capacity) and were submitted to several washes with water–DMF (1:2) and to CIP. The CIP 
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consisted of washing functionalized chitosan-based monoliths with NaOH (1 M) until the 
absorbance at 270 nm be zero, with water (10 mL), then with regeneration buffer (NaOH 0.1M 
in 30% of isopropanol) until the absorbance at 270 nm be zero, and finally, again with distilled 
water (10 mL). The functionalized chitosan-based monoliths were equilibrated with sodium 
phosphate buffer (50 mM, pH 8.0) and sodium citrate buffer (50 mM, pH 3.0) until the 
absorbance at 270 nm be zero. The extinction coefficient of ligand 22/8 was determined at its 
maximum absorbance wavelength (ɛ270 = 10.72 L g
-1
 cm
-1
), respectively. The ligand 22/8 
density was determined by subtracting the amount of ligand contained in all the washing liquors 
from the initial ligand used in the immobilization step. The chitosan-based monoliths containing 
ligand 22/8 were characterized in terms of morphological and mechanical properties as referred 
previously. 
 
 
Figure 2.1- Schematic representation showing the functionalization strategy of chitosan-based monoliths 
with ligand 22/8 using non-thermal plasma surface activation. 
 
2.2.5. STATIC PARTITION EQUILIBRIUM EXPERIMENTS 
Partition equilibrium experiments were performed in a batch system as described by Barroso et 
al.
88
 The adsorption of hIgG and BSA on the chitosan-based monoliths was investigated using a 
sample of native and functionalized chitosan-based (10 mg) monoliths varying the concentration 
of hIgG and BSA (0.0–45 mg mL
-1
, 400 µL) in phosphate buffer (50 mM, pH 8.0) solutions. All 
experiments were conducted in duplicates at 25 ºC, at a stirring rate of 200 rpm during 12 h. At 
the end of this period, the native and functionalized chitosan-based monoliths were removed 
from the medium. The amount of adsorbed hIgG and BSA was determined by measuring the 
initial and final concentrations of hIgG within the adsorption medium. A calibration curve was 
prepared using hIgG and BSA in phosphate buffer solutions (50 mM, pH 8.0) (0.0–45 mg mL
-1
). 
The concentration of protein was measured at 280 nm on a microplate reader (Tecan Infinite 
F200, filter, l = 280 nm). The adsorption phenomenon followed the Langmuir–Freundlich 
model
102,136
 and it was represented by: 
 
  
      
  
      
  
(Equation 2.5) 
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where Kd is the apparent dissociation constant (M) that includes contributions from ligand 
binding to support, Qm is the maximum binding capacity (mg protein g
-1
 support), C is the 
concentration of protein in the liquid at the equilibrium (M) and n represents the Langmuir–
Freundlich coefficient. 
 
2.2.6. FRONTAL ANALYSIS-BREAKTHROUGH CURVES AND BINDING CAPACITY 
The dynamic loading capacity of the packed columns with native and functionalized chitosan-
based monoliths was determined using frontal analysis according with the equation below.
6
 
 
  
  
                
 
(Equation 2.6) 
 
where Q corresponds to the estimated adsorbent capacity and Ve corresponds to the elution 
volume. 
This technique consisted in loading hIgG and BSA solutions (8 mL, 0.5 mg mL
-1
) in sodium 
phosphate buffer (50 mM, pH 8.0) through the equilibrated monolithic packed columns at 
different flow rates, 1 and 2 mL min
-1
 until the protein concentration of the output and input 
streams were identical. Then, packed monolithic columns were washed with phosphate buffer 
(50 mM, pH 8.0) and the bound protein was eluted with sodium citrate buffer (50 mM, pH 3.0). 
Each collected millilitre during loading, washing and elution steps were analysed by absorbance 
at 280 nm, using a microplate reader, in order to estimate the amount of protein bounded and 
eluted. 
 
2.2.7. CHROMATOGRAPHIC EXPERIMENTS 
In order to estimate the capacity of functionalized chitosan-based monoliths, Varian columns 
(with a capacity of 3 mL and an effective volume of 1.2 cm
3
) were packed with these polymeric 
affinity structures. The columns were connected to a peristaltic pump using rubber tubing in 
order to allow flow control. The affinity capturing experiments were performed in a step-wise 
adsorption–desorption process by switching eluents at room temperature and at atmospheric 
pressure. Packed columns with functionalized chitosan-based monoliths were loaded with 1 mL 
of hIgG and BSA solution (5 mg mL
-1
) in order to estimate the capacity of the columns for each 
protein. Then, columns were washed with sodium phosphate buffer (50 mM, pH 8.0) until the 
absorbance measured at 280 nm reached ≤0.005, in order to remove all the protein physically 
adsorbed. The bound protein was eluted and recovered with sodium citrate buffer (50 mM, pH 
3.0). Packed columns with functionalized chitosan-based monoliths were then regenerated as 
described above in order to be reused. These chromatographic experiments were repeated 
during 3 cycles and one more after auto-claving in order to evaluate the column capacity over 
time. The total amount of IgG bound, eluted and regenerated from the chitosan-based monoliths 
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was initially determined by absorbance measured at 280 nm and by the BCA (microplate reader 
assay). As the results were consistent only absorbance measured at 280 nm was further used 
for protein quantification. 
 
2.2.8. PURIFICATION OF MONOCLONAL ANTIBODIES FROM MAMMALIAN CRUDE 
EXTRACTS 
In order to evaluate the possibility to capture directly antibodies from non-clarified crude 
extracts, packed columns with native and functionalized CP monoliths were loaded with a 
mammalian crude extract solution (1 mL, 1.3 mg of total protein per millilitre). After crude extract 
loading, packed columns were washed with the sodium phosphate buffer (15 mL, 50 mM, pH 
8.0) until the absorbance measured at 280 nm reached ≤0.005, and the bound protein was after 
eluted and recovered with sodium citrate buffer (50 mM, pH 3.0). All collected samples were 
analysed by the BCA assay in order to quantify the amount of total protein bound and eluted 
from the solid support. The BCA assay consists in adding the BCA working reagent (200 µL) to 
the samples (25 µL). The microplates were incubated in the dark for 30 min at 37ºC. A standard 
curve was determined for each assay (200–1000 µg mL
-1
). SDS-PAGE was performed on 
acrylamide gel (12.5%) in Tris-Glycine buffer system pH 8.3. Electrophoresis apparatus (from 
BIO-RAD) was connected with power supply at 120 V, 190 mA for 1 h. The gel was revealed 
using a silver staining kit from BIO-RAD. 
 
2.3. RESULTS AND DISCUSSION 
2.3.1. PREPARATION AND CHARACTERIZATION OF NATIVE CHITOSAN-BASED 
MONOLITHS 
Supports for protein separation must ideally possess high hydrophilicity, chemical and 
mechanical resistance, a narrow pore size distribution, as well as enough reactive functional 
groups for ligand attachment.
4,40
 In this work, chitosan-based monoliths were prepared by a 
combination of freezing and lyophilization methods and further evaluated according to their 
morphological and mechanical properties. It is known that the macromolecular morphology of 
monoliths is influenced by the conditions employed during their preparation - in general, the 
freezing and lyophilization processes generate open pore microstructures with a high degree of 
interconnecting pores in the composite materials. Large pores and high interconnectivities 
contribute to high fluxes across the materials and faster bioseparation processes.
120
 
Native monoliths prepared only with chitosan (CHT_N) present regular and spherical pores 
(data not shown); the addition of PVA facilitates the formation of monoliths (CP_N) with large 
and semi-spherical pores (Fig. 2.2 A), while the copolymerization of GMA (CG_N) generates 
even larger and more elongated pores (Fig. 2.2 B). 
 
CHAPTER 2: BIOINSPIRED AND SUSTAINABLE CHITOSAN-BASED MONOLITHS FOR 
ANTIBODY CAPTURE AND RELEASE 
23 
  
 
Figure 2.2 - SEM images of chitosan (CHT) based-monoliths before and after functionalization with the 
ligand 22/8: (A) CP_N, native monolith prepared from chitosan and poly(vinyl alcohol )(CP); (B) CG_N, 
native monolith prepared from chitosan and glycidyl methacrylate (CG); (C) CP_22/8, CP monolith 
functionalized with ligand 22/8 and (D) CG_22/8, CG monolith functionalized with ligand 22/8. All the 
images have a magnification of 300 and the scale bar in white indicates 10 µm. 
 
In order to look deeper into the porous network prepared, analysis by MIP was performed. The 
average pore size diameter for CHT_N monoliths is 17 µm, while those of CP_N and CG_N 
monoliths are 53±5 and 123±5 µm, respectively (Table 1), which corroborate the conclusions 
taken from SEM image analysis.  The porosity values are similar for all chitosan-based 
monoliths, varying between (70–75)±5%, which was expected due to the constant temperature 
conditions employed during monolith preparation. Typically, the pore size decreases with the 
decrease of freezing temperature.
120,121
 During the freezing process, water ice crystals are 
formed and separate from the solutes which will be confined to the interstitial regions between 
ice crystals. Large ice crystal formation is expected in less viscous casting solutions and higher 
freezing temperatures, and the opposite is also true.
121
 In this work, chitosan-based casting 
solutions were frozen at -80 ºC, a temperature at which a low average pore size diameter-
between 20 and 100 µm is obtained.
40,121
 This average pore size diameter is within the range of 
interest for the purpose of the work. Concerning bioseparation applications, monoliths with large 
pores and high porosities are required to enable the fast permeation of cellular components and 
proteins present in crude samples.
132
 Therefore a delicate balance between pore size diameter, 
porosity and surface area is needed during monolith design. If monoliths have larger pores 
(≥150 µm) the surface area available for further functionalization decreases, leading to a low 
density of the affinity ligand.
40,121,135
 Also, a decrease of specific surface area with increasing 
average pore size diameter is expected.  
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Table 2.1 - Morphological and mechanical characterization of chitosan-based monoliths before and after 
functionalization with ligand 22/8. All data was obtained from triplicated measurements.  
 
Monolith 
Average 
pore
 
size 
diameter
 
(µm)
 a
 
Porosity
 
(%)
a
 
Surface 
Area
 
(m
2 
g
-1
)
 a
 
 
Permeability 
(L m
-2
 h
-1
 atm
-1
) 
 
Density 
×10
-3
 (g cm
-3
) 
Compressive 
Modulus (kPa) 
Dry Wet Dry Wet 
CP_N 53±5 70±5 1.3±0.1 294±15 4±2 165±10 0.41±0.5 0.2±5 
CG_N 123±5 75±5 0.9±0.1 390±5 3±2 177±5 0.26±0.5 n.a
b
 
CP_22/8 45±5 68±5 2.3±0.2 123±15 3±2 146±5 14±5 9±4 
CG_22/8 85±10 60±10 1.5±0.2 323±10 5±2 131±10 8±2 4±2 
a
: Determined for dried monoliths by mercury porosimetry analysis. 
b
: The mechanical assay was impossible to perform due to high swelling of CG_N 
 
The monoliths inner surface area (total pore area) is within the range of values of similar 3D 
porous structures reported in the literature.
132,133,134
 The permeability and the compressive 
modulus of native chitosan-based monoliths are included in Table 2.1. The highest permeability 
value is registered to CG_N monolith, 390 L m
-2
 h
-1
 atm
-1
, followed by CP_N and CHT_N 
monoliths with permeability values of 294 and 142 L m
-2
 h
-1
 atm
-1
, respectively. These results 
indicate a clear concordance between the permeability of the materials and their morphological 
properties, and also a good interconnectivity between the pores. The density of the dried and 
wet chitosan-based monoliths (Table 2.1) was calculated by measuring the weight and 
dimensions of the prepared materials. Dried native chitosan-based monoliths present similar 
values of density. Wet native monoliths also showed similar densities although 50 times greater 
than the dried ones, due to their huge water uptake ability. The compressive mechanical 
properties were studied by uniaxial compression measurements also under dry and hydrated 
conditions. The compression modulus (kPa), given by the slope of stress–strain curves, 
translates the material stiffness (Table 2.1). In general, a high compression modulus indicates a 
stiffer material.
136
 Native CHT-based monoliths present lower compression modulus values 
when compared to the functionalized materials. In more detail, CP_N monoliths at different 
stages, wet or dry, always present higher values of compression modulus than CG ones. The 
hydrated CG_N monolith exhibits a huge swelling and consequently becomes fragile, losing the 
initial integrity. These results are consistent with the morphological and mechanical properties 
previously discussed - supports with lower average pore size diameter and porosity are more 
rigid and present higher compression modulus. It is also known that the compression modulus 
of porous structures prepared at higher freezing temperatures (e.g. -30 and -20 ºC) are lower 
than those prepared at -80 ºC, due to the smaller pore size attained at this temperature.
132,133,134
 
Another factor that can influence the support stiffness is the water absorption ability, and the 
proof of it is the dramatic decrease of mechanical properties observed for monoliths in the 
hydrated sate. 
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2.3.2 PREPARATION AND CHARACTERIZATION OF AFFINITY CHITOSAN-BASED 
MONOLITHS 
Several methodologies for affinity monoliths activation and ligand coupling have been described 
by diverse authors.
4,40
 Herein the functionalization of chitosan monoliths with a triazine-based 
ligand (ligand 22/8) followed two different strategies. The first one was based on the optimized 
procedure for agarose
113
 and also applied to cellulose membranes
88
 due to the similarity in the 
chemical composition of these supports, namely the high content of free hydroxyl groups.  
Native chitosan-based monoliths were activated with epichlorohydrin in order to add epoxide 
functionality for subsequent amination. As this epoxyactivation procedure occurs through the 
reaction of epichlorohydrin with free OH groups, the density and availability of OH groups 
determine the extension of the epoxide functionality achieved. The epoxy activation yielded 
densities for CHT, CP and CG were 187±51, 226±72 and 364±100 µmol g
-1
 of moist monolith, 
respectively. These epoxy densities are significantly higher than those reported in the literature 
for agarose (50 µmol of epoxy per gram of moist weight gel)
113
 and for cellulose membranes 
(130±10 µmol of epoxy per gram of moist membrane)
88
. The second strategy consisted of the 
activation of native chitosan-based monoliths by argon (Ar)-plasma treatment. Plasma treatment 
is a solvent free technique which allows the surface modification according to the gas and 
power applied.
122
 In this work, Ar-plasma treatment introduced radicals onto the chitosan 
materials for subsequent reaction with 1,6-diaminohexane in batch system out of plasma. The 
latter acts as a spacer arm
112,113
  between the surface of the epoxy or plasma activated 
chitosan-based monoliths and the small biomimetic ligand 22/8, contributing to an optimal 
interaction between the ligand and the target protein (Fig. 2.1). The amination values achieved 
were significantly higher for all chitosan-based scaffolds activated by plasma treatment (Table 
2.2).  
 
Table 2.2 - Functionalization of monoliths with amine groups using either the traditional or the plasma 
activation routes and surface density of affinity ligand achieved by non-thermal plasma activation of the 
supports. 
 
Monolith 
Epoxy activation Plasma activation Plasma activation 
[NH2] 
(µmol g
-1
 support) 
[NH2] 
(µmol g
-1
 support) 
Ligand 22/8 immobilization         
(µmol g
-1
 support) 
CP 226 ± 72 1747 ± 47 910 ± 17 
CG 364 ± 100 906 ± 246 667 ± 24 
 
The maximum amount of amines introduced using epoxy activated chitosan-based monoliths 
was 364±50 µmol g
-1
 support. In marked contrast, using the new approach based on plasma 
surface activation this value increased almost 5-fold (1747±47 µmol g
-1
 support). Due to these 
remarkable yields of amination, chitosan-based monoliths activated by plasma treatment were 
subsequently coupled with ligand 22/8. This ligand was prepared following the procedure 
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described by Lowe and colleagues
113
 and was immobilized onto the aminated chitosan-based 
monoliths still containing a labile chloride on the triazine ring for nucleophilic substitution. 
Different yields of ligand immobilization were obtained (Table 2.2), according to the monolith 
materials. Although the highest value of ligand immobilization was obtained for the CP monolith, 
910±17 µmol g
-1
 support, CG monolith also presented a very high functionalization ratio, 677±24 
µmol g
-1
 support. The different ligand densities on CP and CG monoliths can be related with the 
surface area available in each support. CP monoliths have a smaller pore size diameter and 
porosity than CG monoliths suggesting that CP supports have higher surface area available for 
further functionalization. These facts contributed to a decrease of possible active sites in CG 
monoliths, and consequently to lower ligand density compared to the CP ones. Herein, the 
density of ligand 22/8 immobilized in chitosan-based monoliths was 10-fold the value reported 
for ligand 22/8 immobilized in agarose beads,
10,113
 70-fold on cellulose membranes,
88
 and less 
than 2-fold on magnetic nanoparticles.
114
 It can also be noted that, in general, the density of 
immobilized ligand 22/8 is quite high when compared to the values obtained for immobilized 
natural ligands.
47,129
 To the best of our knowledge, this is the first report on the preparation of 
affinity monoliths with such a high ligand density. After ligand 22/8 immobilization, the 
morphological and mechanical properties of chitosan-based monoliths were evaluated. SEM 
images represented in Fig. 2.2 C and D show that the porous network and architecture did not 
change significantly after the functionalization procedure proving the potential of the new 
strategy developed in this work. The average pore size diameter, porosity and surface area 
values obtained for affinity CP_22/8 and CG_22/8 monoliths registered in Table 2.1 were kept 
approximately within the combined experimental errors. Permeability values obtained for CP 
and CG monoliths decreased from 294 to 123 L m
-2
 h
-1
 atm
-1
 for CP_22/8, and from 390 to 323 
L m
-2
 h
-1
 atm
-1
 for CG_22/8 monoliths. The flow reduction can be explained by the presence of 
the affinity ligand which confers a hydrophobic character to the supports. However, it should be 
noted that the permeability still shows the target values for separation processes whilst allowing 
enough residence time for the contact between the protein and the support.
112
 The apparent 
density of dried affinity monolithic supports did not change compared to the native ones at the 
same conditions, while wet monoliths showed a slight increase. 
After functionalization, CP_22/8 and CG_22/8 registered a decrease in density values which 
can be also explained by the hydrophobic nature of ligand 22/8 leading to a reduction in water 
uptake capability. The compressive modulus increased (~10-fold) for all monoliths after ligand 
coupling (refer to Table 2.1). The improvement of the monolith mechanical properties whether in 
dry or wet conditions was expected as the incorporation of a synthetic ligand confers rigidity and 
robustness to the monoliths. Therefore, the sustainable functionalization strategy of the 
monoliths based on plasma activation, and further ligand 22/8 coupling is able to keep most 
morphological properties of the native supports while improving their mechanical properties.  
In order to evaluate the stability of the affinity monoliths at typical operating conditions used 
during purification processes, monoliths were incubated at several pH solutions (from pH 1 to 
12), corresponding to those employed in equilibration, elution, regeneration and cleaning-in-
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place of chromatographic matrices. The amount of ligand released from the support was 
monitored (Fig. 2.3). The maximum amount of ligand 22/8 released from CP_22/8 and CG_22/8 
was 12% and 7%, after 4 and 2 h of  incubation, respectively (Fig. 2.3 A and C). In particular, at 
the pH conditions used in the binding and elution of antibodies from ligand 22/8 supports, pH 3 
and 8 respectively, the greatest amount of ligand leaching was observed after 2 and 4 h, for 
CP_22/8 and CG_22/8, respectively. In general, the maximum time of monolith exposure to 
these conditions during a typical purification run is 30 min, far below the threshold time for 
ligand leaching, which was only observed after 2 h of exposure. On the other hand, the highest 
loss of ligand from CP_22/8 and CG_22/8 occurs with sodium hydroxide solutions after 2 h (Fig. 
2.3 B and D). Nevertheless the maximum contact time of each functionalized monolith at these 
harsh conditions (CIP conditions) is about 10–20 min, the time at which no ligand release was 
registered. 
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Figure 2.3 - Stability evaluation of CP_22/8 (A and B) and CG_22/8 (C and D) monoliths immersed over 
12 h in solutions typically used during cleaning-in-place (CIP) procedures, including solutions with pH 
values between 1 and 12. All data was obtained from duplicated measurements with errors of ±5. 
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2.3.3. EVALUATION OF AFFINITY MONOLITHS FOR ANTIBODY PURIFICATION 
To evaluate the affinity constants for hIgG and BSA on native and functionalized chitosan-based 
monoliths, static partition equilibrium measurements were performed in duplicate. To attain the 
equilibrium between proteins and affinity supports,
115
 partition equilibrium studies were 
performed in a batch system over 12 h, varying the protein concentration. 
The experimental data was fitted using a Langmuir–Freundlich isotherm that is the indicated 
model for porous structures with heterogeneous morphology.
102
 Different affinity constants (Ka), 
theoretical maximum capacity (Qmax) and Langmuir–Freundlich coefficients (n) were obtained 
(Fig. 2.4) with errors of ±0.5, ±40.0 and ±0.1, respectively. The affinity monoliths always 
presented higher values of Ka and Qmax (14 and 3-fold, respectively) when compared to the 
native ones. The CG_22/8 monolith registered the highest value of Ka and Qmax, 4.0×10
4
 M
-1
 
and 590 mg hIgG g
-1
 support, respectively. Calculated Ka values exhibit the same order of 
magnitude usually obtained for similar affinity devices fitted with Langmuir–Freundlich 
isotherm.
136,137,138
 In addition, Ka values obtained for CP_22/8 and CG_22/8 are an order of 
magnitude lower than the Ka values reported for agarose,
113
 magnetic nanoparticles
114
 and 
cellulose membranes
88
 functionalized with ligand 22/8 and fitted with a Langmuir isotherm 
model. However, it should be remarked that values of Ka in a range between 10
4
 and 10
6
 M
-1
 
indicate a medium affinity interaction, considered optimal for bioseparation processes while 
facilitating protein recovery.
6
 The values of Qmax for CP_22/8 and CG_22/8, 475 and 590 mg 
hIgG g
-1
 support respectively, are 2-fold those for agarose
113
 and magnetic particles
114
 
functionalized with ligand 22/8, and very close to the one obtained for cellulose membrane.
88
  
 
 
Figure 2.4 - Langmuir–Freundlich adsorption isotherms for (A) CP and (B) CG monoliths: (♦) native and 
(▲) functionalized. (C) Summarizes the estimated parameters of the Langmuir–Freundlich isotherms and 
standard errors for CP and CG monoliths before and after functionalization with ligand 22/8. 
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Values of Langmuir–Freundlich coefficients higher than 1 (n>1) were registered for all 
functionalized monoliths suggesting a positive cooperativity in binding (attractive forces due to 
lateral interactions) and a heterogeneous nature of protein adsorption. The cooperativity 
depends on the macromolecular nature and multiple functional groups, which usually results in 
multiple interactions.
102,136,139
 It should be noted that the same adsorption assays were 
performed with bovine serum albumin (BSA), a model contaminant protein of antibodies in 
serum and cell culture supernatants and none of the tested isotherms could fit the experimental 
data. This result indicates a nonspecific adsorption of BSA. 
The dynamic binding capacity of a stationary phase is one of the most critical factors to evaluate 
its chromatographic performance. To assess the mass transfer and dynamic binding properties 
of the affinity monoliths, breakthrough curves of purified hIgG were measured in duplicates for 
two flow rates (Fig. 2.5), as the binding capacity and elution efficiency of supports are affected 
by the residence time on the monolithic chromatographic column. 
Both supports, CP_22/8 and CG_22/8, duplicated the binding and elution capacities when the 
flow rate decreased from 2 to 1 mL min
-1
 (Fig. 2.5). The estimated binding capacities for 
CP_22/8 and CG_22/8 were 57±10 and 15±5 mg hIgG g
-1
 support respectively, when using a 
flow rate of 2 mL min
-1
 and 110±15 and 26±8 mg hIgG g
-1
 support for a flow rate of 1 mL min
-1
, 
respectively. The elution capacity for CP_22/8 and CG_22/8 increased from 40 to 90±5% and 
from 30 to 60±5% when the flow rate decreased from 2 to 1 mL min
-1
.  
 
 
Figure 2.5 - Breakthrough profiles for human IgG upon (A) CP_22/8 and (B) CG_22/8 monoliths at 
different flow rates: (♦) 1 mL min
-1
 and (▲) 2 mL min
-1
. All data was obtained from duplicated 
measurements with errors of ±0.05. 
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2.3.4. OPTIMIZATION OF AN AFFINITY MONOLITH FOR ANTIBODY RECOVERY 
Due to the promising morphological, mechanical and physicochemical properties, high stability 
at different pH conditions and high static and dynamic binding capacities towards hIgG, CP 
monoliths were selected for the optimization of IgG purification process. In order to evaluate and 
enhance the efficiency of affinity CP monoliths for antibody capture and recovery, three 
consecutive chromatographic cycles and a fourth one after monolith autoclaving (After_AC) 
were performed in duplicates at two different flow rates, 2 and 1 mL min
-1
. BSA, the model 
contaminant, was used as a control in the same experiments in order to evaluate the selectivity 
and affinity of CP_N and CP_22/8 towards hIgG. CP monoliths exhibited different performances 
on capturing and eluting hIgG and BSA (Fig. 2.6 and Fig. 2.7). In detail, Fig. 2.6 A and B show 
that CP_N has approximately the same low capacity to capture and elute hIgG and BSA over 
the four cycles, suggesting residual non-specific interactions between the support and the 
proteins. In marked contrast, the functionalized CP_22/8 monoliths showed a substantial 
increase in binding and elution capacity towards hIgG (Fig. 2.6 C) while only a negligible 
amount of BSA was retained (Fig. 2.6 D). Although presenting affinity and selectivity to hIgG 
molecule, the affinity monoliths lost their capacity for re-utilization, especially after autoclaving 
which is translated by a slight decrease in the bind and elution values. At these operational 
conditions, CP_22/8 loses around 20% of capacity after 3 chromatographic cycles, and 50% 
after autoclaving (Fig. 2.6 C). 
 
 
Figure 2.6 - Evaluation of chromatographic performance for (A, B) native and (C, D) functionalized CP 
monoliths using pure IgG and BSA solutions, respectively. The chromatographic procedures (bind, elution 
and regeneration steps) were performed consecutively along four cycles at a flow rate of 2 mL min
-1
. The 
last cycle was performed after autoclaving (After_AC). 
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Figure 2.7 - Evaluation of chromatographic performance for (A, B) native and (C, D) functionalized CP 
monoliths using pure IgG and BSA solutions, respectively. The chromatographic procedures (bind, elution 
and regeneration steps) were performed consecutively along four cycles at a flow rate of 1 mL min
-1
. The 
last cycle was performed after autoclaving (After_AC). 
 
On the other hand, only 25% of the captured hIgG was recovered in the elution step, whereas 
75% was washed during the regeneration step under extremely harsh conditions deleterious for 
the protein. Subsequent assays, performed at a lower flow rate (1 mL min
-1
), allowed an 
increase of the residence time and the achievement of affinity equilibrium between the attached 
ligand and the receptor in the solution (Fig. 2.7). Comparing the chromatographic runs showed 
in Fig. 2.6 C and 2.7 C, it is clear that CP_22/8 exhibited a great improvement in the binding 
and elution of hIgG as only reducing the flow rate to a half led to an over 3-fold increase of 
captured and eluted hIgG, 150±10 and 135±5 mg g
-1
 support, respectively. Consequently, the 
amount of hIgG recovered during the regeneration step was significantly reduced, 10±5 mg g
-1
 
support. The bind and elution capacity of the monoliths was maintained with a slight decrease 
after autoclaving (a decrease of 15%). This remarkable performance of monoliths for recovering 
IgG using the flow rate of 1 mL min
-1
 led to results that depart considerably from the reported 
outcomes obtained with affinity membranes, particles and other monoliths used in antibody 
purification.
88,113,114,135,140,141
 
The most critical part of the study was to evaluate the direct capture of monoclonal antibodies 
(mAbs) from a non-clarified homogenate.  
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Figure 2.8 - Chromatogram of mAbs purification from crude extract using (A) CP monoliths: (♦) native and 
(▲) functionalized, at a flow rate of 1 mL min
-1
. The fractions collected included the flowthrough (F.T.) 
followed by the washing and elution steps. The acrylamide gel from SDS-PAGE performed with the 
fractions collected during the mAbs purification (B): lane 1 corresponds to the molecular weight marker, 
lane 2 represents the loading, lane 3 is the flowthrough, lane 4 corresponds to the first wash (phosphate 
buffer (50 mM, pH 8.0)), and lane 5 and lane 6 are the first and second elution fractions (sodium citrate 
buffer (50 mM, pH 3.0)). 
 
Fig. 2.8 presents the chromatogram of non-clarified crude extract of mAbs using CP_N and 
CP_22/8 monoliths (A) as well as the SDS-PAGE gel,
142,143
 revealed using a silver staining kit 
from BIO-RAD, obtained from the recovered samples during the chromatographic experiment 
(B). The chromatogram obtained from crude extract sample shows that CP_N did not capture 
any protein (Fig. 2.8 A) while the affinity monolith CP_22/8 captured 61±10% of mAbs from a 
mammalian crude extract with initially 1.3 mg of total protein per millilitre, and eluted 80±8% of 
bounded protein. When considering the purity of the samples, the flow-through (3) and the wash 
(4) contained contaminant proteins and antibody, while the elution fractions (5, 6) showed a 
high purity of the antibody (estimated as 98% by ImageJ analysis). These results confirm the 
efficacy of CP_22/8 in capturing and eluting mAbs with great purity from a real crude extract. 
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2.4. CONCLUDING REMARKS 
Herein, it was developed a strategy to prepare affinity chitosan-based monoliths by combining a 
freeze drying process with surface activation by plasma treatment to modify them with a robust 
biomimetic affinity ligand, previously reported as an artificial Protein A, for antibody purification. 
It was demonstrated that the morphological and mechanical properties of monoliths can be 
tuned according to the polymer blend composition, while the new strategy to couple the affinity 
ligand was able to improve the chemical and physical stability towards the final application. The 
functionalization strategy based on plasma activation proved to be safer and more efficient than 
traditional activation procedures which involve multiple steps and numerous organic solvents. 
The main practical advantages of the strategy described are that by fast and solventless plasma 
activation of different substrates, a direct procedure of functionalization could be applied leading 
to robust affinity monoliths able to selectively capture and elute antibodies even from 
homogenate crude extracts. Preliminary results of mAbs capture from a non-clarified 
homogenate suggested that CP_22/8 is able to recover mAbs with 98% of purity. 
A straightforward extension of the materials and functionalization approach based on plasma 
technology herein described can be envisaged for the production of polymeric devices with 
different geometries and properties, and for the conjugation of a wide range of biological and 
artificial receptors. The properties of affinity polymeric devices can be tuned towards different 
applications in addition to the example here presented. For instance, they can find applications 
on the pre-concentration and solid-phase extraction of compounds, on organo- and bio-catalysis 
processes, on analytical and biosensing systems, on tissue engineering and as supports for 
cellular growth and expansion. 
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SUMMARY 
 
This work presents a sustainable strategy for improving the capture of antibodies by affinity 
chromatography. A novel biomimetic ligand (4-((4-chloro-6-(3-hydroxyphenoxy)-1,3,5-triazin-2-
yl)oxy)naphthalen-1-ol) (TPN-BM) was synthesized using a greener and simple protocol to 
overcome solubility limitations associated to ligand (2-(3-aminophenol)-6-(4-amino-1-naphthol)-
4-chloro-s-triazine (22/8), known as artificial Protein A. Furthermore, its subsequent 
immobilization on chitosan-based monoliths induced by plasma surface activation allowed the 
design of a fast and efficient chromatographic platform for IgG purification. The TPN-BM 
functionalized monoliths exhibited high binding capacity (160±10 mg IgG per gram of support), 
and a selective capture of monoclonal antibodies directly from mammalian crude extracts in 
85±5% yield and 98% of purity. The synthesis of ligand TPN-BM and the routes followed for 
monoliths preparation and functionalization were inspired in the green chemistry principles 
allowing the reduction of processing time, solvents and purification steps involved, turning the 
integrated system attractive from an economical and chemical point of view. 
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3.1. INTRODUCTION 
The ability to produce substantial quantities of pure, safe and efficacious therapeutic proteins 
from isolated genes is an on-going challenge for the biotechnology industry.
144
 The impact of 
cost-containment in healthcare management, environmental and safety legislation together with 
the imminent appearance of generic biopharmaceuticals, is likely to drive the industry towards 
the introduction of high throughput, cost-effective and flexible manufacturing processes.
11,144
 
Highly selective techniques, such as affinity chromatography, play a crucial role in downstream 
processing.
11,145
 However, there is still scope for improvement of the affinity ligands and the 
chromatographic supports employed in this process. 
The majority of the affinity adsorbents currently adopted is based on natural biological ligands 
such as proteins A, G and L which present high affinity to IgG-Fc and IgG-Fab.
4
 However, these 
biological ligands tend to be fragile and extremely expensive to produce and optimize. Thus, a 
strong effort has been made by manufacturers and researchers to find alternative ligands with 
improved capacity and chemical stability that could offer similar selectivity at a lower cost.
4,146,147
 
In recent years, special attention has focused on different biomimetic approaches using 
synthetic affinity ligands based on the triazine scaffold,
144
 ´one-pot´ multi-component reaction,
12
 
boronic acids
24
 and small peptides.
148
 Triazine-based ligands are the older generation of the 
affinity biomimetic ligands however, they are still ideally suited for the purification of high value 
biopharmaceutical proteins since they are inexpensive, chemically defined, nontoxic, and 
contain no fissile bonds.
11,144
 Also, these ligands are resistant to both chemical and biological 
degradation, are sterilizable, can be cleaned in situ and readily immobilized to yield selective 
affinity adsorbents with workable capacities for their complementary proteins.
4,145
 Some of these 
are already commercially available and offer excellent selectivity, high binding capacities and 
chemical stability.
146,147
 The design and development of such ligands has been greatly boosted 
by an increasing access to structural data, the advances in computer-assisted molecular 
design, and by combinatorial chemistry coupled to high throughput screening methodologies.
4,11
 
These approaches have been used to obtain ligands that mimic protein A,
138,149
 being ligand 
22/8 the most popular for the purification of hIgG
150
 and monoclonal antibodies from either 
simple and complex media. This ligand has been immobilized on different supports such as, 
agarose,
11
 magnetic particles,
114
 cellulose
88
 and chitosan-based monoliths.
82
 However, despite 
of its high performance for antibody purification, this ligand presents low solubility in most 
common polar and non-polar solvents, becoming hard to manipulate.
150
 In an attempt to 
overcome these drawbacks, this work presents the synthesis and characterization of a new 
triazine-based biomimetic ligand (TPN-BM) and the evaluation of its performance for antibody 
purification. 
Ligand TPN-BM is structurally similar to ligand 22/8, where the amino groups attached to the 
triazine core were replaced by ether groups. The core substituents from ligand 22/8 were 
maintained to ensure IgG recognition. (Fig. 3.1) The synthesis of this novel ligand was inspired 
in the principles of green chemistry,
151
 which seeks reinvention of production routes capable of 
minimize the inherent cost and wastes as well as the elimination of hazardous 
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compounds/solvents during their conception. Therefore, TPN-BM was designed in order to save 
time and energy consumption and to reduce solvents and purification steps. 
 
 
 
 
Figure 3.1 - Chemical structures of ligand 22/8 and TPN-BM. 
 
Monolithic supports based on chitosan and activated by solvent-free plasma treatment,
82,122
 as 
described in Chapter 2, were selected as the best stationary phases for ligand attachment by 
representing the greener option among the diversity of matrices tested.
11,82,88,114,150
 Taking 
advantage of the best available chromatographic tools, this work envisages the development of 
an integrated green “bottom-up” strategy to produce affinity chromatographic devices through 
the introduction of a new optimized synthetic affinity ligand, and its immobilization on a chitosan-
based monolith by solvent-free plasma treatment. Having considered the main issues of an 
affinity separation process as well as the need to design it according to restricted chemical 
regulations, a new low cost and sustainable approach to purify antibodies is proposed. 
 
3.2. EXPERIMENTAL AND METHODS 
3.2.1. MATERIALS 
Ammonium persulphate (purity≥98%), citric acid (purity≥99%), sodium hydrogen phosphate 
monobasic (pro analysis), disodium hydrogen phosphate dibasic (pro analysis), disodium 
tetraborate, ethanol absolute and sodium citrate dihydrate were purchased from Merck. 
Isopropanol and sodium bicarbonate were purchased from Riedel-de-Haën. Acetone 
(purity≥99%), and ethyl acetate were supplied by Roth. Acetic acid (purity≥99%), caproic acid, 
1,4-dihydroxynaphthalen (purity≥99%), cyanuric chloride (purity≥98%), 1,6-hexanediamine 
(purity≥98%), diisopropylethylamine, N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), 
tetrahydrofuran (THF), ninhydrin, potassium cyanide, pyridine, sodium hydroxide (purity≥99%) 
and resorcinol (purity≥99%) were purchased from Sigma Aldrich. Chitosan (75~85% 
deacetylated, medium molecular weight), poly(vinyl alcohol) (purity≈99%), 
N,Nmethylenebisacrylamide (MBAm, purity≥85%), tetramethylethylenediamine (TEMED) 
(purity≈99%), bicinchoninic acid (BCA) kit, bovine serum albumin (BSA) (purity≥98%) were 
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supplied by Sigma Aldrich. Human IgG was purchased by Octapharma (Gammanorm, 
purity≥99%). 
 
3.2.2. LIGAND SYNTHESIS AND CHARACTERIZATION 
The synthesis of ligands 3-((4,6-dichloro-1,3,5-triazin-2-yl)oxy)phenol (TP-BM) and 4-((4-chloro-
6-(3-hydroxyphenoxy)-1,3,5-triazin-2-yl)oxy)naphthalen-1-ol (TPN-BM) (Fig. 3.1) was performed 
following a modified procedure.
152
 
Following a typical procedure for an aromatic nucleophilic substitution,
152
 cyanuric chloride (5.55 
g, 0.03 moles), resorcinol (1.65 g, 0.015 moles) and diisopropylethylamine (3.02 mL) were 
reacted in dry THF at 0 ºC for 2h under stirring (120 rpm). The volume of THF used was just 
sufficient to dissolve the reactants: approximately 10 mL to dissolve 5.55 g of cyanuric chloride 
and 4 mL to dissolve 1.65 g of resorcinol. After warming to room temperature, the reaction 
mixture was filtered to remove amine salts and the solvent was evaporated under vacuum. The 
resultant solid was recrystallized from acetone to yield TP-BM as a white powder (7.13 g, 90% 
yield). FT-IR (KBr) λmax (cm
-1
): 3396, 1506, 1404, 1295, 1257, 1224, 1179, 1018, 922, 852, 803, 
788, 691. 185 
1
H NMR (400 MHz, CDCl3) δ (ppm): 11.28 (1H, OH), 7.56 (1H, t, J= 8.4 Hz, Hb), 
7.20 (2H, dd, J= 2.0, 8.4 Hz, Hc+Hd), 7.10 (1H, s, He). 
13
C NMR (100 MHz, CDCl3) δ (ppm): 
173.39 (Triazine-O), 172.62 (Triazine-Cl), 170.85 (Phenol-OH), 151.55 (Phenol-O), 131.01 
(Phenol-H), 119.91 (Phenol-H), 115.10 90 (Phenol-H). The isolated TP-BM ligand revealed a 
persistent chemical instability which precluded complete microanalytic characterization. For the 
synthesis of TPN-BM, TP-BM (6.00 g, 0.023 moles), 1,4-dihydroxynaphthalen (3.74 g, 0.023 
moles), dissolved in dry THF (approximately 10 and 5 mL, respectively), and 
diisopropylethylamine (33 mL) were reacted at 0 ºC for 2h (Fig. 3.1). The crude reaction mixture 
was then filtered to remove amine salts and the solvent evaporated, giving brownish oil, which 
was dried under vacuum. The crude mixture was then recrystallized from acetone at -78ºC to 
yield TPN-BM as a pasty brownish solid (8.11 g, 88% yield). FT-IR (KBr) λmax (cm
-1
): 3225, 
1594, 1535, 1479, 1392, 1357, 1270, 1147, 1064, 850, 818, 769. 
1
H NMR (400 MHz, CDCl3 + 
DMSO-d6 drops) δ (ppm): 10.69 (2H, OH), 8.00 (1H, d, J= 8.4 Hz, Hb), 7.71-7.62 (3H, m, 
Hc+Hd+He), 7.12-6.91 (4H, m, Hf+Hg+Hh+Hi), 6.49 (2H, m, Hj+H
l
). 
13
C NMR (100 MHz, CDCl3) δ 
(ppm): 173.26 (Triazine-O-Phenol), 171.21 (Triazine-O-Naphtol), 170.72 (Triazine-Cl), 152.33 
(Phenol-OH), 150.42 (Phenol-O), 146.62 (Naphtol-OH), 138.66 (Naphtol-O), 135.23 (Phenol-H), 
133.93 (Naphtol-C), 131.89 (Naphtol-C), 130.29 (Naphtol-H), 127.38 (Phenol-H), 126.41 
(Phenol-H), 110 122.67 (Naphtol-H), 121.31 (Naphtol-H), 119.77 (Phenol-H), 117.36 (Phenol-
H). MS (EI) calculated for C19H12ClN3O4, 381.1; found 381.1[M]
+
. 
1
H NMR spectra were recorded on a Bruker ARX 400MHz spectrometer. Approximately 10 mg 
of sample were dissolved in 500 µL of deuterated chloroform with a few drops of 
dimethylsulfoxide, for TP-BM and TPN-BM, respectively. FT-IR measurements were performed 
using Winfirst 5 Lite equipment (16 scans and 1 cm
−1
 resolution). Thin pellets containing a small 
amount of each product mixed with dried KBr (1:5 mass ratio) were made before recording. All 
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mass spectral analyses were carried out by the Laboratory for Mass Spectrometry at Santiago 
de Compostela (Spain). 
 
3.2.3. MONOLITHS PREPARATION AND FUNCTIONALIZATION WITH TPN-BM 
Chitosan-based monoliths were prepared according to Barroso et al.
82
 by blending chitosan with 
Poly(vinyl alcohol )(monolith designated by CP) and by cryopolymerizing of glycidyl 
methacrylate, GMA, (monolith designated by CG). The functionalization of chitosan-based 
monoliths with TPN-BM followed the strategy based on plasma activation, as in previously 
chapter for the immobilization of ligand 22/8 in same supports.
82
 Thus, plasma surface 
activation was used to introduce radicals on monolith surfaces for further amination (outside 
plasma) and it was carried out in a radio frequency plasma reactor (Plasma system FEMTO, 
version 5). Native (N) chitosan-based monoliths (30 mg of CP and CG) were introduced in 
plasma chamber which was thoroughly purged with a continuous flow of argon to reduce trace 
amounts of air and moisture. During the treatment, the argon flow was adjusted to maintain a 
constant pressure of 0.3 Torr inside the chamber. A power of 60 W was applied during 5 
minutes. At the end of the experiment the plasma chamber was ventilated and the activated 
samples were immediately immersed in 7 mL of 1,6-hexanediamine to be aminated for 12 h at 
45 ºC. At the end aminated samples were washed with water (10 mL) in order to remove 
unreacted 1,6-hexanediamine. The extent of amination was determined by the Kaiser test.
82
 
The immobilization of ligand TPN-BM followed a similar protocol adapted for the immobilization 
of ligand 22/8 in the same supports using just DMF as solvent and not a DMF-water mixture as 
in the case of ligand 22/8. An excess of TPN-BM (3 equiv. to the amination content, 530 µmol, 
200 mg), was added to the aminated chitosan-based monolith samples (approximately 60 mg) 
in DMF (5 mL). The volume of solvent used was sufficient to cover the chitosan-based 
monoliths, and the solution was incubated on a rotary shaker (140 rpm) for 72 h at 85 ºC. Then, 
functionalized chitosan-based monoliths were washed with DMF (6 mL) until no detection of 
absorbance at 267 nm. Moreover, in order to assure a complete exclusion of non-absorbed 
ligands into and onto monoliths, the functionalized samples were introduced in a Varian column 
(a reservoir with a capacity of 3 mL and an internal diameter of 10 mm) and were loaded with 5 
mL of DMF and submitted to a clean-in-place (CIP) procedure. The CIP procedure consisted in 
a sequential washing of the functionalized chitosan-based monoliths: first with NaOH (1 M, 5 
mL), (until no absorbance was observed at 267nm), then with water (10 mL) and regeneration 
buffer (NaOH 0.1 M in 30 % of isopropanol, 5 mL) until no absorbance at 267 nm, and finally 
with distilled water (10 mL). The functionalized chitosan based monoliths were equilibrated with 
sodium phosphate buffer (50 mM, pH 8.0) and sodium citrate buffer (50 mM, pH 3.0) until no 
absorbance at 267 nm. The extinction coefficient of TPN-BM was determined at its maximum 
absorbance wavelength (ε267=3.72 L g
-1
 cm
-1
), and extend of coupling was determined by 
subtracting the amount of ligand contained in all the washing liquors from the initial quantity 
used in the immobilization step. In order to reuse the unreacted TPN-BM and the DMF collected 
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from the washes for further immobilizations procedures, the ligand was precipitated by adding 
diethyl ether as an anti-solvent and the DMF recovered. 
 
3.2.4. BIOMIMETIC MONOLITHS CHARACTERIZATION 
Morphological and mechanical properties of native (used as control) and functionalized 
monoliths (modified with the affinity ligand) were evaluated. The morphology was investigated 
using scanning electron microscopy (SEM) in Hitachi S 2400 equipment with accelerating 
voltage set to 15 kV. The samples were frozen and fractured in liquid nitrogen for cross-
sectional analysis and gold coated before analysis. The porosity, average pore size diameter 
and surface area were determined in duplicate by MIP (Micromeritics, autopore IV). Water 
fluxes were determined at 25 ºC and varying the applied hydrostatic pressure (within 0-0.4 MPa) 
using a stainless steel high-pressure cell (with an effective volume of 1.2 cm
3
). At least, three 
measurements of distilled water flux were performed for each monolith. The permeability (Lp) 
was calculated from the slope of the linear relation between flux and pressure, using the Darcy 
law (see Chapter 2). Uniaxial compression was used to determine the mechanical properties of 
the monoliths using tensile testing equipment (MINIMAT firm-ware v.3.1) at room temperature in 
dry and wet state. Samples were prepared in a cylindrical shape (10 mm in diameter thickness). 
The length between clamps was set to 5 mm, the speed set to 1 mm min
-1
, a full scale load of 
20 N and maximum extension of 90 mm was used. The compression modulus was calculated 
from the slope of the linear portion of the stress-strain curve (see Chapter 2).
82
 
 
3.2.5. STATIC PARTITION EQUILIBRIUM STUDIES 
Partition equilibrium experiments were performed in a batch system as described in a previously 
work.
82
 The adsorption of hIgG and BSA on the chitosan based monoliths was investigated 
using a sample of native and functionalized ones (15 mg) varying the concentration of hIgG and 
BSA (0.0-45.0 mg mL
-1
, 400 µL) in phosphate buffer solutions (50 mM, pH 8.0). All experiments 
were conducted in duplicates at 25 ºC, under orbital agitation at 200 rpm during 12 h. After 
incubation, monoliths were removed from the medium. The amount of adsorbed hIgG and BSA 
was determined by measuring the initial and the final concentrations of protein in the 
supernatant. A calibration curve was constructed using hIgG and BSA (0.0–45.0 mg mL
-1
) in 
phosphate buffer solutions (50 mM, pH 8.0). The concentration of protein was measured at 280 
nm on a microplate reader (Tecan Infinite F200). The adsorption phenomenon followed the 
Langmuir-Freundlich model,
139,141
 represented by the equation below: 
 
  
      
  
      
 
 
          Equation 3.1 
where Kd is the apparent dissociation constant (M), Kd is the inverse of the affinity constant Ka, 
that includes contributions from ligand binding to support, Qm is the maximum binding capacity 
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(mg protein g
-1
 support), C is the concentration of protein in the liquid at the equilibrium (M) and 
n represents the Langmuir-Freundlich coefficient. 
 
3.2.6. FRONTAL ANALYSIS – BREAKTHROUGH CURVES AND BINDING CAPACITY 
The dynamic loading capacity of the packed columns (for both native and functionalized 
chitosan-based monoliths) was determined using frontal analysis according with the equation 
below:
6
 
  
  
                
 
          Equation 3.2 
where Q is the estimated adsorbent capacity and Ve is the elution volume. 
This technique consisted in the loading of hgG and BSA solutions (8 mL, 0.5 mg mL
-1
) in 
sodium phosphate buffer (50 mM, pH 8.0) through equilibrated monoliths inserted in Varian 
columns (with a capacity of 3 mL and an internal diameter of 10 mm) at a flow rate of 1 mL min
-1
 
until the protein concentration of the output and input streams were identical. Then, packed 
columns were washed with phosphate buffer (50 mM, pH 8.0) and the bound protein was eluted 
with sodium citrate buffer (50 mM, pH 3.0). Each millilitre collected during loading, washing and 
elution steps were analysed by absorbance at 280 nm, using a microplate reader, in order to 
estimate the amounts of bounded and eluted protein. 
 
3.2.7. CHROMATOGRAPHIC EXPERIMENTS WITH PURIFIED PROTEIN SOLUTIONS 
Functionalized CP and CG monoliths were packed in Varian columns (with a capacity of 3 mL 
and an internal diameter of 10 mm). The columns were connected to a peristaltic pump using 
rubber tubing. The affinity capturing experiments were performed in a step-wise adsorption-
desorption process by switching eluents at room temperature and at atmospheric pressure. The 
packed columns with functionalized chitosan-based monoliths were loaded with 1 mL of hIgG or 
BSA solution (5 mg mL
-1
) and then washed with sodium phosphate buffer (50 mM, pH 8.0) until 
the absorbance measured at 280 nm reached ≤0.005. The bound protein was then eluted and 
recovered with sodium citrate buffer (50 mM, pH 3.0). The packed columns with functionalized 
chitosan-based monoliths were then regenerated using a buffer solution (NaOH 0.1M in 30% of 
isopropanol). These chromatographic experiments were repeated twice along 3 cycles and one 
more cycle was performed after monoliths autoclaving for 20 min at 120 ºC. 
3.2.8. PURIFICATION OF MONOCLONAL ANTIBODIES FROM MAMMALIAN CRUDE 
EXTRACTS 
To evaluate the possibility of capturing antibodies directly from non-clarified crude extracts, 
columns packed with native and functionalized CP monoliths were loaded with a mammalian 
crude extract solution (1 mL, 1.3 mg of total protein per millilitre). After loading, packed columns 
were washed with sodium phosphate buffer (15 mL, 50 mM, pH 8.0) until the absorbance 
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measured at 280 nm reached a value ≤0.005 and the bound protein was further eluted with 
sodium citrate buffer (50 mM, pH 3.0). All collected samples were analysed by the BCA assay 
(microplate reader assay) to quantify the amount of total protein bound and eluted from the solid 
support. All collected samples (Loading (LD), Flowthrough (FT) and Elutions (E)) were analysed 
by SDS-PAGE 12.5 % acrylamide/bisacrylamide in denaturing conditions and stained with 
Silver Staining kit (BioRad). The electrophoresis apparatus (from BIO-RAD) was connected with 
a power supply at 120 V, 190 mA for 1 h.
143
 
 
3.3. RESULTS AND DISCUSSION 
3.3.1. TPN-BM SYNTHESIS 
The structure of ligand 22/8 was refined to improve the synthesis procedure and ligand 
solubility. The improved ligand designated as TPN-BM maintained the functionalities necessary 
for protein recognition. The first reaction led to the formation of TP-BM using cyanuric chloride 
as a starting material. Cyanuric chloride is a valuable scaffold for ligand design, combinatorial 
chemistry and self-assembly since triazine-based molecules can act both as hydrogen donors 
and acceptors.
152
 Acting as an electrophilic core, it reacted with resorcinol which was added 
dropwise to avoid di-substitution at 0 °C for 2h under stirring. The intermediate formed (TP-BM) 
was isolated in very good yield (90%) and characterized by NMR, FT-IR (Fig. 3.2 A and B, 
respectively) and mass spectrometry.  
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Figure 3.2 – (A) 
1
H-NMR spectrum of TP-BM in CDCl3 and (B) FT-IR spectrum of TP-BM. 
 
In the 
1
H NMR spectra a downfield shift in the aromatic protons of resorcinol was observed, 
caused by the deshielding effect arising from the presence of the triazine ring. In the FT-IR 
spectrum the appearance of an intense band near 1257 cm
-1
, characteristic of CO stretching 
vibration in aryl ethers, confirm the formation of the desired compound and thus, the success of 
the reaction. The purification of TP-BM was found to be much easier than the one in which the 
first product of ligand 22/8 synthesis is obtained, as it only involved the evaporation of THF 
under vacuum and washings of the product with distilled water (20 mL) in order to remove 
unreacted diisopropylethylamine. In a similar procedure 1,4-dihydroxynaphthalen, which was 
also added dropwise to avoid disubstitution, reacted smoothly with TP-BM to afford ligand TPN-
BM in very good yield (88%). The 
1
H NMR spectrum of TPN-BM (Fig. 3.3 A) is very similar to 
ligand 22/8,
88
 only showing a downfield shift corresponding to the protons of the naphthol ring. 
The presence of a peak with m/z=381.1 in the mass spectra also confirmed the presence of the 
desired product. 
CHAPTER 3: A SUSTAINABLE BIOMIMETIC LIGAND FOR DIRECT IMMOBILIZATION ON 
(BIO)POLYMERIC SUPPORTS 
44 
 
 
 
 
Figure 3.3 – (A) 
1
H-NMR spectrum of TPN-BM in CDCl3 and (B) FT-IR spectrum of TPN-BM. 
 
Comparing the two syntheses (ligand 22/8
88
 versus TPN-BM) it was found that in the case of 
TPN-BM a more sustainable protocol was achieved, with a clear reduction of purification steps, 
solvents, energy and time (Table 3.1). 
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Table 3.1 - Comparison between synthetic routes of ligand 22/8 and TPNBM from a green chemistry point 
of view. 
 
 
3.3.2. IMMOBILIZATION OF LIGAND TPN-BM ONTO NATIVE CHITOSAN-BASED 
MONOLITHS 
Numerous methodologies for the activation of monoliths and ligand coupling have been 
described.
18,40
 Herein, the immobilization of ligand TPN-BM onto native chitosan-based 
monoliths followed a procedure based on plasma activation surface as described in our 
previous work.
82
 This strategy demonstrated to be more efficient to induce ligand 22/8 
attachment onto chitosan-based monoliths with a 5-fold higher amination yield achieved, (1.75± 
0.05)×10
3
 µmol g
-1
 support, comparing with traditional strategies. Thus, argon (Ar)-plasma 
treatment produces highly reactive radicals in the monoliths surface, that allow its coupling with 
the spacer 1,6-diaminehexane.
11
 Since the TPN-BM triazine core still has a reactive chloride 
that can participate again in an aromatic nucleophilic substitution, the ligand is easily 
immobilized onto aminated surfaces. The immobilization yields are registered in Table 3.2, and 
are compared with the results previously obtained for ligand 22/8. 
 
Table 3.2 - Amination and ligand densities of chitosan-based monoliths. 
 
Monolith 
[NH2] ×10
-3
 
(µmol g
-1
 support) 
TPN-BM immobilization 
×10
-3
  (µmol g
-1
 support)  
22/8 immobilization  
×10
-3
 (µmol g
-1
 support)
82
  
CP 1.75 ± 0.05 0.89 ± 0.02 0.91 ± 0.02 
CG 0.9 ± 0.2 0.74 ± 0.02 0.67 ± 0.02 
a
 All the values were obtained in duplicates. 
 
The highest value for TPN-BM immobilization was obtained using the CP monolith, 
(0.89±0.02)×10
3
 µmol g
-1
 support, which was similar to the one obtained for the same support 
using ligand 22/8. The CG monolith also presented a high functionalization capacity, 
(0.74±0.02)×10
3
 µmol g
-1
 support, a value that is slightly higher than the one obtained using the 
same support but with ligand 22/8. The difference between amination yields and consequently 
ligand immobilization values of CP and CG monoliths might be due to their distinguished 
Process Parameters Ligand 22/8 TPN-BM Green Chemistry 
Solvents involved 6 4 Safer solvents 
Temperatures involved (ºC) 0-45 0 Energy maximization 
Purification steps 6 4 Design for separation 
Time consuption (h) 7 4 Time efficiency 
Mass productivity (%) 2.4 26 Atom economy 
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morphological features such as average pore size diameter and specific surface area. These 
results suggest that the strategy involving the plasma treatment is much more efficient than 
traditional activation procedures based on epoxy chemistry, and it can be extended to other 
ligands, independently of the type of support used.
82,88,114
 Additionally, the novel strategy 
applied for the immobilization step also simplified the overall ligand functionalization procedure. 
Considering that ligand TPN-BM is completely soluble in DMF, it was possible to avoid the use 
of the DMF-water system enabling an easier DMF recovery. More importantly, the high solubility 
of the ligand enables its accurate quantification on the monolithic supports. 
After ligand TPN-BM immobilization, the morphological, mechanical and physico-chemical 
properties of chitosan-based monoliths were studied in order to evaluate the integrity of the 
modified structures. The SEM images (Fig. 3.4) show that a different surface topology was 
obtained after ligand coupling. A surface roughness appeared due to the ligand covering the 
porous network, suggesting that the coupling procedure was successfully achieved. The 
average pore size diameter and the porosity values obtained for native and functionalized 
CP_TPN-BM and CG_TPN-BM monoliths are registered in Table 3.3 and suggest that the 
porous network was not strongly affected by the functionalization procedure or by the ligand 
nature. Permeability values obtained for CP and CG monoliths decreased from 294 to 163 L m
-2
 
h
-1
 atm
-1
 for CP_TPN-BM and from 390 to 290 L m
-2
 h
-1
 atm
-1
 for CG_TPN-BM monoliths. The 
flow reduction, as previously observed for ligand 22/8 functionalized chitosan-based 
monoliths,
82
 can be explained by the hydrophobic character of the material after ligand coupling. 
However, it should be noted that this property can be much favourable to the separation 
process, since the permeability values are still acceptable allowing enough residence time for 
the contact between the protein and the affinity support during chromatographic experiments. 
Also, a decrease of the specific surface area was expected with the increase of average pore 
size diameter. The inner surface area (total pore area) is within the range determined for 
chitosan-based monoliths functionalized with ligand 22/8 and are also similar to other 3D porous 
structures designed for the same.
82,133,134
 The compressive modulus increased (~10-fold) for all 
monoliths after ligand coupling in dry or wet state (refer to Table 3.3), as observed in our 
previous work using ligand 22/8,
82
 probably because the triazine-based ligands confer rigidity to 
all porous network. Thus it should be underlined that the ligand TPN-BM that was synthesized 
by a greener chemical route presented the same structural rigidity than ligand 22/8. 
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Figure 3.4 - SEM images of chitosan based-monoliths before and after functionalization of ligand TPN-
BM: (A) CP_N, native monolith prepared from chitosan and polyvinyl alcohol; (B) CG_N, native monolith 
prepared from chitosan and glycidyl methacrylate; (C) CP_TPN-BM, CP monolith functionalized with TPN-
BM and (D) CG_TPN-BM, CG monolith functionalized with TPN-BM. All the images have a magnification 
of 300 and the scale bar in white corresponds to 50 µm. 
 
Table 3.3 - Morphological and mechanical characterization of chitosan-based monoliths before and after 
functionalization of ligand TPN-BM. 
 
Monolith 
Average 
pore size 
diameter
a
 
(µm) 
Porosity
a
 
(%) 
Surface Area
a
 
(m
2
g
-1
 
monolith) 
Permeability
b
 
(L m
-2
 h
-1
 atm
-1
) 
Compressive  
Modulus (kPa)
b
 
Dry Wet 
CP_N 53±5 70±5 1.3±0.1 294±15 0.41±0.2 0.2±0.2 
CG_N 123±5 75±5 0.9±0.1 390±5 0.26±0.2 n.a
c
 
CP_TPN-BM 57±7 72±10 2.9±0.2 163±10 10±4 6±4 
CG_TPN-BM 101±10 83±10 1.3±0.1 290±15 7±5 2.5±2 
a
 Determined for dried monoliths by mercury porosimetry analysis in duplicates; 
b
 The experiments were performed in 
triplicates; 
c
 The mechanical assay was impossible to perform due to the high swelling of CG_N. 
 
The stability at typical operating conditions used during the purification processes was further 
evaluated, and the monoliths were incubated at several pH conditions (from pH 1 to 12), 
corresponding to those employed in equilibration, elution, regeneration and CIP of 
chromatographic matrices. The amount of ligand released from the support at each condition 
was examined (Fig. 3.5), and the maximum amount of ligand TPN-BM released from CP_TPN-
BM and CG_TPN-BM was 18% and 15%, after 2 and 4 hours of incubation, and at pH 2 and 12, 
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respectively (Fig. 3.5 A and C). Specifically, at the pH used in the binding (pH 8) and elution (pH 
3) of antibodies from TPN-BM ligand supports, the highest amount of ligand leaching was 
observed after 2 and 4 hours, for CP_TPN-BM and CG_TPN-BM, respectively. In general, 
during a typical purification run of 30-60 minutes, the maximum contact time of the monolith with 
these conditions is far below the onset for ligand leaching, as it was observed for monoliths 
functionalized with ligand 22/8.
82
 In contact with the typical aggressive solutions used in 
downstream processes (Fig. 3.5 B and D), especially in chromatographic steps, the highest loss 
(approximately 20%) of ligand from CP_TPN-BM and CG_TPN-BM occurs when using 
hydrochloridric acid (0.1 M) after 2 and 4 hours (Fig. 3.5 B and D), respectively. However, the 
maximum contact time of each functionalized monolith under CIP conditions is around 30 
minutes; time at which no ligand was released. Comparing the stability profile obtained for the 
monoliths TPN-BM at different pH and conditions with those obtained for chitosan-based 
monoliths functionalized with ligand 22/8 under similar conditions (see Chapter 2), it is possible 
to verify that a higher quantity of ligand TPN-BM is leached from the support. A primary 
conclusion could be that ligand TPN-BM is less robust at drastic conditions than ligand 22/8. 
However, it should be noted that ligand TPN-BM was designed to overcome the poor solubility 
of 22/8 and, consequently, its quantification became much more rigorous and valid. Thus, we 
can postulate that in previous experiments the amount of ligand 22/8 released to the medium
82
 
probably was not accurately determined due to solubility issues, and lower amounts of released 
ligand were detected. 
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Figure 3.5 - Stability evaluation of CP_TPN-BM (A and B) and CG_TPN-BM (C and D) monoliths 
immersed, over 12 hours, in solutions typically used during cleaning-in-place (CIP) procedures, including 
solutions with pH values between 1 and 12. All data was obtained from duplicated measurements with 
errors of ± 6. 
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3.3.3. EVALUATION OF TPN-BM MONOLITHS AS AFFINITY DEVICES FOR hIgG 
PURIFICATION 
To evaluate the affinity constants for hIgG and BSA on native and functionalized chitosan-based 
monoliths, static partition equilibrium experiments were performed in duplicates. To attain the 
equilibrium between proteins and affinity supports, partition equilibrium studies were performed 
in a batch system for 12 hours varying the proteins concentration. 
The experimental data was fitted using a Langmuir-Freundlich isotherm since it has been 
indicated to predict the adsorption equilibrium for affinity heterogeneous systems.
137,153
 
According to the monolith’s material, different affinity constants (Ka), theoretical maximum 
capacity (Qmax) and Langmuir-Freundlich coefficients (n) were estimated (Fig. 3.6) with an error 
of ±0.5, ±40.0 and ±0.1, respectively. The TPN-BM monoliths always presented higher values of 
Ka and Qmax when compared with the native ones. CG_TPN-BM monolith that registered a small 
decrease in the Ka and Qmax values (3.5 M
-1
 and 410 mg IgG g
-1
 support) comparing with the 
ones registered for CG_22/8 (4.0 M
-1
 and 590 mg hIgG g
-1
 support).
82
 These results show the 
less regular behaviour exhibited by CG monoliths.  
As it was observed for supports functionalized with ligand 22/8, the obtained Ka values for TPN-
BM monoliths have the same order of magnitude (10
-4 
M). This order of magnitude is lower than 
the one verified for Ka reported for agarose
11
, magnetic nanoparticles
114
 and cellulose 
membranes
88
 functionalized with ligand 22/8, fitted with a Langmuir isotherm model. 
Nevertheless, values of Ka in a range between 10
4
 and 10
6
 M
-1
 indicate a medium affinity 
interaction, ideal in purification processes for target protein capture and release.
154
 The values 
of Qmax for CP_TPN-BM and CG_TPN-BM, 810 and 410 mg hIgG g
-1
 support, respectively, are 
at least 2-fold higher than those obtained for other affinity supports functionalized with ligand 
22/8.
82,114,138
 In addition, the results registered for Langmuir-Freundlich coefficients of TPN-BM 
monoliths were higher than those obtained for native monoliths, and higher than 1, clearly 
suggesting a positive cooperativity in binding and an heterogeneous nature in protein 
adsorption.
141
 It should be noted that the same adsorption assays were performed BSA, a 
model contaminant protein of antibodies in serum and cell culture supernatants and none of the 
tested isotherms could fit the experimental data, which indicates a nonspecific adsorption profile 
of BSA. 
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Figure 3.6 - Langmuir-Freundlich adsorption isotherms for (A) CP and (B) CG monoliths: (♦) native and (●) 
functionalized with TPN-BM. In (C) are summarized the estimated parameters of Langmuir-Freundlich 
isotherms and standard errors, for CP and CG monoliths before and after functionalization with ligand 
TPN-BM and ligand 22/8 (
a
).
82
 
 
In order to evaluate the mass transfer and dynamic binding properties of TPN-BM affinity 
monoliths, breakthrough curves of purified hIgG were performed in duplicates at a flow rate of 1 
mL min
-1
 (Fig. 3.7). The residence time of a protein in a column is intrinsically related with the 
supports nature and morphological properties. Since the availability to interact with the protein 
of an immobilized ligand depends on the stereo-chemical hindrance, and on the morphological 
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and physicochemical properties of the monolith porous network, the flow rate has a key role in 
the establishment of ligand-protein interaction. Thus, based on the knowledge acquired in our 
previous work (Chapter 2),
82
 where the optimal operating conditions for functionalized chitosan-
based monoliths were evaluated, an optimal flow rate of 1 mL min
-1
 was chosen. Moreover, 
since the chemical groups of TPN-BM available after its coupling on chitosan-based monoliths 
are the same than ligand 22/8, the hydrophilicity of the affinity system will be similar justifying 
the use of the best flow-rate previously estimated. The estimated binding capacities for 
CP_TPN-BM and CG_TPN-BM were 125±7 and 60±5 mg hIgG g
-1
 support, with associated 
elution capacities of 78 and 40±5%, respectively. 
Comparatively the analogue supports functionalized with ligand 22/8, show similar binding 
capacities: CP_22/8 (110±15 hIgG g
-1
 support, 90±5%) and CG_22/8 (90±5 mg hIgG g
-1
 
support, 60±5%). 
 
 
Figure 3.7 - Breakthrough profiles for human IgG upon CP_TPN-BM (♦) and CG_TPN-BM (▲) monoliths 
at a flow rate of 1 mL min
-1
. All data was obtained from duplicated measurements with errors of ± 0.05. 
 
3.3.4. OPTIMIZATION OF TPN-BM AFFINITY MONOLITH FOR ANTIBODY PURIFICATION 
The optimization of the purification process was developed for CP_TPN-BM, since this monolith 
revealed the most promising morphological and mechanical properties, and presented also 
more attractive dynamic binding and elution capacities towards hIgG. The reuse capacity of the 
TPN-BM affinity monoliths for binding hIgG and BSA was assessed during three consecutive 
cycles, and a last cycle after autoclaving. BSA, a model protein, was used as a model 
contaminant. Based on our knowledge, native CP monoliths (before functionalization) exhibited 
similar performances on capturing and eluting hIgG and BSA, which are expressed by the low 
capacity to bind (20±5 mg protein per gram of monolith) and to elute (10±5 mg protein per gram 
of monolith) both proteins over the four cycles. On the opposite, CP_TPN-BM monoliths showed 
an extensive increase in binding and elution capacities towards hIgG (Fig. 3.8 A) while only a 
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minor amount of BSA was retained in the column (Fig. 3.8 B). Also, the most interesting feature 
was that the affinity and selectivity towards hIgG molecule is maintained over re-utilization, even 
after autoclaving. CP_TPN-BM monoliths are able to recover around 160±10 mg hIgG g
-1
 
monolith and to elute 140±10 mg hIgG g
-1
 monolith. On the other hand, the amount of hIgG 
recovered during the regeneration step was negligible, around 20±5 mg g
-1
 support. This 
outstanding performance of CP monoliths functionalized with the TPN-BM ligand is very similar 
to those obtained for the same support functionalized with ligand 22/8. Furthermore, the binding 
and elution capacities of these sustainable CP_TPN-BM monoliths towards IgG are highly 
competitive with the ones obtained using affinity membranes, particles and other monoliths 
applied for antibodies purification, with the advantages resulting from their greener 
preparation.
11,13,82,114,135,139,141
 To utterly validate the performance of the CP_TPN-BM monoliths, 
the purification of monoclonal antibodies (mAbs) from a non-clarified homogenate was 
evaluated. 
 
 
Figure 3.8 - Evaluation of chromatographic performance for CP_TPN-BM monoliths using pure human IgG 
(A) and BSA (B) solutions, respectively. The chromatographic procedures (binding, elution and 
regeneration steps) were performed consecutively along four cycles at a flow rate of 1 mL min
-1
. The last 
cycle was performed after autoclaving (After_AC). 
 
The data of CP_22/8 related with mAbs purification was added to enable a direct comparison 
between the performance of CP monoliths functionalized with ligands TPN-BM and 22/8. The 
chromatogram obtained from crude extract sample confirms that the non-functionalized 
monolith CP_N did not capture any protein (Fig. 3.9 A) while the affinity monoliths CP_22/8 and 
CP_TPN-BM captured respectively 61±10 and 75±5% of mAbs from a mammalian crude extract 
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with initial 1.3 mg of total protein per millilitre, eluting both around 80±10% of bounded protein. 
Additionally, concerning the purity of the samples (SDS-PAGE), the flow-through (3, 7) and 
washes (4, 8) bands showed the presence of contaminated proteins and antibody, while the 
elution (5, 6, 9, 10) fractions exposed only the corresponding bands of the mAbs fragments with 
high purity (estimated as 98% by densitometry analysis with Image J software). 
 
 
Figure 3.9 - Chromatogram of mAbs 
(◊) functionalized with ligand 22/8 and (Δ) functionalized with TPN-BM at a flow rate of 1 mL min
-1
. The 
fractions collected included the flowthrough followed by the washing and elution steps. Acrylamide gel 
from SDS-PAGE performed with the fractions collected during the mAbs purification (B): lane 1 
corresponds to the calibration proteins, lane 2 represents the loading for CP_22/8 and CP_TPN-BM, lane 
3 and 7 are the flowthrough for CP_22/8 and CP_TPN-BM, lane 4 and 8 corresponds to CP_22/8 and 
CP_TPN-BM first wash using phosphate buffer (50 mM, pH 8.0), and lane 5, 6, 9 and 10 are the first and 
second elution fractions of CP_22/8 and CP_TPN-BM using sodium citrate buffer (50 mM, pH 3.0). 
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3.4. CONCLUDING REMARKS 
This work proposes a sustainable strategy to produce new affinity platforms for antibody 
purification with particular regard to the material support (chitosan), functionalization procedure 
of the supports (based on plasma activation) and the affinity ligand synthesis.  Specifically, this 
novel approach is focused on the replacement of ligand 22/8 (artificial protein A) by an 
analogous biomimetic ligand (TPN-BM) synthesized using a green protocol (with high chemical 
yield, fast reaction time, and less solvents and purification steps involved). If at small scale the 
synthesis herein proposed presented benefits, at larger scales the advantages are expected to 
be considerably higher, specially the reduction in time which allows for advances and/or 
refinements to be made in other stages of the process. TPN-BM was also characterized and 
further immobilized onto plasma-activated chitosan monoliths, creating a greener purification 
device which exhibited high performance towards antibody capture and elution (160±10 and 
145±5 mg hIgG per gram support, respectively), and mAbs purification from a non-clarified 
homogenate with 98% of purity. 
The strategy presented for the production of affinity purification devices can be a strong 
competitor to traditional affinity beads and membranes currently employed in chromatographic 
processes. It is expected that this new affinity platform will give an efficient answer to the 
current demand of antibodies in the diagnostic medicine and pharmaceutical fields with potential 
for industrial scale implementation. 
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CHAPTER 4 
STRUCTURAL EVALUATION OF AN ALTERNATIVE PROTEIN A BIOMIMETIC 
LIGAND TOWARDS ANTIBODY PURIFICATION 
 
 
 
 
SUMMARY 
 
In this chapter it is intended to evaluate the potential of TPN-BM as an alternative affinity ligand 
towards antibody recognition and binding, namely IgG, at an atomic level, since it has already 
been tested, after immobilization onto chitosan-based monoliths, and demonstrated interesting 
affinity behaviour for this purpose. Herein, combining automated molecular docking and 
molecular dynamics simulations (MD) it was predicted that TPN-BM has high propensity to bind 
IgG through the same binding site found in the crystallographic structure of SpA_IgG complex 
as well as theoretically predicted for ligand 22/8_IgG complex. Furthermore, it was found that 
TPN-BM established preferential interactions with aromatic residues at the Fab domain (Trp 50, 
Tyr 53, Tyr 98 and Trp 100), while in the Fc domain the main interactions are based on 
hydrogen bonds with pH sensitive residues at operational regime for binding and elution like 
histidines (His 460, His 464, His 466). Moreover, the pH dependence of TPN-BM_IgG complex 
formation was more evident for the Fc domain, where at pH 3 the protonation state and 
consequently the charge alteration of histidine residues sited at the IgG binding site induced 
ligand detachment, which explains the optimal elution condition at this pH observed 
experimentally. 
 
 
 
 
 
 
Article: Telma Barroso, Ricardo Branco, Ana Aguiar-Ricardo and Ana C. A. Roque, Structural evaluation of 
an alternative Protein A biomimetic ligand towards antibody purification, Submitted. 
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4.1. INTRODUCTION 
Over the last decade, the evaluation of biological and chemical interactions at atomic level has 
become central to understand numerous phenomena, like molecular recognition and specific 
binding found in Nature.
155
 
Currently, there is a plethora of computational methods and bioinformatic tools
155,156,157
 available 
which comprise different protein-ligand docking algorithms, or molecular mechanics force fields 
that together enable to create strategies to address complex biochemical systems with a direct 
impact and potential applications in different areas of knowledge, like protein purification 
through affinity chromatography.
150,158,159,160
 
As aforementioned, an extensive computational and experimental effort has been made to 
optimize affinity chromatographic methods in order to reduce associated costs to antibody 
purification.
23,112
 Consequently, the development of synthetic affinity ligands has been pursued 
in order to design mimetic ligands of Protein A with better chemical stability, and an analogous 
specificity profile to the natural counterparts, at lower cost.
9
 Particularly, ligands 22/8 and TPN-
BM are biomimetic ligands based on substituted triazine ring that up to now, have shown great 
proficiency in antibody purification, from simple and complex mediums, when immobilized onto 
different supports such as: agarose,
11
 magnetic nanoparticles,
114
 cellulose membranes
88
 and 
chitosan-poly(vinyl alcohol) (CP) monoliths.
82,161
 However, in contrast to ligand 22/8 that after a 
theoretical evaluation through extensive molecular dynamic studies revealed to be an excellent 
Protein A biomimetic ligand, regarding the similar molecular interactions found in this affinity 
pair,
150,159,158
 the molecular recognition and binding mechanism between TPN-BM and IgG 
affinity pair remains unveiled. Furthermore, the pH dependence that is required for the affinity 
chromatography elution and that was also rationalized for ligand 22/8 and Protein A in complex 
with IgG, is also unknown for ligand TPN-BM. Therefore, it is important to characterize the 
potential binding sites between the ligand TPN-BM and IgG, as well as to understand, at atomic 
level, the main intermolecular interactions responsible for the binding/unbinding molecular 
mechanism both at physiological (pH 7) and elution conditions (pH 3).
159
  
In the following chapter, automated molecular docking followed by MD simulations,
160
 were 
performed with TPN-BM and human IgG fragments, Fab and Fc, at pH 7 and 3, based on 
previous computational and experimental knowledge, in order to better understand the potential 
of this affinity pair for chromatographic purposes, in comparison with the performance of ligand 
22/8 and natural Protein A. 
 
 
 
 
 
 
 
 
CHAPTER 4: STRUCTURAL EVALUATION OF AN ALTERNATIVE PROTEIN A 
BIOMIMETIC LIGAND TOWARDS ANTIBODY PURIFICATION 
59 
  
4.2  METHODS 
4.2.1. MOLECULAR MODELLING 
The Fab fragment (Chains L and H with 214 and 230 amino acids, respectively) and Fc 
fragment (Chains H and K with 239 and 236 amino acids, respectively), were retrieved from the 
crystallographic structure of human IgG, with the Protein Data Bank (PDB) code 1HZH,
162
 and 
used as the target protein in this study. Ligand TPN-BM was used as the synthetic affinity 
ligand. The 4-chloro position of the triazine ring was substituted by a HN-CH3 moiety, to model 
the chemical effect of the spacer arm used experimentally for the immobilization of the ligand on 
a solid support afterwards (Fig. 4.1). 
 
 
Figure 4.1 - Schematic representation of the ligand 4-((4-chloro-6-(3-hydroxyphenoxy)-1,3,5-triazin-2-
yl)oxy)naphthalen-1-ol (TPN-BM) labeled with the atom identification for convenience. (Software used: 
ChemBioDraw Ultra 13.0). 
 
4.2.2. MOLECULAR DOCKING 
The Gasteiger partial charges and AutoDock atom types were automatically assigned to the 
receptor and ligand coordinate files through the AutoDock 4.2 python scripts. A blind docking 
using a grid map with 78 Å side (comprising 100 grid points in each orthogonal x, y and z axis, 
with a grid spacing of 0.78 Å ), covering entirely the special volume occupied by each IgG 
fragment, was setup around the receptor’s centre of mass using the AutoDock 4.2 tool 
package.
163
 A sigmoidal distance-dependent dielectric function was used for the dielectric 
continuum solvent with a constant value of −0.1465 by default.
164
 A total of 256 independent 
solutions were evaluated during conformational search using a Lamarckian Genetic Algorithm 
(LGA) with the following parameters set: an initial population of 150 conformations, a maximum 
number of 2,500.000 energy evaluations, a maximum number of 27,000 generations, a mutation 
rate of 0.02, and a crossover rate of 0.8. Non-specified settings were assumed by default. A 
RMSD cut-off value of 2.0 Å was used in the automated cluster analysis. The total number of 
torsional degrees of freedom on the TPN-BM (TORSDOF) was 4. Docking results were 
interpreted taking into account two criteria: (i) energy criteria – the top-scoring docking solutions 
with the best estimated binding free energy were selected; (ii) geometry criteria – as the affinity 
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ligands are used for purification purposes, docking solutions leading to ligand interactions in the 
target receptor inner cavities were discarded. Additionally, only solutions where the anchoring 
point of TPN-BM affinity ligand to the solid support was exposed to the solvent were selected, 
taking into account the constraints imposed by the solid support on the conformational space 
available for ligand to explore.
165
 
 
4.2.3. MD SIMULATIONS 
Molecular dynamics were performed using the GROMACS 4.5 simulation package
166
 running in 
parallel on the in-house Sun Grid Engine (SGE) high performance computing cluster. The top-
ranked docking solutions of ligand TPN-BM with Fab and Fc fragments of IgG were taken as 
starting structures for the MD simulation runs. Amino acids protonated state was adjusted 
according to their pKa values, at specific pH condition. The topology and force field 
parameterization of the ligand TPN-BM were derived from the Dundee PRODRG web server.
167
 
The TPN-BM_IgG complex was solvated in a truncated octahedral box with explicit SPC water 
model, keeping a buffer distance between the protein and the box edges of 12 Å due to the 
periodic boundary simulation conditions. The electro neutrality of the box was ensured by the 
addition of a correspondent number of Na
+
 or Cl
−
 counter ions, depending on the global charge 
of the protein system. The complex was simulated using the GROMOS 53A6 force field.
168
 The 
simulation protocol comprised three phases: (1) potential atomic clashes were removed through 
a steepest descent minimization algorithm in 2,000 steps followed by 1,000 steps using the 
conjugate gradient algorithm, (2) TPN-BM_IgG complex system was equilibrated in three 
subsecutive steps of 100 ps each, reducing gradually the force constant for positional restraint 
of heavy atoms from 1,000, 100 to 10 KJ mol
-1
 and (3) total relaxation of the system during 
production phase. All simulations ran under periodic boundary conditions in an isothermal-
isobaric (NPT) ensemble, coupled to the Berendsen barostat with a reference pressure of 1.0 
bar and a coupling time constant of 0.6 ps,
169
 as well as to the V-rescale thermostat with a 
reference temperature 300 K and a coupling time constant of 0.1 ps.
170
 A simulation time step of 
2 fs was used. The LINKS algorithm was applied to constrain all H-bonds,
171
 and the 
electrostatic term was described by using the particle mesh Ewald algorithm for long-range 
electrostatics, as implemented in GROMACS software. Finally, in the production phase all 
atomic force constraints were removed and each system was simulated during 20 ns. The 
particle composition of MD simulation boxes are summarized in Table 4.1.  
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Table 4.1 - Properties of molecular system used on MD simulation. 
The sequence numbering further referred to in this chapter was based on the numbering of the crystallographic 
structure PDB code 1HZH. The visualization software PyMol 1.2
172
 and VMD 1.9
173
 were used to generate the graphical 
artwork. 
 
 
4.3. RESULTS AND DISCUSSION 
The main interactions of SpA and ligand 22/8 with Fab and Fc fragments from immunoglobulin 
G (IgG) are very well studied in the literature.
150,159,158
 It was found that SpA binds to hIgG at a 
consensus binding site (CBS) located in the hinge between the CH2 and CH3 regions of Fc 
domain and composed by the residues: Met 252, Ile 253, Gln 330, His 464, Asn 465, His 466 
and Tyr 467, according to the 1HZH protein sequence numbering.
158
 The binding site predicted 
for the interaction of ligand 22/8 with the Fc domain comprised the following amino acids: Leu 
333, Asn 334, Gln 330, His 329, Glu 461, Ala 462, Leu 463, His 464, Asn 465 and His 466 
which correspond to the CBS predicted for the biological interaction with SpA.
150
 Moreover, also 
Zamolo et al. found out a similar set of molecular interactions for the small biomimetic ligand - 
A2P.
165
 In this work, docking studies were firstly performed to evaluate preferential binding sites 
between ligand TPN-BM and IgG fragments separately. The top-ranked docking solutions, e.g. 
the ones with the higher estimated binding free energy in module, were evaluated in terms of 
MD 
trajectory 
ID 
IgG 
fragment 
Simulation conditions System composition 
MD 
trajectory 
lenght 
 (ns) 
pH 
Box  
dimensions 
Counter 
ions 
Number  
of water 
molecules 
Total 
number 
of atoms 
in the 
system 
103 
Fab 
 
7.0 11.31; 10.66; 9.23 9 Cl 34507 108031 20 
3.0 11.31; 10.66; 9.23 37 Cl 34485 108021 20 
049 
7.0 10.72; 10.11; 8.75 9 Cl 29394 92692 20 
3.0 10.72; 10.11; 8.75 37 Cl 29367 92667 20 
024 
7.0 10.72; 10.11; 8.75 9 Cl 29390 92680 20 
3.0 10.70; 10.10; 8.74 37 Cl 29381 92681 20 
145 
7.0 10.72; 10.11; 8.75 9 Na 29387 92671 20 
3.0 10.72; 10.11; 8.75 37 Cl 29356 92643 20 
204 
Fc 
 
7.0 10.62; 10.01; 8.67 3 Na 28209 89136 20 
3.0 10.57; 9.97; 8.64 41 Cl 28179 89128 20 
255 
7.0 10.62; 10.01; 8.67 3 Na 28202 89115 20 
3.0 10.62;10.01; 8.67 41 Cl 28162 89077 20 
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the population size of each cluster of solutions and eventual geometrical constraints at the 
protein binding site. According to the selection criteria, the chosen docking solutions were 
further investigated through MD simulations. Since the affinity purification of antibody fragments 
by adsorption/desorption mechanisms is known to be pH dependent,
159
 the evaluation of ligand-
protein interactions at the commonly used experimental conditions for chromatographic loading 
and elution of antibody (pH 7 and 3, respectively) was also performed. 
 
4.3.1. INTERACTIONS OF LIGAND TPN-BM WITH IgG FRAGMENTS 
The top-ranked docking solution of ligand TPN-BM at the Fab domain of IgG presented an 
estimated binding free energy of −7.32 kcal mol
-1
 and a cluster population of 4 docking 
solutions. Additionally, the second and third top-ranked clusters with an estimated binding free 
energies ranging between -6.78 and −7.32 kcal mol
-1
 and with a significant population of 8 and 
13 solutions each, were also filtered and further analysed, according to energetic and 
geometrical criteria described in the Methods Section. The remaining clusters were discarded 
because they exhibited either lower estimated binding energies or represented unreachable 
inner binding cavity solutions, which from a practical point of view could never take place in a 
real situation for an immobilized ligand onto a support. Remarkably, 3 out of 5 docking solutions 
showed a clear preference to interact with the Fab domain in a specific aromatic region located 
in the heavy chain H and establishing main interactions with residues: Trp 50, Tyr 53 and Tyr 
98. The 3 similar cluster solutions reinforce the preference of ligand binding to Fab fragment, 
with an estimated associated affinity constant (Ka) of 2.11×10
5
 M
-1
 (-7.08 kcal mol
-1
, average of 
estimated binding free energies) (Table 4.2). This value is in accordance with previous 
theoretical predictions, since it is within the range of the affinity constants obtained for SpA_IgG 
(4.64×10
7
 M
-1
) and ligand 22/8_IgG systems (7.00×10
3
 M
-1
) (Table 4.2).
150
 
Regarding the docking of ligand TPN-BM at the Fc fragment, the maximum estimated binding 
free energy was -7.77 kcal mol
-1
. After applying the same filtering criteria as for Fab domain, 
only 4 out of 31 clusters were considered with estimated binding free energies of -6.79, -6.73,    
-6.70 and -6.67 kcal mol
-1
 with 7, 2, 3 and 1 elements, respectively. The first 2 top-ranked 
cluster solutions were selected, considering the highest affinity constant of Ka=8.60×10
4
 M
-1
 
(Table 4.2). The Ka obtained is one order of magnitude inferior when compared with the one 
estimated for Protein A and ligand 22/8, 8.09×10
5
 and 1.47×10
5 
M
-1
, respectively.
150
 However, a 
range 10
3
-10
9
 M
-1
 for Ka corresponds to a median affinity value
6
 thus, the estimated Ka value 
obtained for the complex between Fc fragment and ligand TPN-BM is significant. Moreover, 
comparing theoretical and experimental Ka’s obtained for CP monolith functionalized with ligand 
TPN-BM (Ka=4.50×10
4
 M
-1
) it is possible to observe that the values are comparable, and are in 
agreement. 
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Table 4.2 - Experimental and theoretical values of affinity constants for Immunoglobulin G and protein A, or 
ligand 22/8 or ligand TPN-BM. 
 
Therefore, the characterization of the predicted TPN-BM_IgG complexes was fully investigated 
by MD, over 20 ns in total. The main amino acids contributions for the affinity ligand binding 
were then evaluated and quantified in order to understand better the recognition and binding 
mechanism behind. 
From the MD simulations of TPN-BM_Fab complexes, it was noticeable a high preference of 
ligand TPN-BM to bind to a narrow aromatic pocket defined by the side chains of Trp 50, Tyr 
53, Tyr 98 and Trp 100 residues at the surface of heavy chain H. In fact, TPN-BM is stabilized 
by the π-π* stacking interaction established between the phenolic group of the ligand, and the 
side chains of Tyr 53 and Tyr 50, representing ca. 34% of total simulation time. Furthermore, an 
H-bond interaction between OAW and OAV oxygen atoms from the ligand and Tyr 53 hydroxyl 
group respectively, act as driving forces by positioning the ligand toward additional H-bond 
interactions. These interactions induce the repositioning of the ligand, which become entrapped 
by the naphtol ring between Trp100 and Tyr 98 through a typical π-π* stacking interaction, both 
with the two ligand substituents at the opposite side of the binding pocket, has depicted in Fig. 
4.2. These interactions prevail during 24% of the simulation time (Table 4.3). Moreover, Tyr 96, 
Tyr 91 and Trp 50 side chains also exhibit a considerable influence on the capture of TPN-BM 
by this hydrophobic binding site, considering a threshold distance of 5 Å between TPN-BM 
atoms and IgG residues as well as bellow 3 Å between heavy atoms for a strong interaction. 
The aromatic interactions that drive the complex formation between the ligand TPN-BM and Fab 
fragment are well supported by previous theoretical studies.
150,158,159
 
 
 Experimental, Ka (M
-1
) Theoretical, Ka (M
−1
) (ΔG in kcal mol
-1
) 
 IgG Fab Fc Fab Fc 
Protein A
150
 
1.40×10
7 
3.65×10
5
 
1.20×10
7 
 
10
3 
(10.46) 
4.64×10
7 
 
8.09×10
5 
 
Ligand 22/8
150
 1.40×10
5
 n.a. n.a 7.00×10
3
 (-5.24) 1.47×10
5 
(-7.05) 
Control 0/0
150
 ~0.0 ~0.0 ~0.0 
No significant 
docking 
solutions below 
3.00×10
3
  
(ca. −4.74) 
No significant 
docking  solutions 
below 4.00×10
3
  
(ca. −4.94) 
Ligand TPN-BM n.a. n.a. n.a. 2.11×10
5
 (-7.08) 8.60×10
4
 (-6.73) 
CP_22/8
82
 4.00×10
4
 n.a. n.a. n.a. n.a. 
CP_TPN-BM
161
 4.50×10
4
 n.a. n.a. n.a. n.a. 
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Figure 4.2 - Image showing the preferential binding site of ligand TPN-BM in the Fab fragment of IgG 
(PDB code 1HZH). Highlighted regions in the Fab represent residues that are within 5 Å from the ligand, 
colored by hydrophobicity. (Software used: Pymol 1.3. and VMD 1.9.1). 
 
Considering the dynamical behavior of TPN-BM when complexed with the Fc fragment of IgG, 
two binding poses from docking were further evaluated. The first one, in the CBS, was also 
reported by Branco et al.
150
 and Huang et al.,
158
 located in the hinge region between the CH2 
and CH3 domains of Fc fragment. The main CBS’s amino acids involved are His 460, His 464, 
Asn 465, His 466 and Tyr 467. In bold are amino acids reported in the literature as anchoring 
points for the natural binding domain SpA, or affinity ligands as 22/8 or A2P to the Fc 
domain.
150,159,165
 Particularly, Tyr 467 has a pivotal behaviour by anchoring the TPN-BM ligand 
and exposing it to a histidine rich environment (His 460, His 464, His 466), which will have a key 
role in the pH-dependent behaviour at elution conditions. The His 466 side chain establishes a 
close contact (≤5 Å distance) with the naphtol OAV group of the ligand during 80% of the 
simulation time (Fig. 4.3 B). Moreover, His 464 and His 460 side chains also have a significant 
contribution for the ligand binding at a short distance between 3 and 5 Å. Therefore, the CBS 
site for the Fc_TPN-BM system is maintained mostly by histidine residues. An alternative 
binding site to the CBS located in the heavy chain K was also investigated. The main residues 
involved in this binding site are His 302, Thr 306, Asn 303 and Lys 287 (Fig. 4.3 A). 
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Figure 4.3 - Image showing alternative binding sites of ligand TPN-BM in the Fc fragment of IgG (PDB 
code 1HZH). Highlighted region in the Fc represents the residues that are within 5Å from TPN-BM, colored 
by hydrophobicity. (Software used: Pymol 1.3. and VMD 1.9.1). 
 
However, His 302:HAZ and Thr 306:OAV at the naphtol side play the most important role to 
anchor the TPN-BM bound to the Fc domain during 24% and 56% of the simulation time, 
respectively (see Table 4.3). Smaller contributions from Asn 303 (interaction during 5% of the 
simulation time with OAZ from the naphtol ring) and Lys 287 (interaction during 10% of the 
simulation time with OAW from the phenol ring) also contribute to the stabilization of the ligand. 
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Table 4.3 - Resume of the main type of interactions and their contributions over simulation time for TPN-
BM_IgG complexes. 
N/O: Not observed 
 
4.3.2. pH DEPENDENCE ON THE AFFINITY BETWEEN TPN-BM AND IgG 
The natural ligand SpA as well as the biomimetic affinity ligands 22/8 and A2P have shown a 
considerable pH dependence on IgG binding, both at experimental and theoretical levels. This 
dependence is of crucial importance for the capture and recovery of antibodies, as the elution 
process is trigger by a drastic change in the pH. In order to confirm the experimental evidence 
that TPN-BM affinity ligand binds and elutes IgG efficiently at pH 7 and 3, respectively, MD 
simulations of the complexes of TPN-BM with IgG fragments were run in parallel also at pH 3 for 
all solutions previously considered and evaluated at pH 7 for the binding conditions. 
Regarding the Fab domain, the key interactions observed at pH 7 were conserved at pH 3 
however with an inferior contribution, namely for the Trp 50, Tyr 53, Tyr 98 and Trp 100 
residues (see Table 4.3). It is not surprising that the main interactions are still maintained at pH 
IgG 
target 
Binding 
site 
MD 
trajectory 
ID 
Main Interactions Interactions type 
Contribution (%) 
pH 7 pH 3 
Fab 
1 103 
Tyr 53 – OBA; HAZ; 
OAV: OAW 
Hydrophobic 
π – π
*
  
(aromatic staking) 
21 11 
Trp 50 - OBA N/O 9 
1 049 
Leu 104 - HBA 
H-bonds 
N/O 26 
Arg106 - OAZ N/O 43 
1 024 
Trp 50 - OAW Hydrophobic 13 N/O 
Tyr 98 - OAW H-bond 10 (4-6Å) 10 
Asn 31 - OAW H-bond N/O 31 
Asn 34 - OAV H-bond N/O 23 
2 145 
Trp 100 - OAZ H-bond 24 4 
Tyr 98 - HBA 
π – π
*
  
(aromatic staking) 
24 21 
Fc 
1 204 
His 466 - OAV H-bond 10 (4-6Å) N/O 
Tyr 467 - OAW H-bond 6 N/O 
His 464 and His 460 around binding site 100 (6Å) N/O 
2 
255 His 302 - HAZ H-bond 24 21 
 Thr 306 - OAV H-bond 56 41 
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3, since these amino acids have essentially an aromatic character and an invariant protonation 
state over the simulated pH range between 7 and 3. Then, the adjustment of the ligand position 
at pH 3 only implied a slight decrease of the interactions with Tyr 53, Tyr 98 and Trp 100 side 
chains and the formation of four new ones. These new interactions were established between 
OAW and OAV from the backbone of TPN-BM ligand and Asn 31 and Asn 34 of IgG, respectively, 
as well as the interaction between the OAZ atom from the naphtol ring and OAW from the phenol 
ring and Arg 106 and Leu 104 side chains of IgG, respectively, which account for 23-43% of the 
total simulation time (see Table 4.3). These results reinforced the tendency of triazine-based 
ligands to recognize preferentially aromatic containing binding sites in the Fab domain, despite 
the fact that the precise location of the TPN-BM binding site does not coincide with the ones 
described previously for analogue ligands.
150,165
 The pH dependence results are consistent with 
the different amino acid nature of IgG fragment domains, since the amino acid composition of 
Fab binding site recognized by TPN-BM, in contrast to the His rich binding site found in Fc, is 
not sensitive to drastic changes in pH, in accordance with previous works.
150,158,159
 In a marked 
contrast, the pH dependence of CBS in the Fc binding domain is considerably pronounced. At 
pH 3, the His and Glu residues at the CBS become protonated and the formal charge of the 
protein system, and in particular at the Fc binding site, increase inducing the ligand to detach 
from the former tightly bound pocket, as observed experimentally
161
 (see Fig. 4.4). MD 
trajectories simulated at pH 3 have shown the ligand moving away from the binding site (8Å) 
and losing interactions with IgG residues at the surface. The second TPN-BM binding site found 
at the Fc domain involved the His 302 and Thr 306 side chains which reduced the binding 
interaction in 3% and 15% of simulation time at pH 3, respectively. However, special attention 
should be paid not only to the percentages of interactions in time, but mainly to the histidine 
profile at both pH’s (Fig. 4.5). At lower pH the ligand is still bound through the hydrophilic 
interaction of Thr 467, accounting for 56% of the simulation time, nevertheless the tendency for 
the interaction disruption is clear. At pH 3, the ligand moved away from a closer distance 
between 3 and 5 Å to 15 Å from the Fc domain along the simulation trajectory. These 
observations suggest that, the affinity of the TPN-BM ligand to the Fc domain become weaker 
at lower pH, which seems to be directly related to the highly His content surrounding the Fc 
binding site. Also Branco et al.
150
 found that for SpA_IgG and ligand 22/8_IgG systems the 
complex dissociation was reached at lower pH due to the repulsive interactions developed at 
the binding site. Another aspect that should be taken into account concerning the pH 
dependence rationalization was addressed by Huang et al.
159
 on the influence of pH on the 
affinity of SpA_hIgG complex formation. It was concluded that SpA always binds the surface of 
hIgG during the simulation but slides slowly on the surface of hIgG and moves away from the 
binding site at pH 3. They understood, based on the calculation of binding free energies of 
electrostatic and non-polar interactions, that the dissociation at pH 3 is mainly driven by the 
electrostatic interactions, since the majority of SpA and IgG residues at pH 3 were positively 
charged, becoming favourable the electrostatic repulsion, as highlighted by the present results. 
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Figure 4.4 - pH dependence of ligand binding to the Fc fragment of IgG (PDB code 1HZH). Protonation 
state of the protein residues adjusted to pH 7 (A) where the naphtol ring of the ligand is anchored within 5 
Å to the polar and hydrogen bonding interaction with the Fc domain; and pH 3 (B), where main hydrogen 
bond interactions were disrupted forcing the ligand to drift away from the receptor (distances above 8Å). 
Both regions of interactions are coloured by hydrophobicity of the correspondent residues. (Software used: 
Pymol 1.3 and VMD 1.9.1). 
 
Moreover, they also pointed out the important role of His 137 of SpA. They observed that His 
137 contributed for a high association to IgG at pH 7 and to a high dissociation at pH 3 due to 
the charge of the residue at both pH. Herein, a similar effect was observed between the 
imidazole rings from His and phenolic substituents of the ligand. Thus, we strongly believe that 
histidines present in the Fc domain are the main responsible residues for the pH dependence of 
TPN-BM_IgG complexes in a more general view. 
 
CHAPTER 4: STRUCTURAL EVALUATION OF AN ALTERNATIVE PROTEIN A 
BIOMIMETIC LIGAND TOWARDS ANTIBODY PURIFICATION 
69 
  
 
Figure 4.5 - Graphical representation of the distance between the His 466 (A) and His 302 (B) with the 
ligand atom type OAV and OHAZ, respectively at both pH (pH 7 line coloured in black and pH 3 line coloured 
in gray), monitored along the 10 ns of simulation time. 
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4.4. CONCLUDING REMARKS 
Automated molecular docking coupled with MD simulations constitute a powerful set of tools to 
predict and evaluate the most energetically favorable binding modes of ligand TPN-BM to the 
Fab and Fc domains of IgG. The dynamical behavior of the best docking hits was fully 
characterized and compared with other SpA biomimetic analogues already described in the 
literature. 
In particular, MD simulations revealed 3 putative binding sites on the Fab domain with an 
estimated affinity constant in the range of Ka≈10
5
 M
-1
. This value is comparable with previous 
theoretical predictions for the SpA_IgG complex (Ka=4.64×10
7
 M
-1
), and also for the analogue 
ligand 22/8_IgG complex (Ka=7.00×10
3
 M
-1
). Moreover, MD simulations indicate that TPN-BM 
interacts stronger with the Fab domain, mainly based on aromatic interactions through amino 
acids Trp 50, Tyr 53, Tyr 98 and Trp 100. This cavity is similar in nature to the ones reported for 
SpA_IgG and ligand 22/8-IgG complexes, despite the fact that these residues location does not 
coincide. Regarding the Fc domain, two top-ranked cluster solutions with an affinity constant of 
8.60×10
4
 M
-1
 were further investigated. Interesting enough, the estimated affinity constant is 
similar to the one measured experimentally, using CP monoliths functionalized with TPN-BM. 
Conversely to the Fab fragment, in the Fc domain the TPN-BM is in two histidine rich binding 
regions involving His 460, His 464, Asn 465 and His 466 residues. MD results suggest that the 
binding site found in the crystallographic structure of the systems SpA_IgG and in the 
simulations of the ligand 22/8-IgG complex, was also identified in the TPN-BM_IgG complex, 
which is localized at the hinge between CH2 and CH3 regions of Fc fragment involving His 464, 
Asn 465 and His 466 as the key players. 
Moreover, the pH dependence of TPN-BM_Fc complex was tested at pH 3 and confirmed for 
the Fc fragment. Due to the high density of histidines at the Fc binding site, the on-off binding 
mechanism was validated by simulating lower pH conditions, which determined the protonation 
state of histidine and glutamic acid residues, and consequently induced repulsive interactions 
between the ligand and the protein target upon an increase in the protein surface charge. This 
reversible on/off binding behaviour shown by the TPN-BM_IgG complex helps to rationalize the 
required operating conditions during a binding/elution chromatographic purification process. 
All the information presented in this chapter, although to corroborate with the obtained 
experimental data involving the use of a “greener chromatographic approach” (TPB-BM ligand 
immobilized onto CP monoliths for IgG purification) (see Chapter 3), allows understanding this 
affinity pair at atomic level. Additionally, all these findings can also contribute to the design of 
novel affinity ligands towards antibody purification as well as to evaluate their potential as a 
sustainable affinity chromatographic solution. 
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SUMMARY 
 
This work presents a hybrid approach for antibody (Ab) capture and release. Using mostly 
natural polymers and sustainable processes, it was possible to create macroporous monoliths 
with well-defined porous networks tuneable mechanical properties and easy functionalization 
with a biomimetic ligand specific for Ab. Magnetic nanoparticles (MNPs) were embedded on the 
monolith network to confer a controlled magnetic response that facilitates and accelerates Ab 
recovery in the elution step.  The hybrid monolithic systems prepared with agarose or 
chitosan/poly(vinyl alcohol) (PVA) blends exhibited promising binding capacities of Abs directly 
from cell-culture extracts (120±10 mg Ab g
-1
 support) and controlled Ab magnetically-assisted 
elution yielding 95±2% recovery. Moreover, a selective capture of mAbs directly from cell culture 
extracts was achieved comprising 96% of purity. 
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A. Roque, Hybrid monoliths for magnetically-driven protein separations. Submitted. 
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5.1. INTRODUCTION 
Over the last years different synthetic polymers have been used to prepare a wide range of 
chromatographic supports.
15
 However, regulatory laws are pressing the industry to redesign 
products and processes toward sustainable and disposable alternatives.
23
 Chitosan (CHT),
20,82 
agarose (AG)
40,72
 and dextran (DXT)
174
 are alternative and natural polymers widely used for 
biomedical and biotechnological purposes,
175,176
 namely in the design of macroporous 
structures for cell growth,
128
 isolation and immobilization of proteins,
177
 drug delivery and tissue 
engineering.
178
 Natural polymers present outstanding properties; they possess high density of 
functional chemical groups, fouling resistance, biocompatibility and biodegradability.
71
 “Smart” 
or “intelligent” materials
179
 are also interesting due to their capacity to respond to very slight 
changes (pH, temperature, light and electric or magnetic field) in the surrounding environment 
leading to modifications in shape, surface characteristics, solubility and others.
180,181 
With the 
rapid development of nanotechnology, iron oxide magnetic nanoparticles (MNPs) are one of the 
most explored smart materials in a widespread range of different fields including magnetic 
resonance imaging,
182,183 
drug delivey,
184,185
 immobilization of biomolecules and 
separations.
114,186
 In particular, MNPs can be combined with various polymers and 
functionalized with ligands commonly employed in chromatographic methods, leading to nano 
and micro absorbents suitable for Ab purification.
1,176,187,188 
The combination of hydrogels or 
cryogels with MNPs has also been explored for the production of different magnetic 
macroporous structures with interconnected pores in the micrometer range.
188,189,190 
Additionally, 
these composite materials, in the presence of a moderate magnetic field, are able to deform 
which enables the flux of water or other fluids enhancing the release of biological agents like 
cells and proteins. Thus, this feature permits controlled actions and consequently, faster 
processes. However, these macroporous materials were never tested for chromatographic 
applications. 
Inspired by these features, this work aimed (1) the design of hybrid monoliths following green 
chemistry guidelines, and (2) the evaluation of the hybrid monoliths as purification devices using 
a novel magnetically-assisted elution protocol. The hybrid concept results from the synergy 
between the capturing of Ab through affinity interactions and a magnetic response for improved 
Ab elution. Macroporous monoliths based on chitosan, agarose, dextran and PVA, with and 
without MNPs embedded, were prepared by combining freezing and lyophilization processes.
78
 
Conversely to the traditional procedures,
187,191,192
 in this work the natural polymers were not 
chemically modified but physically entrapped by the polymeric network built from glycidyl 
methacrylate (GMA), acrylamide and bisacrylamide, that worked as  monomers and crosslinking 
agents, respectively. This strategy assures the biodegradability of the monoliths, since the 
natural polymers remain unchanged, and offer a sustainable solution for robust materials 
processing. The macroporous materials were then aminated using plasma technology,
122,193
 a 
solvent free technique, for further ligand coupling. The amination based on plasma treatment 
takes advantage of the high reactivity of argon(Ar)-plasma which generates free radicals sites 
located at monoliths surface, promoting in situ heterogeneous chemical reactions with gas-
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phase molecules like amines (1,6-hexanediamine, in this case). The functionalities introduced 
allowed the coupling of TPN-BM, a synthetic affinity ligand previously developed as a Protein A 
mimic.
161
 The presence of MNPs at the monolithic porous network will confer a magnetic 
response to the material which facilitates Ab recovery by controlled shrinking. 
This strategy intends to develop a smart, efficient, fast and eco-friendly approach for Ab 
purification which can be extended to other biotechnological and biomedical applications. 
  
5.2. EXPERIMETAL AND METHODS 
5.2.1. MATERIALS 
Ammonium persulfate (APS, purity≥98%), citric acid (purity≥99%), disodium hydrogen 
phosphate monodibasic (pa), disodium hydrogen phosphate dibasic (pa), disodium tetraborate, 
ethanol absolute and sodium citrate dihydrate were purchased from Merck. Isopropanol and 
sodium bicarbonate were purchased from Riedel-de-Haën. Agarose (electrophoresis grade) 
was purchased from nzytech. Acetone (purity≥99%), and ethyl acetate were supplied by Roth. 
Acetic acid (purity≥99%), aminocaproic acid, 3-aminophenol, 4-amino-1-naphthol hydrochloride, 
cyanuric chloride (purity≥98%), 1,6-hexanediamine (purity≥98%), N,N-dimethylformamide 
(DMF), dimethylsulfoxide (DMSO), chloridric acid (HCl), glycine, ninhydrin, iron (II) chloride 
tetrahydrate (FeCl2.4H2O, purity≥99%), iron (III) chloride hexahydrate (FeCl3.6H2O, purity≥99%), 
potassium cyanide, pyridine, sodium hydroxide (purity≥99%), sulfuric acid (H2SO4, purity≥95%), 
sodium phosphate monobasic monohydrate (H2NaO4P.H2O, purity≥98%), di-sodium hydrogen 
phosphate 2-hydrate (Na2HPO4.2H2O, purity≥98%) were purchased from Sigma Aldrich. 
Acrylamide (C3H5NO, purity≥99%), anthrone (C14H10O, purity≈97%), ammonium hydroxide 
(NH4OH, 5.0N) chitosan (75~85 % deacetylated, medium molecular weight), dextran 
((C6H10O5)n), hydroxylamine hydrochloride (H3NO.HCl, purity≥99%), poly(vinyl  alcohol) 
(purity≈99%), N,N-methylenebisacrylamide (MBAm, purity≥85%), N,N,N’,N’-
tetramethylethylenediamine (TEMED, purity≈99%), bicinchoninic acid (BCA) kit, bovine serum 
albumin (BSA) (purity≥98%) were supplied by Sigma Aldrich. Human IgG (Gammanorm) was 
supplied by Octapharma (purity≥99%). 1.10-phenonthroline 1-hydrate (C12H8N2.H20, 
purity≈99%) was acquired from Panreac. 
 
5.2.2. PREPARATION OF MAGNETIC NANOPARTICLES 
Magnetic nanonopaticles were synthesized via alkaline precipitation of FeCl3 and FeCl2 using a 
Fe
2+
/Fe
3+
 molar ratio of 0.5, according to Batalha et al.
114
 In a sealed stirred reactor with 
agitation at approximately 1200 rpm, 250 ml of a solution of 0.7 M ammonium hydroxide in 
deionized water was purged with N2 during 30 min. Then, a freshly prepared iron solution (5.4 g 
of FeCl3.6H2O and 2.0 g of FeCl2.4H2O in 25 ml of deionized water) was added dropwise. The 
reaction occurred for 2 h under an inert atmosphere. The pH was maintained at 10 by the 
addition of ammonium hydroxide. At the end, the particles were washed five times with 
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deionized water by magnetic separation. MNPs were characterized by dynamic light scattering 
(DLS) and a diameter of 384 ±19 nm was obtained with a polydispersity (PI) of 0.97± 0.11. 
5.2.3. EVALUATION OF POLYMERS ADSORPTION ON MNPs 
The evaluation of polymers adsorption on MNPs was performed in order to determine the ratio 
of MNPs/polymer necessary to prepare stable porous structures with low MNPs leaching 
events. The adsorption capacity of chitosan, dextran and agarose onto MNPs was studied by 
static partition equilibrium experiments. 10 mg of MNPs (10 mg mL
-1
) were incubated with 
various solutions of polymers (0–15 mg mL
-1
) prepared in deionized water (agarose and 
dextran) and in acidic deionized water (1% v/v) (chitosan). All experiments were performed in 
duplicates at 80 ºC, as this is the temperature employed for polymers solubilisation, at 200 rpm 
for 24 h. At the end, MNPs were removed from the medium by magnetic separation and the 
amount of adsorbed polymer was determined by the anthrone method.
194
 
 
5.2.4. PREPARATION OF NATIVE AND MAGNETIC MONOLITHS 
Native monoliths were prepared in 4 steps. (1) Chitosan (90 mg), agarose (70 mg) and dextran 
(70 mg) were dissolved in 3 mL of deionized water which was 1% (v/v) acidic only for chitosan-
based casting solutions. In order to improve the mechanical properties of monoliths, for agarose 
and dextran casting solutions, 10 mg of acrylamide and 70 µL of GMA were added. In case of 
chitosan a new casting composed by 45 mg of chitosan and 45 mg of PVA was prepared as 
described by Barroso et al.
82
 (2) The crosslinker agent, MBA, was also added (2 % (wt per wt)) 
to the casting solutions, which were further placed in glass tubes (1 cm of diameter and 3 cm of 
height) and stirred at 80 ºC to assure homogeneous solutions. (3) After a complete solubilisation 
of polymers and crosslinker, the initiator and catalyst, TEMED (23 µL) and APS (40 µL) 
respectively, were added to promote the crosslinking process (see Fig.5.1). The crosslinking 
process occurred at 0 ºC during 30 minutes under stirring. (4) Then, casting solutions were 
frozen at -80 ºC for 12 h and lyophilized (Telstar cryodos-50) until dryness (24h). 
Magnetic monoliths (see Fig 5.2) were prepared following a similar procedure except that after 
step 2, 40 mg of MNPs were added to each casting solution and the mixture incubated at 80 ºC 
for 24 h in order to promote the polymer adsorption onto MNPs. Then, the casting solutions 
followed the same treatment as described in steps (3) and (4). 
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Figure 5.1 – Schematic representation of the natural-based monoliths design and composition. CHT 
indicates chitosan monolith, CP means chitosan/poly(vinyl alcohol) monolith, AA represents 
agarose/acrylamide monolith and DXT designates dextran-based monolith. 
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5.2.5. PREPARATION OF HYBRID MONOLITHS 
Magnetic monoliths were introduced in a plasma chamber which was thoroughly purged with a 
continuous flow of nitrogen to reduce trace amounts of air and moisture. During the treatment, 
free radicals were generated under inert-gas discharge environments on selected monoliths 
surface. Then, 1,6-hexanediamine was fed to the reaction chamber under vacuum by 
evaporating the 1,6-hexanediamine contained in a flask maintained at 150 ºC. The plasma 
treatment occurred at a power setting of 80 W and a constant pressure of 0.3 Torr inside the 
chamber during 30 minutes.
195
 The extent of amination was determined using the Kaiser test, as 
in previous works, involving the determination of amines in monoliths (Fig. 5.2 B).
82,161
  
 
 
Figure 5.2 - Illustration of the materials produced in this work (A) and schematic representation of the 
procedures applied for the production and functionalization of the magnetic monoliths (B). 
 
For immobilization of ligand TPN-BM, an excess of ligand (3 equiv. to the amination content, 
150 mg), was added to the aminated monolith samples (approximately 60 mg) in 6 mL of DMF 
and incubated on a rotary shaker (140 rpm) for 72 h at 85 ºC. TPN-BM functionalized magnetic 
monoliths were then washed with DMF until the absorbance at 267 nm, maximum absorbance 
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wavelength of TPN-BM ligand, was ≤0.005. In order to assure a complete removal of physically 
adsorbed ligand, the functionalized monoliths were hosted in a Varian column with 3 mL of 
capacity and 1 cm of inner diameter, and further washes with DMF and a CIP procedure were 
performed. The CIP procedure involved sequential washing with NaOH 1 M, 10 mL of water, 
regeneration buffer (NaOH 0.1 M in 30% of isopropanol) and again with 10 mL of distilled water 
until the absorbance at 267 nm was ≤0.005 in each step. The functionalized monoliths were 
finally washed with sodium phosphate buffer (50 mM, pH 8.0), sodium citrate buffer (50 mM, pH 
3.0) and glycine buffer (50 mM, pH 11) until the absorbance at 267 nm was zero. The ligand 
TPN-BM density was calculated by subtracting the amount of ligand collected in all washes from 
the initial ligand used in the immobilization step. 
 
5.2.6. CHARACTERIZATION OF NATIVE, MAGNETIC AND HYBRID MONOLITHS 
The morphological and mechanical properties of monoliths before (native) and after MNPs 
incorporation (magnetic), and after affinity ligand functionalization (hybrid) were investigated 
using SEM, MIP, water flux measurements and tensile-strain tests. SEM was performed in 
Hitachi S 2400 equipment with an accelerating voltage set to 15 kV. Firstly, the samples were 
frozen and broken in liquid nitrogen for cross-sectional analysis and, gold coated before 
analysis. Monoliths porosity, average pore size diameter and surface area were determined by 
MIP (Micromeritics, autopore IV). The water fluxes were determined at room temperature and 1 
atmosphere. Due to the high porosity of the scaffold network no pressure was applied. Thus, 
Varian columns (with a capacity of 3 mL and an effective volume of 1.2 mL) were packed with 
monoliths and charged with 1 mL of distilled water. The run time was registered and at least 
three measurements of distilled water flux were recorded. 
Uniaxial compression was used to determine the mechanical properties of the monoliths using 
tensile testing equipment (MINIMAT firmware v.3.1) at room temperature. Samples were 
prepared in a cylindrical shape (10 mm in diameter thickness). The length between clamps was 
set at 10 mm, the speed set to 1 mm min
-1
, a full scale load of 20 N and maximum extension of 
90 mm was used. The compression modulus was calculated from the slope of the linear portion 
of the stress-strain curve (see Chapters 2 and 3).
82
 
Uniaxial deformation induced by magnetic field was also performed in order to evaluate the 
response of monoliths at different magnetic fields.  Monolithic samples were submited at 
different permanent magnetic fields, 0.25, 0.5, 1.5 and 2.5 T, and their deformation, translated 
by the decrease of monolith’s length, was monitored during 20 minutes. At the end, the 
magnetic field was removed and the reversibility of the magnetic-shape memory was 
assessed.
196
 These tests were performed in dry and wet conditions, since the monoliths 
magnetic response can change according to the hydrate sate of the porous network. 
X-ray photoelectron spectroscopy (XPS) analyses were performed in order to examine the 
elemental compositions of native, magnetic and hybrid monoliths. The studies were conducted 
on a XSAM800 X-ray spectrometer, operated in the fixed analyser transmission (FAT) mode, 
with a pass energy of 20 eV, a power of 120 W and using a non-monochromatic radiation from 
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Mg anode (hλ=1253.6 eV). Spectra were collected with a step of 0.1 eV, using a Sun SPARC 
Station 4 with Vision software (Kratos). The curve fitting for component peaks was carried out 
with a non-linear least-squares algorithm using a product of Gaussian and Lorentzian peak 
shapes. The freeware XPSPeak 4.1 was used. No flood gun was used for charge accumulation 
neutralization. The charge shift was corrected taking as reference the C 1s binding energy at 
lower energy equal to 285 eV except in the samples containing the ligand TPN-BM where the 
value was set to 284.7 eV due to the existence of sp2 carbons.
197
 Sensitivity factors used were: 
C 1s – 0.25, O 1s – 0.66, N 1s – 0.44 and Fe 2p3/2 – 3.0. 
The stability of hybrid materials was evaluated by immersing them (15 mg) in 500 µL of 
solutions with different pH values and typical solutions employed in CIP procedures using a 96 
well block for 24 hours at 150 rpm. Samples of 200 µL were collected, and fresh 200 µL were 
added in order to maintain the total volume. The ligand leaching was quantified by absorbance 
at 267 nm and the release of MNP was quantified by the magnetite assay.
198
 
 
5.2.7. DESIGN OF A PERMANENT MAGNET 
In order to tailor a permanent magnet of 0.5 T with a straight-hole magnet shape to assist 
chromatographic experiments, FEM studies of a permanent magnet were conducted using 
Comsol Multiphysics Software© to identify the optimal permanent magnet characteristics 
(magnetic flux density strength in the z-direction,  outer diameter and height) for further order. 
The magnet was design on purpose and supplied by First4magnets. 
 
5.2.8. DETERMINATION OF STATIC AND DYNAMIC BINDING CAPACITIES 
Partition equilibrium experiments were performed in a batch system as described by Barroso et 
al,
82,161
 in order to estimate the static binding capacities. The adsorption of hIgG and BSA on the 
native and hybrid monoliths was investigated. Monolith samples (10 mg) were incubated with 
hIgG and BSA (0.0–60 mg mL
-1
, 500 µL) prepared in phosphate buffer (50 mM, pH 8.0). All 
experiments were performed in duplicates at 25 ºC, at a stirring rate of 200 rpm for 24 h. After 
incubation, the amount of protein in the supernatants was quantified at 280 nm on a microplate 
reader (Tecan Infinite F200, filter, λ=280 nm). In the meanwhile, a calibration curve was 
prepared using hIgG and BSA in phosphate buffer solutions (50 mM, pH 8.0) (0.0–60 mg mL
-1
). 
The adsorption phenomena followed the Langmuir–Freundlich model represented by:   
 
  
      
  
      
  
                 Equation 5.1 
where Kd is the apparent dissociation constant (M) that includes contributions from ligand 
binding to support, Qm is the maximum binding capacity (mg protein g
-1
 support), C is the 
concentration of protein in the liquid at the equilibrium (M) and n represents the Langmuir–
Freundlich coefficient. 
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The dynamic loading capacity of the packed columns with hybrid magnetic monoliths was 
determined using frontal analysis according with the equation below: 
 
 
               Equation 5.2 
where Q corresponds to the estimated adsorbent capacity and Ve corresponds to the elution 
volume. This procedure consisted in loading hIgG and BSA solutions (6 mL, 0.5 mg mL
-1
) in 
sodium phosphate buffer (50 mM, pH 8.0) through the equilibrated monolithic packed columns 
at gravitational conditions until the protein concentration of the output and input streams were 
equal. At that point, packed monolithic columns were washed with phosphate buffer (50 mM, pH 
8.0) to remove unbound protein and the bound protein was eluted using two different buffers, 
sodium citrate buffer (50 mM, pH 3.0) and glycine buffer (50 mM, pH 11.0). Samples collected 
(1 mL) during loading, washing and elution stages were examined by measuring absorbance at 
280 nm on a 96-well format. 
 
5.2.9. CAPTURE AND RELEASE OF IgG FROM PURE SOLUTIONS 
The affinity capturing experiments were performed in a step wise adsorption–desorption 
process by switching eluents at room temperature and at atmospheric pressure. Columns (with 
diameter and length 1 and 7 cm, respectively) were packed with hybrid monoliths, and then 
washed and equilibrated as described in the previous section. Then, 1 mL of hIgG (3 mg mL
-1
) 
was added and columns were washed with sodium phosphate buffer (50 mM, pH 8.0) until the 
absorbance measured at 280 nm reached  ≤0.005. The IgG bound was recovered with two 
elution buffers, either sodium citrate buffer (50 mM, pH 3.0) or glycine buffer (50 mM, pH 11.0) 
with and without magnetic compression. Packed columns with functionalized magnetic 
monoliths were then regenerated as previously described (applying CIP), in order to be reused. 
These chromatographic experiments were repeated during 3 cycles and one more after auto-
claving (SIP) in order to estimate the column capacity over time. The total amount of protein 
bound, eluted and regenerated from the hybrid monoliths was initially determined by 
absorbance measured at 280 nm and by the BCA method (microplate reader assay).
82
 
 
5.2.10. PURIFICATION OF MONOCLONAL ANTIBODIES, mAbs, DIRECTLY FROM CRUDE 
SAMPLES 
In order to evaluate the possibility to capture monoclonal antibodies directly from non-clarified 
crude extracts, columns packed with hybrid CP monoliths were tested with a mammalian crude 
extract solution (1 mL, 2 mg of total protein per millilitre). After crude extract loading, packed 
columns were washed with sodium phosphate buffer (5 mL, 50 mM, pH 8.0) until the 
absorbance measured at 280 nm reached ≤0.005, and the bound protein was further eluted with 
sodium citrate buffer (50 mM, pH 3.0) or glycine buffer (50 mM, pH 11) in the presence of 
magnetic field. All collected samples were analysed by the BCA assay to quantify the amount of 
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total protein bound and eluted from the monoliths. SDS-PAGE was performed on acrylamide gel 
(12.5%) in Tris-Glycine buffer system pH 8.3. Electrophoresis apparatus (from BIO-RAD) was 
connected with power supply at 120 V, 190 mA for 1 h. The gel was revealed using a silver 
staining kit from BIO-RAD. 
 
5.3. RESULTS AND DISCUSSION 
5.3.1. CHARACTERIZATION OF NATIVE AND MAGNETIC MONOLITHS 
All monoliths, native (N-without MNPs) and magnetic (M-with MNPs), were characterized 
according to their morphological, mechanical, magnetic and physico-chemical properties and 
stability. Fig. 5.3 exhibits the SEM images of native (Fig. 5.3 A, D, G, J) and magnetic (Fig.  5.3 
B, E, H, K) monoliths based on natural polymers. Regarding the porous network it is noticeable 
that the addition of MNPs to the 3D structure of the native monoliths did not influence 
significantly their architecture. The presence of MNPs well dispersed in the pore’s wall of 
magnetic monoliths is evident. Moreover, depending on polymer composition, monolithic porous 
network can be adjusted and different designs can be achieved. Monoliths composed of 
chitosan (CHT; Fig. 5.3 A-B) crosslinked with MBA, and chitosan blended with poly(vinyl 
alcohol) and entrapped also by the crosslinked (MBA) network (CP; Fig. 5.3 D-E), exhibit 
smaller, spherical and heterogeneous pores. On the other hand, monoliths prepared from 
casting solutions of agarose (AG; Fig. 5.3 G-H) or dextran (DXT; Fig. 5.3 J-K), both blended 
with GMA cryopolymerized with acrylamide, present a lacy structure with elongated pores. 
These supermacroporous structures were expected since monoliths based on agarose and 
dextran are known to form spongy networks, independently of their processing method.
72,192,199
 
All monoliths presented as semi-rigid single blocks with dimensions of the mould where they 
were prepared. Still, monoliths were able to fit in any support which presents the same 
dimensions or even with a higher diameter, since all of them were able to swell and fit to various 
supports wall.  The average pore size diameters and the porosity values calculated by MIP for 
each monolith before and after MNPs addition (Table 5.1) are in agreement with the SEM 
images. 
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Figure 5.3 - SEM images of natural-based monoliths before (native, N) and after MNP’s incorporation 
(magnetic, M) and hybrid monoliths (magnetic with ligand TPN-BM coupled, M_TPN-BM): (A) native 
chitosan monolith (CHT_N), (B) magnetic chitosan monolith (CHT_M), (C) hybrid chitosan monolith 
(CHT_M_TPB-BM), (D) native chitosan blended with poly(vinyl alcohol) monolith (CP_N), (E) magnetic 
chitosan blended with poly(vinyl alcohol) monolith (CP_M), (F) hybrid chitosan blended with poly(vinyl 
alcohol) monolith (CP_M_TPN-BM), (G) native agarose-based monolith (AG_N), (H) magnetic agarose-
based monolith (AG_M), (I) hybrid agarose-based monolith (AG_M_TPN-BM), (J) native dextran-based 
monolith (DXT_N), (K) magnetic dextran-based monolith (DXT_M) and (L) hybrid dextran-based monolith 
(DXT_M_TPN-BM). All the micrographs have a magnification of 300 and the scale bar in white indicates 
10 µm.  
 
 
The magnetic monoliths exhibited some differences regarding the values of average pore size 
diameter comparing with the native ones. CHT and CP monoliths suffered a noticeable 
enlargement from 17 and 53 to 89 and 88 µm respectively, after MNPs embedding, while 
monoliths prepared with agarose and dextran maintained average pore size diameters between 
70 and 90 µm. In addition, porosity values are similar for all monoliths (82-91%). High porosity 
values were expected since they are mainly related with the freeze-drying method employed in 
monoliths production, which normally generate high porosities.
200,201
 The specific surface area 
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values obtained for all monoliths were within the range 0.5 and 3.0 m
2 
g
-1
, which it is agreement 
with obtained values of porosity, since the surface area varies inversely to the porosity.
202
 
Materials for bioprocessing must be hydrophilic with well-organized porous networks to allow 
fast fluxes and easy permeations, and present mechanical stability to preserve their 
architecture. Table 5.1 also comprises the estimated water fluxes and compressive modulus 
measured, which translate the hydrophilicity and stiffness of material respectively, for all 
polymeric monoliths before and after MNPs addition. All monoliths presented values of water 
fluxes between 100 and 300 L m
-2
 h
-1
. CHT and CP monoliths revealed a decrease of water flux 
value after the incorporation of MNPs, from 142 and 294 to 110 and 120 L m
-2
 h
-1
, respectively. 
Conversely, AG and DXT monoliths, after MNPs addition, increased the water flux values from 
102 and 100 to 212 and 176 L m
-2
 h
-1
, respectively. This can be explained by morphological 
features and composition of each support. CHT and CP monoliths, although they exhibit an 
increase of pore size diameter after MNPs embedding, possess a very well organized 3D 
porous structure which in wet conditions, behaves homogenously with controlled swelling, 
namely when confined to a column. After MNPs addition, monoliths stay even better stabilized 
with a higher water uptake capacity. In a marked contrast, AG and DXT monoliths, which in 
native conditions already presented high swelling capacity, also exhibit a heterogeneous porous 
network that hampers a regular profile of water permeation. Furthermore, with the incorporation 
of MNPs, pores suffer an additional elongation due to MNPs mobility in a random way, and 
consequently higher water fluxes are achieved. Nevertheless, the obtained values for all 
supports assure efficient and convenient water fluxes.
82,203
 
The compressive mechanical properties were studied by uniaxial compression measurements 
under dry and hydrated conditions to validate the mechanical resistance of native and magnetic 
monoliths. In general, higher compression modulus indicate stiffer materials.
136
 Concerning the 
native supports, DXT monolith is stiffer at dry conditions, followed by CHT, CP and AG 
monoliths (Table 5.1). However, due to their larger pores, DXT in wet state becomes softer (0.6 
kPa) while CHT exhibits the highest value of compressive modulus (1.9 kPa). The remaining 
monoliths present similar values between 0.4-0.7 kPa. The mechanical behaviour of CHT in wet 
conditions is mainly related with its hydrogel nature which excels in the hydrated state. The 
addition of MNPs to the structures kept the same trend of their mechanical behaviour 
concerning monolith’s material, and hydration degree. Additionally, the obtained values are in 
the range of similar 3D porous structures.
82,200,203
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Table 5.1 - Morphological and mechanical characterization of natural-based monoliths before (native (N)) and after magnetic nanoparticles embedding (magnetic (M)). All data 
was obtained from duplicated and triplicated measurements. 
 
a
 Determined for dried monoliths by mercury porosimetry analysis. 
Table 5.2 - Morphological and mechanical characterization of hybrid monoliths. All data was obtained from duplicated and triplicated measurements. a Determined for dried 
monoliths by mercury porosimetry analysis. 
 CHT_M_TPN-BM CP_M_TPN-BM AG_M_TPN-BM DXT_M_TPN-BM 
Average pore size diameter (µm)
a
 125±5 20±5 18±5 13±5 
Porosity (%)
a
 79±9 75±9 76±5 61±5 
Water Flux  
(L m
-2
 h
-1
) 
176±9 135±8 186±9 78±5 
Surface Area (m
2
 g
-1
 )
a
 1.4±0.2 1.1±0.2 2.9±0.2 3.4±0.2 
Compressive Modulus (kPa) 
Dry Wet Dry Wet Dry Wet Dry Wet 
0.3±0.1 0.2±0.1 191±9 55±5 0.5±0.2 0.5±0.2 0.7±0.4 0.3±0.2 
 CHT_N CHT_M CP_N CP_M AG_N AG_M DXT_N DXT_M 
Average pore 
size diameter 
(µm)
a
 
17±5 89±5 53±5 88±5 73±5 71±5 96±5 75±5 
Porosity (%)
a
 91±2 90±2 88±2 86±2 93±2 92±2 82±2 98±2 
Water Flux  
(L m
-2
 h
-1
) 
142±5 110±7 294±7 120±9 102±9 212±9 100±5 176±8 
Surface Area 
 (m
2
 g
-1
 )
a
 
2.7±0.3 0.5±0.2 0.4±0.2 1.0±0.2 1.0±0.3 2.1±0.3 3.0±0.5 3.0±0.5 
Compressive 
Modulus 
(kPa) 
Dry Wet Dry Wet Dry Wet Dry Wet Dry Wet Dry Wet Dry Wet Dry Wet 
2.3±0.7 1.9±0.3 2.2±0.5 0.4±0.1 0.6±0.2 0.4±0.2 1.8±12 0.5±0.2 0.7±0.2 0.5±0.2 0.5±0.1 0.3±0.1 5.3±0.5 0.7±0.2 4.1±0.4 0.5±0.2 
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In order to evaluate the magnetic response of magnetic monoliths, samples in dry and wet 
conditions, with 1 cm of diameter and height, were placed in contact with different permanent 
magnets, and the physical deformation (shrinkage) was monitored over time. Fig. 5.4 shows the 
magnetic deformation of each support after 20 minutes in contact with permanent magnets with 
different intensities (0-2.5 T in dry and wet state).  
 
 
Figure 5.4 - Magnetic deformations of different magnetic natural-based monoliths: chitosan, CHT_M (A), 
chitosan- poly(vinyl alcohol), CP_M (B), agarose, AG_M (C) and dextran, DXT_M (D). All data was 
obtained from triplicated measurements with errors of ± 5. 
 
In general, independently of the monolith`s composition all wet supports presented higher 
magnetic deformations. This was expectable since beside in wet conditions the monoliths are 
less stiff, the MNPs inside offer a higher mobility to all 3D structure allowing a pronounced 
shrinking. Contrarily, dry magnetic samples are more rigid, therefore the shrinking capacity is 
inferior or negligible. Another aspect studied was the reversibility of the magnetically induced 
shrinkage. At low magnetic fields (0.25 and 0.5 T) monoliths have no magnetic memory as they 
can return to the initial position at both dry and wet conditions (Fig. 5.4). At 1.5 T the magnetic 
deformation varies depending on the monolith porous architecture and hydrated state. Thus, 
CHT_M and AG_M in dry and wet conditions present magnetic response while CP_M and 
DXT_M only exhibit it in wet conditions. At 2.5 T all monoliths revealed higher magnetic 
deformations which led to a total collapse of 3D porous structures and consequently to the loss 
of a magnetic reversible response. Thus, analyses suggest that a magnetic field of 0.5 T is 
enough to operate with natural magnetic based monoliths in on-off magnetic cycles without 
damaging the porous network. All macroporous monoliths were tested over four ON-OFF cycles 
at 0.5 T and always maintained their superparamagnetic behaviour. 
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Figure 5.5 - Evaluation of magnetic nanoparticles (MNPs) leaching from chitosan, CHT_M (A, B), 
chitosan- poly(vinyl alcohol), CP_M (C, D), agarose, AG_M (E, F) and dextran, DXT_M (G, H) magnetic 
monoliths immersed over 12 h in solutions with pH values between 1 and 12 and typically used during 
cleaning-in-place (CIP) procedures, respectively. All data was obtained from duplicated measurements 
with errors of ±8. 
 
 
For an efficient operation with magnetic monoliths, iron leaching is an important issue to 
address. The leaching of MNPs was investigated at different conditions employed in Ab 
purification processes mainly during the cleaning and regeneration steps. Fig. 5.5 shows the 
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MNPs leaching profiles from different natural magnetic based monoliths over time (12 hours). In 
general, MNPs leaching is negligible since the highest values achieved were around 4-6% at pH 
5 after 4 h, and between 4 and 9% upon contact with alcohols, after 1h. Chitosan has a pKa 
around 6-6.5 and at pH 5, chitosan based-structures exhibit high swelling capacity (porous 
network opening) which justifies the accentuated MNPs leaching. In addition, although agarose 
and dextran are uncharged polysaccharides, the acrylamide presented in monoliths composition 
has a NH2 group with a pKa value around 6, which, due to the same reason previously 
mentioned, leads to high MNPs release at pH 5. DXT_M revealed the most unstable support 
since, except with regeneration buffer and NaOH solution, the MNPs leaching is higher. This 
MNPs leaching control was crucial since it allowed choosing the best conditions to operate with 
each support, assuring their magnetic properties. 
 
5.3.2. PREPARATION AND CHARACTERIZATION OF HYBRID MONOLITHS 
Magnetic monoliths were functionalized with TPN-BM affinity ligand resulting in a hybrid 
material. The immobilization of functional molecules onto polymeric materials surfaces requires 
the presence of active chemical groups as primary amines.
88
 Plasma technology was the 
selected tool to fulfil this requirement in a green and sustainable way as it allows diverse solvent 
free modifications on supports within short periods.
193,195,204,
 Firstly free radicals were generated 
under inert-gas discharge environments on selected monoliths surface, followed by a second 
step reaction in which the 1,6-hexanediamine was dragged under vacuum condition (in situ) to 
react with the activated supports for further ligand coupling (Fig. 5.6 A). As shown in Fig. 5.6 B, 
large densities of amines were introduced in all magnetic supports, particularly in CHT_M 
(460±44 µmol of NH2 per gram of support). The application of plasma technology for the 
activation and amination of monoliths saved time and solvents consumption when comparing 
with traditional procedures applied for the same purpose.
88,114
 In this work, 30 minutes were 
sufficient to aminate the supports in contrast with the typical 13 hours needed in the traditional 
approach (1h for the epoxyactivaction and 12h for the amination).
23
 It should be noted that in 
Chapters 2 and 3, it was possible to improve the activation step from 1h to 5 min. However, in 
this work it was possible to save 12h of the traditional amination procedure, and use only 30 
minutes to activate and aminate the supports. Aminated monolithic platforms were subsequently 
functionalized with ligand TPN-BM. Different yields of ligand immobilization were reached 
according with the previous amination levels (Fig. 5.6 B). The highest immobilization value of 
TPN-BM was obtained for CHT_M and DXT_M monoliths (around 400 µmol TPN-BM g
-1
 
support) followed by CP_M, and AG_M (370 and 280 µmol TPN-BM g
-1
 support, respectively). 
The results from ligand immobilization suggest that most of amines reacted with TPN-BM which 
makes the immobilization strategy, herein proposed, extremely effective. After TPN-BM 
immobilization all magnetic supports were again characterized.  
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Figure 5.6 – Schematic representation of: (A) the amination procedure, assisted by plasma technology, of 
magnetic natural-based monoliths. (B) Graphical representation of the amination and TPN-BM 
immobilization yields obtained for all magnetic monoliths. 
 
SEM images presented in Fig. 5.3 F and I show that the porous networks of hybrid CP and AG 
monoliths (CP_M_TPN-BM and AG_M_TPN-BM respectively) were maintained after the 
functionalization procedure. Contrarily, hybrid CHT and DXT monoliths (CHT_M_TPN-BM (Fig. 
5.3 C) and DXT_M_TPN-BM (Fig. 5.3 L), respectively) exhibited morphological differences, 
namely pore enlargement and deformation coiled pores, respectively. In addition, all monoliths 
presented an increase in pores thickness which might be indicative of the ligand attachment. 
Differences regarding average pore size diameter, porosity and surface area values of supports 
after ligand coupling were also registered (Table 5.2). The CHT_M_TPN-BM registered an 
increase in average pore size diameter (from 89 to125 µm) while the remaining registered a 3-
fold decrease of the pore size. After TPN-BM coupling, all monoliths revealed a higher rigidity 
and, in dry conditions used during MIP analysis, the pores are more collapsed turning hard the 
mercury intrusion porosimetry. Porosity and surface area values kept close to the ones obtained 
before functionalization. The water flux values decreased for all supports which can be 
explained by the hydrophobic nature of TPN-BM. Still, all monoliths exhibited acceptable water 
uptake capabilities that assure the permeation of Ab or other large biomolecules. The 
compressive modulus of CHT_M_TPN-BM and DXT_M_ TPN-BM decreased, which is in 
agreement with the enlargement and winding of the porous network upon functionalization, 
since larger pores and high porosities led to soft materials.
136
 Conversely, CP_M_TPN-BM 
became stiffer in dry and wet conditions (~20-fold comparing to non-functionalized supports) 
which is in accordance with the pore size decrease. AG_M_TPN-BM maintained their 
mechanical behaviour. In addition all supports were tested for magnetic response under a 
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magnetic field of 0.5 T. All monoliths maintained the deformation in both states, dry and wet, as 
before ligand coupling, except for CP_M_TPN-BM which lost magnetic response in dry 
condition. 
Also the surface chemical composition was analysed by XPS for hybrid monoliths CP_M_TPN-
BM and AG_M_TPN-BM. For control, the corresponding amination step (CP_M_Amine and 
AG_M_Amine) as well as the native monoliths (CP_N and AG_N) were analysed and 
compared. Detailed XPS regions C 1s, N 1s, and Fe 2p are shown in Fig. 5.7 A – F. In CP_N 
besides the aliphatic carbons at a binding energy (BE) of 285 eV from PVA, C 1s also includes 
peaks centred at 286.0, 286.7 and 288.2 eV assigned mainly to chitosan carbons C-N, C-O and 
O-C-O, respectively.
197
 Carbon singly bound to oxygen also exists in PVA and the peak at 286.0 
eV can also include the contribution of C-N from the cross-linker (MBA), as attested by the peak 
centred at 288.8 eV attributed to N-C=O from MBA.
197
 The C 1s region of agarose-based native 
monolith, AG_N, was fitted with four peaks centred at 285, 286.7, 288.2 and 290.2 eV. The 
most intense peak (at 286.7 eV) corresponds mostly to C-O in agarose, and the peak centred at 
288.2 eV includes not only agarose O-C-O carbons, but also N-C=O from acrylamide and/or the 
MBA cross-linker, which existence is attested by the presence of nitrogen. Finally, the peak 
centred at higher BE can be attributed to carbon in a very electronegative neighbourhood such 
as a carbonate for instance. However, since carbonates are not likely to exist in this system, this 
shifted peak is compatible with a differential charge effect, i.e. it can correspond to carbon 
atoms in a phase with a loose electrical contact with the other phase, revealing an 
heterogeneous sample. In both native monoliths (which are composed by chitosan or agarose 
entrapped by PVA or acrylates respectively, (see Fig.5.1), the XPS N 1s regions include the 
contribution of amines and amides. Even in the presence of MNP and after functionalization 
with diamines followed by the ligand (TPN-BM), just one single peak centred at 399.8 eV was 
fitted. In fact, this peak can be the sum of different nitrogen atoms (in samples with ligand it can 
also include aromatic N), regardless the different chemical neighbourhoods.
197
 The only 
exception is N 1s of AG_N that shows two narrower peaks slightly shifted to higher BE which is 
most probably due to a differential charge effect already suspected in C 1s region.  
A large decrease of iron was observed since Fe 2p region is rarely or not detected in 
functionalized samples, revealing an efficient coating of the MNPs. However, in aminated 
samples iron was detected. Fe 2p3/2 has three peaks, centred at 709.3, 711.1 and 713.4 eV, 
assigned to Fe
2+
, Fe
3+
 in oxide (Fe2O3) or oxyhydroxide (Fe(OH)O) and iron in a very 
electronegative environment superimposed to a multiplet structure typical of Fe
2+
 oxides, 
respectively.
205,206
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Figure 5.7 – XPS regions C 1s, N 1s, and Fe 2p of native monoliths (black), magnetic and aminated 
(green) and hybrid monoliths (blue). 
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Also the quantitative results were gathered in Table 5.3. 
 
Table 5.3 – Binding Energies (eV) ± standard deviations and quantitative results obtained for 
chitosan/poly(vinyl alcohol )(CP) and agarose based-monoliths (AG) in native (N), magnetic (M), aminated 
(A) and hybrid (TPN-BM) conditions. 
 
XPS peak 
(BE, eV) 
AG_M_ 
TPN-BM 
AG_M_ 
Aminated 
N-AG 
 CP_M_ 
TPN-BM 
CP_M_ 
Aminated 
N-CP 
C 1s (284.7±0.1) 20.6 n.o. n.o.  21.8 n.o. n.o. 
C 1s (285.0±0.1) 16.8 48.6 10.5  23.0 38.0 36.2 
C 1s (286.0±0.1) n.o. n.o. n.o.  n.o. n.o. 9.0 
C 1s (286.7±0.1) 24.7 8.3 29.3  14.9 15.9 13.7 
C 1s (288.2±0.2) n.o. n.o. 22.0  8.2 7.9 4.1 
C 1s (288.8±0.1) 5.4 6.4 n.o.  n.o. n.o. 3.0 
C 1s (290.2±0.1) n.o. n.o. 4.9  n.o. n.o. n.o. 
O 1s (530.4±0.1) 4.4 9.4 n.o.  n.o. n.o. n.o. 
O 1s (531.7±0.3) n.o. 137 6.6  8.1 26.5 5.9 
O 1s (533.1±0.5) 23.7 5.5 23.1  19.3 n.o. 20.9 
N 1s (399.8±0.1) 4.1 6.6 n.o.  4.8 10.5 7.3 
N 1s (401.4±0.1) n.o. n.o. 1.9  n.o. n.o. n.o. 
N 1s (404.0±0.1) n.o. n.o. 1.8  n.o. n.o. n.o. 
Fe 2p3/2 
(709.3±0.2) 
0.1 0.3 n.o. 
 
n.o. 0.5 n.o. 
Fe 2p3/2 
(711.1±0.3) 
0.2 0.9 n.o. 
 
n.o. 0.5 n.o. 
Fe 2p3/2 
(713.4±0.4) 
0.1 0.4 n.o. 
 
n.o. 0.4 n.o. 
Atomic Ratios        
Fe/C 0.007 0.026 n.o.  n.o. 0.021 n.o. 
N/C 0.06 0.10 0.06  0.07 0.17 0.11 
n.o.: Not observable 
 
Comparison of monoliths containing MNPs show that the MNPs were effectively embedded in 
the polymer matrix since upon functionalization with TPN-BM, the XPS atomic ratio Fe/C 
decreased (becoming almost zero when the ligand is present). Moreover, comparing 
CP_M_TPN-BM and AG_M_TPN-BM, it is also evident that MNPs coating with 
polymer/amine/TPN-BM is more efficient in the CP-based hybrid (where the Fe/C ratio in the 
aminated monolith is lower and decreases to values that were not quantifiable when the ligand 
TPN-BM was added) than in the AG-based one. Additionally, the XPS N/C atomic ratio is larger 
in aminated monoliths than in the native ones, showing that in fact, the monoliths were 
efficiently modified with 1,6-hexanodiamine through the functionalization strategy based on 
plasma technology. Also, the N/C ratio is larger in aminated monoliths than in the monoliths 
subsequently functionalized with the ligand TPN-BM. This parameter, again, confirms that the 
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more superficial layer is, in fact, the TPN-BM since the stoichiometric ratio N/C in di-hexamine is 
1/3 whereas in the ligand (TPN-BM) is 3/11. 
  
 
Figure 5.8 – Evaluation of TPN-BM leaching from hybrid chitosan, CHT_M_TPN-BM (A, B), chitosan- 
poly(vinyl alcohol), CP_M_TPN-BM (C, D), agarose, AG_M_TPN-BM (E, F) and dextran, DXT_M_TPN-BM 
(G, H) monoliths immersed over 12 h in solutions with pH values between 1 and 12 and typically used 
during cleaning-in-place (CIP) procedures, respectively. All data was obtained from duplicated 
measurements with errors of ±11. 
 
The leaching of ligand TPN-BM was also evaluated for all hybrid supports, under the same 
conditions tested for MNPs leaching. Once again, considering the time of exposure to the harsh 
conditions tested (supports are never exposed more than 1 hour), the monoliths stability is 
assured except for DXT_M_TPN-BM (Fig. 5.8).   
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5.3.3. HYBRID MONOLITHS IN Ab PURIFICATION 
Once completely characterized and evaluated, magnetic and hybrid monoliths were submitted 
to static partition equilibrium measurements with hIgG and BSA (a model contaminant protein), 
in order to estimate the maximum binding capacity to the target molecule (hIgG) as well as the 
level of non-specific adsorption (BSA). The experimental data was fitted using a Langmuir–
Freundlich isotherm that is the indicated model for porous structures with heterogeneous 
morphology and it was also already successfully applied in similar supports.
137,153
 Fig. 5.9 
exhibits the adsorption profiles, while Table 5.4 shows the different affinity constants (Ka), 
theoretical maximum capacities (Qmax) and Langmuir–Freundlich coefficients (n) estimated.  
 
Table 5.4 - Summary of the estimated parameters of the Langmuir–Freundlich isotherms for all magnetic 
and hybrid monoliths. 
 
 
Considering the studies involving hIgG, the controls always exhibit lower Ka, Qmax and n values 
comparing with the functionalized ones. This observation suggests that the addition of TPN-BM 
ligand to the magnetic supports increases their specificity towards hIgG. Concerning the 
experiments with BSA, very few differences between magnetic and hybrid monolithic samples 
were found, suggesting that TPN-BM ligand coupling does not affect BSA adsorption and 
consequently, no affinity for BSA is manifested as expected.  
 
 Ka / (10
4 M-1) 
Qmax 
(mg g-1 support) 
n 
hIgG 
 Control TPN-BM Control TPN-BM Control TPN-BM 
CHT_M 0.9 3.0 600 1400 0.9 1.3 
CP_M 1.2 2.0 180 800 0.8 1.2 
AG_M 1 3.0 500 800 0.8 1.3 
DXT_M 0.2 4.0 500 700 0.9 1.2 
BSA 
CHT_M 0.2 0.2 550 600 0.9 0.9 
CP_M 0.3 0.2 100 200 0.8 0.8 
AG_M 0.2 0.2 625 665 0.8 0.9 
DXT_M 0.6 0.5 450 450 0.8 0.8 
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Figure 5.9 – Graphical representation of experimental adsorption isotherms (Exp) fitted by Langmuir-
Freundlich (LF) model for magnetic (M) and hybrid (M-TPN-BM) monoliths: (A) CHT_M and CHT_M_TPB-
BM (B) CP_M and CP_M_TPN-BM (C) AG_M and AG_M_TPN-BM (D) DXT_M and DXT_M_TPN-BM.   
 
In order to explore dynamic binding and mass transfer properties for the hybrid monoliths, 
breakthrough curves of pure hIgG solutions were estimated in duplicate (Fig. 5.10). Protein 
recovery was estimated using pH 3 (Fig 5.10 A) and pH 11 (Fig. 5.10 B) buffers. Elution buffer 
with pH 3 was chosen for being efficient in IgG recovery when ligands 22/8 and TPN-BM were 
coupled onto CHT and CP monoliths.
82,88
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Figure 5.10 – Breakthrough profiles for human IgG upon CHT_M_TPB-BM (▲), CP_M_TPN-BM (♦), 
AG_M_TPN-BM (●) and DXT_M_TPN-BM (■) monoliths, performing the elution at pH 3 (A) and pH 11 (B). 
(C) Summarizes the binding and elution capacities estimated through breakthrough curves at different 
elution conditions. 
 
On the other hand, pH 11 buffer demonstrated to be the best elution condition for MNPs 
functionalized with the affinity ligand 22/8.
114
  
Regarding the monoliths capacity, DXT_M_TPN-BM monolith presented the poorest scenario 
since it was able to capture 80 mg hIgG per gram of support. Nevertheless, CHT_M_TPN-BM, 
CP M_TPN-BM and AG M_TPN-BM monoliths exhibited better values of hIgG retention 
translated by appreciable values of binding (100, 99 and 103±10 mg hIgG g
-1
 support, 
respectively). Considering the elution profile, DXT_M_TPN-BM monolith showed a lower hIgG 
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recovery (28% of total hIgG bound at pH 3 and 14% of total hIgG bound at pH 11), as opposed 
to CHT_M_TPN-BM, CP M_TPN-BM and AG M_TPN-BM (73, 77 and 63±7%, respectively).In 
addition, elution at pH 3 revealed better values compared to those obtained at pH 11. 
In order to assess the effect of magnetic deformation for a better recovery yield, a tailored 
permanent magnet was designed. This was performed taking into consideration that: (1) the 
magnet needs to provide the required magnetic effect on the monolith without loss of magnetic 
responsive behaviour and, (2) its shape needs to help the extraction of antibody from the 
monolith by mechanical shrinking. 
 
 
Figure 5.11 – Map of the magnetic flux density strength in the z-direction, highlighting the key components 
of the setup. Magnet dimensions: internal radius r_int = 5.5 mm, external radius r_ext = 20 mm, height h = 
15 mm. 
 
In order to satisfy the point (1), a FEM parametric analysis led to the magnet optimal shape (Fig 
5.11) and the magnetic material adopted was neodymium 52, N52, (1.44 T of magnetic 
remanence). For the point (2), a geometrical constraint was fixed: the need to have a straight-
hole magnet shape, with a diameter of 11 mm, i.e. the monolith case diameter. Hence, the 
monolith case was able to be placed inside the magnet’s hole to work as a magnetic 
chromatographic approach. Thus, in a typical chromatographic operation, the loading of the 
sample is performed without magnetic field assuring that all pores of monoliths are completely 
available to process proteins extract without blocking. The same happens during the washing 
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step, where unspecific bound proteins are removed. The elution step is performed in the 
presence of the tailored made magnet as to induce a mechanical deformation onto the hybrid 
monoliths Fig. 5.12 A. The elution capacities (at pH 3.0) for all hybrid supports with and without 
magnetic field are shown in Fig. 5.12 B.  After charging the monolithic supports with 1 mL of 
pure hIgG solution (2 mg mL
-1
), it was possible to accomplish a faster recovery of 15% more 
hIgG under a magnetically-assisted elution. CP_M_A and AG_M_A monoliths revealed higher 
binding capacities and an elution capability of 90±5% when assisted by a magnetic field. 
Moreover, the magnetically-assisted elution takes half time (≤ 30 seconds) than a normal 
elution, which is also a great benefit in terms of time consumption and efficiency. 
 
Figure 5.12 – (A) Schematic representation of the porous network availability of hybrid monoliths during 
typical and magnetically-assisted elution of chromatographic experiments. (B) Graphical representation of 
binding (black), normal elution (grey) and magnetically-assisted elution (white) of hybrid natural-based 
monoliths. 
 
In order to evaluate the re-use capability of the hybrid monoliths, three consecutive 
chromatographic cycles and a fourth one after monolith autoclaving (After_AC) were performed, 
in duplicates, at an approximated flow rate of 1 mL min
-1
 (Fig. 5.13).   
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Figure 5.13 – Evaluation of chromatographic performance of (A) CHT_M_TPN-BM, (B) CP_M_TPN-BM 
and (C) AG_M_TPN-BM monoliths using pure IgG solutions. The chromatographic procedures, bind 
(black), elution (grey) and regeneration (white) steps, were performed consecutively along four cycles at a 
flow rate of 1 mL min
-1
. The last cycle was performed after autoclaving (After_AC). The elution was 
assisted by the permanent magnet (0.5 T). 
 
The DXT_M_TPN-BM monolith was not tested due to its fragile appearance and weak 
performance. Over four cycles, CHT_M_TPN-BM, CP M_TPN-BM and AG M_TPN-BM 
monoliths displayed a similar profile of binding, magnetically-assisted elution and regeneration, 
suggesting a reproducible behaviour in the capture and recovery of hIgG. CP M_TPN-BM 
monolith showed to be the most promising one since its binding capacity achieved 125 mg±15 
mg hIgG g
-1
 support, followed by AG M_TPN-BM (115±10 mg hIgG g
-1
 support) and 
CHT_M_TPN-BM (90±13 mg hIgG g
-1
 support). Concerning the efficiency of hIgG recovery, CP 
M_TPN-BM monolith remains the best one since it is able to release 90±5% of the total hIgG 
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bound, and only 8±5% is removed from the support at drastic conditions (regeneration step). AG 
M_TPN-BM monolith also registered a promising elution profile translated by the recovery hIgG 
value of 88±4%. The lowest elution capacity was verified for CHT_M_TPN-BM monolith since it 
was only possible to recover 70±8% of hIgG bound remaining 30±2% of hIgG in the support that 
was only excluded in the regeneration step. Probably the enlargement of pore size that chitosan 
monoliths suffered until achieved a hybrid character, decreased its stiffness penalizing its 
chromatographic performance. Magnetic monoliths (control) were also tested but only 25 mg of 
IgG per gram of support approximately were retained. In the elution and regeneration steps the 
amount of IgG retained was then recovered. 
The most challenging issue was to evaluate the selectivity of the hybrid materials for mAbs 
purification. As CP_M_TPN-BM and AG_M_TPN-BM monoliths revealed encouraging 
chromatographic profiles, they were selected to proceed with chromatographic studies involving 
mAbs from unclarified crude extracts. Fig. 5.14 summarizes the total amount of protein captured 
and eluted from both supports, at different magnetically-assisted elution conditions (pH 3 and 
11) (A) as well as SDS-PAGE gels (B). Considering the binding capacity, both supports 
revealed similar performance (17±5 mg total protein per gram of monolith) however, in the 
elution capability clear differences are visible.  CP_M_TPN-BM exhibits the highest elution 
value (98% of total protein bound) at pH 3 while AG_M_TPN-BM monolith achieved the same at 
pH 11. In order to assure that the total amount of protein previously quantified corresponds to 
mAbs, SDS gels were performed (Fig. 5.13 B and C). CP_M_TPN-BM (Fig. 5.14 B) and 
AG_M_TPN-BM (Fig. 5.14 C) monoliths proved high selectivity for mAbs since that, in elution 
fractions (lanes 7, 8, 9 and 10) only bands that correspond to mAbs fragments (50-25 kDa) are 
visible with a purity of approximately 97% (estimated by ImageJ analysis). All other components 
were excluded in washes (lanes 4, 5 and 6). These results suggest that CP_M_TPN-BM and 
AG_M_TPN-BM are promising supports for Ab recognition and isolation. CP_M and AG_M 
monoliths (control) revealed no affinity for mAbs capture. 
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Figure 5.14 – Chromatographic performance of CP_M_TPN-BM and AG_M_TPN-BM in mAbs purification 
from a non-heterogeneous crude sample with an associated error of ±5.0.(A)The acrylamide gel from 
SDS- PAGE performed with the fractions collected during the mAbs purification using CP_M_TPN-BM and 
AG_M_TPN-BM (B and C) at the best conditions of elution: lane 1 corresponds to the molecular weight 
marker, lane 2 represents the loading, lane 3 is the flowthrough, from lane 4 to lane 6 are represented the 
washes (phosphate buffer (50 mM, pH 8.0)), and from lane 7 to lane 10 are represented the elution 
fractions with sodium citrate buffer (50 mM, pH 3.0)) (B) and (glycine buffer (50 mM, pH 11.0)) (C), 
respectively. 
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5.4. CONCLUDING REMARKS 
The use of antibodies and derivative structures as effective therapeutics for cancer, 
autoimmune, infectious and inflammation diseases increased exponentially with an annual 
market worth tens of billions of US dollars. Thus, in order to give an answer to such demand, 
herein it is reported report the preparation of hybrid materials for Ab purification. These 
materials based on natural polymers were prepared in such a way that macroporous networks 
with great morphological and mechanical properties were created. Magnetic nanoparticles were 
embedded and an artificial ligand mimicking Protein A (TPN-BM) was coupled into the 
monoliths, turning them hybrid supports. The functionalization with TPN-BM conferred selectivity 
to the supports while the MNPs incorporation increased and accelerated Ab recovery. Green 
and solvent free strategies were employed to prepare and modify the hybrid monoliths, namely 
freeze-drying method and plasma technology.  
The presented hybrid platforms distance from others due to three main aspects: (1) they were 
prepared following metrics of green chemistry and engineering principles in order to save 
solvents, time and energy consumption, and designed for degradation; (2) they gather in just 
one material two main properties, affinity and magnetic response, already employed in different 
purification systems, and (3) they allow an efficient and fast operation, as the magnetic 
response facilitates the release of the target molecule that is typically performed under drastic 
acidic pH. The hybrid materials also exhibited a considerable stability towards CIP and SIP 
which underline their robustness. 
The magnetically-assisted elution process was efficient, faster and selective for Ab purification 
since CP_M_TPN-BM and AG_M_TPN-BM monoliths were able to bind 120 mg±10mg of hIgG 
per gram of monolith and to elute 91±5% for at least four consecutive cycles. Moreover, when 
tested with crude samples, both supports showed a good specificity for mAbs, recovering them 
with 97% of purity.  
The hybrid structures and the magnetically-assisted elution can be easily extended to the 
recognition and separation of different biomolecules with high added value by changing only the 
immobilized ligand. In addition, the application of these systems in biosensing or biomedical 
devices is also envisaged.   
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POROUS CHITOSAN-BASED MONOLITHS PREPARED FROM THE BEST 
COMBINATION OF SUSTAINABLE MATERIALS AND TECHNIQUES 
 
 
 
 
SUMMARY 
 
This work aims to redesign antibody purification processes combining the best and greener 
tools from the materials and techniques points of view, to achieve desirable performances. 
Thus, chitosan-based monoliths, with and without magnetic nanoparticles embedded, were 
produced following two strategies: (1) composed by gelation, water-acetone substitution 
followed by scCO2 phase-inversion and (2) involving swelling and freeze-drying methods, after 
monolith conception by the first strategy, to control the pore opening and, therefore, generating 
new porous network starting points. Both strategies allowed the production of different 
monolithic platforms with high control in pores architecture, great stiffness, magnetic and 
physico-chemical stability and easily functionalized with the biomimetic ligand TPN-BM, specific 
for antibodies. The elution of antibodies from the monolithic systems was tested in the absence 
and in the presence of a magnetic field (0.5 T). CP monoliths prepared only by the first strategy, 
and the magnetic ones further submitted to pores opening attempt, CP 25:75_TPN-BM and CP 
25:75_M_TPN-BM
FD
 respectively, exhibited an indicative affinity behaviour towards IgG which 
comprises acceptable estimated affinity parameters and encouraging binding capacities of 55 
and 32 mg IgG g
-1
 support, respectively. Moreover, CP 25:75_M_TPN-BM
FD
 monolith revealed 
an encouraging performance for mAbs isolation being able to elute magnetically 50% of mAbs 
with 75% of purity however, with low selectivity.  
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6.1. INTRODUCTION 
Over this thesis, the importance of mAbs and the significance of affinity chromatography as the 
major platform for mAbs purification have been widely discussed considering the ligand and 
supports points of view. In this chapter, the main focus is directed for the techniques that allow 
the monoliths production: from the most common to the alternative ones. 
Monoliths have been produced from polymerization of different acrylate monomers and by 
chemical modifications of natural or synthetic polymers combining the sol-gel, gelation, and 
freeze-drying methods.
20,61,82,207,208
 These strategies have enabled the fabrication of numerous 
monolithic platforms with distinguished architectures. However, they are very time consuming  
and/or involve organic solvents which are difficult to eliminate, remaining entrapped inside the 
polymeric network.
209
 Furthermore, there are also difficulties in the achievement and 
preservation of high levels of porosity and of the three-dimensional structure.
22
 Thus, 
sustainable and rigorous methods to design a very well-tuned porous network with macro and 
microstructural characteristics are still required in order to extend monolith applications to new 
targets. 
Over the last decades, supercritical fluids (SCF) have been successfully applied for polymer 
synthesis and processing.
210
 A supercritical fluid is any substance at a temperature and 
pressure above its critical point, that presents liquid like densities and gas like viscosities and 
diffusivities.
21
 Carbon dioxide (CO2) is the most typical substance used at supercritical 
conditions. Besides the environmental advantages of CO2 such as its low cost, non-toxicity, 
non-flammability, availability in high purity from numerous sources and its relative low critical 
temperature (Tc=31 ºC) and critical pressure (Pc=73.8 Pa), supercritical carbon dioxide (scCO2) 
can be used to prepare highly pure materials with high controlled morphology.
211
 Moreover, 
since CO2 can be easily removed from the pores without leaving any solvent residues, scCO2 
based processes are considered sustainable and green alternatives for the controlled design 
and production of polymeric porous structures.
21
 Therefore, different SCF-assisted processes, 
specially involving CO2, have been established such as: non-reactive gelation of SCF solutions 
using organogelators,
22,212,213
 crystallization of SCF-swollen crosslinked polymers (CSX),
22,214
 
foaming
215,216
 and phase inversion.
210,217,218
 Basically, in each process, scCO2 assumes different 
roles (e.g. as solvent, anti-solvent or porogenic agent) and acts in different stages of the 
processes (in the beginning or in the middle of porous structure process formation).
22
 
Particularly, the fact of being organic solvent free procedures, SCF-based processes offer 
significant environmental benefits: the drying steps are energy intensive, porous structure 
collapse is avoided, (since SCF do not give rise to a liquid-vapor interface, allowing high mass 
transfer, due to SCF low solvent viscosity) and polymers plasticization is permitted because it 
exhibits a great plasticizer ability.
22,219
 The efficiency of these tools for the design of tuned 
porous networks is translated in the variety of particles,
220,221,222 
scaffolds,
223,224,225 
and 
membranes
210,226,227
 that have been produced to be employed in tissue engineering,
209,228
 drug 
delivery,
78
 and bioseparation fields.
210,229 
Moreover, process parameters such as pressure, 
temperature, CO2 flow and depressurization rate can be adjusted and controlled easily, and 
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thus are additional process parameters that can be optimized when pursuing a specific 
morphological design.
226
 
Inspired on this panoply of green and efficacious SCF-based methods to produce porous 
platforms, herein it is intended to develop monoliths prepared from blends of chitosan and PVA 
(CP),
82
 and evaluate their performance as monolithic platforms for antibody purification. A 
strategy composed by gelation, water-acetone substitution followed by scCO2 phase-inversion 
was applied, and evaluated to prepare CP monoliths (with and without magnetic nanoparticles, 
MNPs, embedded) with a controlled pore adjustment. A second attempt to control the pore 
opening, involving swelling and freeze-drying methods, was also performed after magnetic CP 
monoliths conception.  
This strategy once established, can open the boundary of monoliths application for different 
targets in bioseparation, tissue engineering, cells growth and biomedical applications. 
 
6.2. EXPERIMENTAL AND METHODS 
6.2.1. MATERIALS 
Disodium hydrogen phosphate monodibasic (PA), disodium hydrogen phosphate dibasic (pro 
analysis), disodium tetraborate, ethanol absolute and sodium citrate dihydrate were purchased 
from Merck. Isopropanol and sodium bicarbonate were purchased from Riedel-de-Haën. 
Acetone (purity≥99%), and ethyl acetate were supplied by Roth. Acetic acid (purity≥99%), 
aminocaproic acid, 3-aminophenol, 4-amino-1-naphthol hydrochloride, cyanuric chloride 
(purity≥98%), 1,6-hexanediamine (purity≥98%), N,N-dimethylformamide (DMF), 
dimethylsulfoxide (DMSO), chloridric acid (HCl), glycine, ninhydrin, iron (II) chloride tetrahydrate 
(FeCl2.4H2O, purity≥99%), iron (III) chloride hexahydrate (FeCl3.6H2O, purity≥99%), maleic acid 
(C4H4O4≥99%), potassium cyanide, pyridine, sodium hydroxide (purity≥99%), sulfuric acid 
(H2SO4, purity≥95%), sodium phosphate monobasic monohydrate (H2NaO4P.H2O, purity≥98%), 
di-sodium hydrogen phosphate 2-hydrate (Na2HPO4.2H2O, purity≥98%) were purchased from 
Sigma Aldrich. Chitosan (75~85 % deacetylated, medium molecular weight), hydroxylamine 
hydrochloride (NH2OH.HCl, purity≥ 99%), poly(vinyl  alcohol) (purity≈99 %), bicinchoninic acid 
(BCA) kit, bovine serum albumin (BSA) (purity≥98%) were supplied by Sigma Aldrich. Human 
IgG was purchased by Octapharma (Gammanorm, purity≥99%). 1.10-phenonthroline 1-hydrate 
(C12H8N2.H20, purity≈99%) was acquired from Panreac. Carbon dioxide (CO2) was supplied by 
Air Liquid with 99.998% purity. All reagents were used without any further purification. 
 
6.2.2. MONOLITHS PREPARATION 
Chitosan-poly(vinyl alcohol) (CP) monoliths were prepared following a strategy based on the 
combination of three protocols already established.
209,215,228
 The methodology starts with the 
preparation of casting solutions by solubilizing chitosan (ranging between 14% and 25%, w/w) 
and poly(vinyl alcohol) (ranging between 76% and 86%, w/w) in acidic water (1% v/v) with a 
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composition of 14 wt%. The casting solutions were homogenized by heating up to 60 ºC with 
continuous stirring at 150 rpm. Then, a crosslinker, 2% of maleic acid (w/w, regarding the total 
mass of PVA),
230
 was added and the reticulation occurred under stirring at 90º C during 90 
minutes. Next, the casting solutions were poured into steel molds having an internal diameter of 
2 cm and height of 1 cm, and further frozen at −20 ◦C for 24 h to obtain a hydrogel (gelation 
process). The hydrogels were removed from the steel containers, immersed in acetone at −20 
◦C during 48 h for water-acetone replacement, and finally dried using scCO2.  
ScCO2 gel drying was performed according to the following procedure: firstly the steel 
containers were loaded again with the hydrogels (1), secondly they were introduced in the high-
pressure cell (2), which was closed and introduced in a thermostatized water bath, where CO2 
was added until the desired pressure, with an exact flow, using a Gilson 305 piston pump, (3) 
and finally, after reaching the normal operational pressure, the supercritical solution passes 
through a back pressure regulator (Jasco 88081) which separates the CO2 from the solvent 
(acetone) (4) (see Fig. 6.1). All these experiments were performed at 20.0±0.7 MPa with a CO2 
flow of 10.0 g min
-1
 during 3 h (estimated time was 1 hour per monolith). At the end, the system 
was depressurized during 10 min and dried porous monoliths were obtained (5). 
The same procedure was applied using CP casting solutions with MNPs. Casting solutions of 
25:75 of CHT-PVA (w/w) were prepared with 2 g of magnetic nanoparticles (MNPs), for a 
concentrated polymeric casting solution of 7 wt% The concentration reduction of the casting 
solution from 14 to 7% was performed to assure the mobility of MNPs in the monolithic 
constructs in order to take advantage of a magnetic monolithic response in the last stage 
(elution) of antibody purification. 
 
 
 
Figure 6.1 – Schematic representation of the chitosan-poly(vinyl alcohol) (CP) hydrogels drying under 
supercritical carbon dioxide (scCO2 drying). 
 
Another strategy was also attempted, and consisted into swelling the magnetic CP 25:75 
monoliths (CP 25:75_M) until the desired water uptake degree was achieved, and then 
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lyophilize them (Fig. 6.2). This approach aims to control the pore opening after monolithic 
platforms achievement. After 2 hours of swelling in water, CP 25:75_M were frozen at -20 ºC 
during 5 hours and lyophilized during 12 hours. At the end, a larger porous network was 
obtained. 
 
 
Figure 6.2 – Schematic representation of the additional procedure for the opening of porous network of 
chitosan-poly(vinyl alcohol) (CP) monolith: after obtaining CP monoliths by scCO2 drying, monoliths 
swelled 2 hours in water and then were frozen at -20ºC and lyophilized. 
 
6.2.3. PREPARATION OF AFFINITY MONOLITHS 
Native CP monoliths (with and without MNPs) were introduced in a plasma chamber which was 
thoroughly purged with a continuous flow of nitrogen to reduce trace amounts of air and 
moisture. Then, the CP monoliths modification followed two steps: (1) surface activation 
followed by (2) in-situ amination. The activation occurs through the radicals generated by Argon 
(Ar)-plasma and the amination by dragging 1,6-hexanediamine into the plasma chamber. For 
the amination step, after 5 minutes of Argon (Ar)-plasma treatment, gaseous1,6-hexanediamine 
was fed to the reaction chamber under vacuum by vaporizing the 1,6-hexanediamine contained 
in a flask that was maintained at 150 ºC, as mentioned in Chapter 5. The entire plasma process 
occurred at a power setting of 80 W and a constant pressure of 0.3 Torr inside the chamber 
during 30 minutes. According to what was previously described on Chapters 2, 3 and 5, the 
degree of amine functionalization was determined using the Kaiser test.
82,161
 For ligand TPN-BM 
immobilization, an excess of ligand (3 equiv. to the amination content, 180 mg), was added to 
the aminated CP monolith samples (approximately 150 mg) in 10 mL of DMF, and incubated on 
a rotary shaker (140 rpm) for 72 h at 85 ºC. TPN-BM functionalized monoliths were then 
washed with DMF until the absorbance at 267 nm, maximum absorbance wavelength of TPN-
BM ligand, becomes less than 0.005. In order to assure a complete removal of physically 
adsorbed ligand, the functionalized monoliths were hosted in syringes with 3 and 10 mL of 
capacity and 1.5 cm of inner diameter, and submitted to washes with DMF and to a CIP. The 
CIP procedure involved sequential washes with NaOH 1 M (until the absorbance at 267 nm was 
≤0.005), 10 mL of water, regeneration buffer (NaOH 0.1 M in 30% of isopropanol) and lastly, 
again with 10 mL of distilled water until the absorbance at 267 nm become lower than 0.005. 
The functionalized monoliths were finally washed with sodium phosphate buffer (50 mM, pH 
CHAPTER 6: POROUS CHITOSAN-BASED MONOLITHS PREPARED FROM THE BEST 
COMBINATION OF SUSTAINABLE MATERIALS AND TECHNIQUES 
106 
 
8.0) and sodium citrate buffer (50 mM, pH 3.0), typical buffer solutions employed in affinity 
chromatographic experiments, until the absorbance at 267 nm become negligible. The total 
ligand TPN-BM density (µmol g
-1
 support) was calculated by subtracting the amount of ligand 
collected in all washes from the initial ligand used in the immobilization step. 
6.2.4. CHARACTERIZATION OF NATIVE AND FUNCTIONALIZED MONOLITHS 
The morphological and mechanical properties of native (with and without MNPs) and 
functionalized monoliths with TPN-BM were investigated using SEM, MIP, water flux 
measurements and tensile-strain tests. SEM was performed in Hitachi S 2400 equipment with 
an accelerating voltage set to 15 kV. Firstly, the samples were frozen and broken in liquid 
nitrogen for cross-sectional analysis and, gold coated before analysis. Monoliths porosity, 
average pore size diameter and surface area were determined by MIP (Micromeritics, autopore 
IV). The water fluxes were determined at room temperature and atmospheric pressure. Varian 
columns with a capacity of 3 mL and an effective volume of 1.2 mL or syringes with 10 mL of 
capacity and 1.5 cm of inner diameter were packed with native and functionalized CP monoliths 
(bare and magnetic ones). The run time was registered and at least three measurements of 
distilled water flux were recorded. 
Uniaxial compression was used to determine the mechanical properties of the monoliths using 
tensile testing equipment (MINIMAT firmware v.3.1) at room temperature. Samples were 
prepared in a cylindrical shape (10-15 mm in diameter thickness). The length between clamps 
was set at 5-10 mm, the speed set to 1 mm min
-1
, a full scale load of 20 N and maximum 
extension of 90 mm was used. The compression modulus was calculated from the slope of the 
linear portion of the stress-strain curve (see Chapters 2 and 3). 
Uniaxial deformation induced by magnetic field was also performed for native and functionalized 
magnetic CP monoliths in order to evaluate their response at a magnet field of 0.5 T, the one 
selected as suitable for monolith shrinking without irreversible deformation (Chapter 5). This 
evaluation occurred during 30 minutes and at the end, the magnetic field was removed and the 
reversibility of the magnetic-shape memory was assessed. These tests were performed in dry 
and wet conditions, since the monoliths magnetic response can change according the hydrate 
sate of the porous network, as mentioned in Chapter 5. 
To evaluate the stability of native and functionalized monoliths, samples (15 mg) were 
immersed in 500 µL of solutions with different pH values, including typical solutions employed in 
CIP procedures, using a 96 well block for 24 hours at 150 rpm. Over the experience, samples of 
200 µL were collected and fresh 200 µL were added in order to maintain the total volume. The 
MNPs and ligand leaching were quantified by measuring the absorbance at 490 nm (following 
the magnetite assay)
198
 and 267 nm, respectively. 
 
6.2.5. DETERMINATION OF STATIC BINDING CAPACITIES 
In order to estimate the static binding capacities, partition equilibrium experiments were 
performed in a batch system as described by Barroso et al..
82
 The adsorption of hIgG on the 
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native and functionalized monoliths was investigated. Particularly, monolithic samples (30 mg) 
were incubated with hIgG (0.0–20 mg mL
-1
, 500 µL prepared in phosphate buffer 50 mM, pH 
8.0) at 25 ºC, 200 rpm during 24 h. These experiments were performed in duplicates. After 
incubation, the amount of protein in the supernatants was quantified at 280 nm on a microplate 
reader (Tecan Infinite F200, filter, l = 280 nm). Meanwhile, a calibration curve was determined 
using hIgG in phosphate buffer solutions (50 mM, pH 8.0) (0.0–20 mg mL).The adsorption 
phenomenon followed the Langmuir–Freundlich model and it was represented by:   
 
  
      
  
      
  
                 Equation 6.1 
where Kd is the apparent dissociation constant (M) that includes contributions from ligand 
binding to the support, Qm is the maximum binding capacity (mg protein g
-1
 support), C is the 
concentration of protein in the liquid at the equilibrium (M) and n represents the Langmuir–
Freundlich coefficient. 
 
6.2.6. DETERMINATION OF DYNAMIC BINDING CAPACITIES 
The dynamic loading capacity of the packed columns with native and functionalized CP 
monoliths was determined using frontal analysis according with the equation below: 
 
 
               Equation 6.2 
 
where Q corresponds to the estimated adsorbent capacity and Ve corresponds to the elution 
volume. This process consists in loading hIgG (6 mL, 0.5 mg mL
-1
) in sodium phosphate buffer 
(50 mM, pH 8.0) through the equilibrated monolithic packed columns at gravitational conditions 
until the protein concentration of the output and input streams were equivalent. At this point, 
packed monolithic columns were washed with phosphate buffer (50 mM, pH 8.0) to remove 
unbound protein, and the bound one was eluted in the presence or absence of the permanent 
magnet using sodium citrate buffer (50 mM, pH 3.0). Samples collected (1 mL) during loading, 
washing and elution stages were examined by measuring absorbance at 280 nm on a 96-well 
format. 
 
6.2.7 MONOLITHS PERFORMANCE OVER CYCLES OF PROTEIN CAPTURE AND 
RELEASE 
The monoliths performance over cycles was conducted in an adsorption–desorption process by 
switching eluents at room temperature and at atmospheric pressure. Varian columns with a 
capacity of 3 mL and 1 cm of inner diameter and, syringes with 10 mL of capacity and 1.5 cm of 
inner diameter were packed with CP monoliths and then washed and equilibrated as described 
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in previous section. At that point, 1 mL of hIgG solution (2 mg mL
-1
) was added and columns 
were washed with sodium phosphate buffer (50 mM, pH 8.0) until the absorbance measured at 
280 nm reached ≤0.005. The bound protein was recovered with sodium citrate buffer (50 mM, 
pH 3.0) with and without magnetic field. Packed columns were then regenerated as previously 
described (applying CIP), in order to be reused. These chromatographic experiments were 
repeated during 3 cycles in order to evaluate the column capacity over time. The amount of 
protein was initially determined by absorbance measured at 280 nm and by the BCA method 
(microplate reader assay). 
 
6.2.8. PURIFICATION OF mAbs DIRECTLY FROM CRUDE SAMPLES 
In order to evaluate the possibility to directly capture antibodies from non-clarified crude 
extracts, packed columns with bare and magnetic CP monoliths, before and after ligand TPN-
BM coupling, were tested with two different mammalian crude extract solutions: one containing 
monoclonal antibodies (mAbs) and another comprising the single chain (scFv) (1 mL, 
approximately 2 and 10 mg of total protein per millilitre, respectively). After loading with crude 
extract, the packed columns were washed with the sodium phosphate buffer (5 mL, 50 mM, pH 
8.0) until the absorbance measured at 280 nm reached less than 0.005. At that point the bound 
protein was eluted and recovered with sodium citrate buffer (50 mM, pH 3.0) at the presence 
and absence of magnetic field. All collected samples were analysed by the BCA assay to 
quantify the amount of total protein bound and eluted from the monoliths. SDS-PAGE was 
performed on acrylamide gel (12.5%) in Tris-Glycine buffer system pH 8.3. Electrophoresis 
apparatus (from BIO-RAD) was connected with power supply at 120 V, 190 mA for 1 h. The gel 
was revealed using a silver staining kit from BIO-RAD. 
 
6.3 RESULTS AND DISCUSSION 
CP monolithic structures with a well-defined porous network were prepared following an 
integrated strategy involving: (1) gelation process, (2) water-acetone substitution and (3) scCO2 
phase-inversion/drying. A further optimization, which consisted in submitting monoliths to an 
additional treatment for opening porous network through swelling and freeze-drying procedures, 
was also investigated. Then, monoliths were functionalized with the biomimetic ligand TPN-BM, 
following the procedure described in Chapter 5, which introduces the activation and amination 
of the surface of the monolith in one step, induced by plasma treatment. A detailed 
morphological, mechanical, magnetic and physico-chemical characterization before and after 
TPN-BM coupling was performed, in order to select the best monolith candidate to proceed with 
the studies of antibody purification involving pure and crude samples. 
6.3.1. MONOLITHS PREPARATION AND FUNCTIONALIZATION 
Chitosan-PVA (CP) solutions were prepared by dissolving chitosan (ranging between 15% and 
25%, w/w) in acidic water (1% v/v) with a composition of 14 wt%, following the steps described 
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in the section 6.2. Then, the casting solutions were frozen at -20ºC in order to form a hydrogel, 
that once formed, was immersed in acetone also at -20 ºC. The frozen water, upon contact with 
acetone, due to the melting depression effect, acquires mobility and start to be substituted by 
acetone (48h), which can easily be removed by drying the hydrogel under supercritical 
conditions (20 MPa, 40 ºC) and using a flow rate of 10 mL min
-1
 during 1 h /monolith. The 
depressurization time was 10 minutes. 
Different methodologies were attempted to achieve dried monoliths. Gelation, water-acetone 
replacement and scCO2 drying times, were significantly optimized. Particularly, water-acetone 
substitution is a crucial step since the polymers involved are only soluble in water that has a 
poor solubility in scCO2. Thus, by a simple immersion in acetone (step 2) of the frozen 
hydrogels, the water crystals formed during gelation step suffer a melting depression which 
enables an easy water/acetone replacement.
231,232
 Since acetone has a great solubility in 
scCO2, its further removal using scCO2 becomes easier (step 3). As Cardea et al. 
established,
228
 for a successful monolith gelation, time and temperature are extremely important 
for the formation of the structure of the gel. This gelation temperature will affect the stability of 
the structure in further processing steps, thus, gelation at low temperatures is necessary. The 
chosen temperature for gelation and subsequent water-acetone substitution, -20 ºC, assures 
that the gel formation occurs in a stable phase allowing for the water-acetone substitution 
without damaging the gel structure previously achieved.
228,233
 Thus, the water-acetone 
replacement is thermodynamically possible since it is established that in the presence of salts or 
organic solvents, the hydrogen bonds (HB) organization of water is severely disrupted, and new 
HB between super-cooled water and acetone are established.
231,232
  
The second attempt to tune monoliths porous network consisted in taking advantage of 
monolith’s swelling degree. Once established, monoliths were immersed in water to swell, and 
consequently, open their porous network. This “opening” was stopped by freezing the supports 
in hydrated state for subsequent lyophilization to attain a larger porous structure. This approach 
enables: (1) to estimate the monolith dimensions in hydrated state and (2) to define a new 
porous network starting point of the monoliths without repeating the entire process of monoliths 
production.  
Once obtained, CP monoliths were modified by plasma treatment for further TPN-BM ligand 
coupling. The modification of CP monoliths consisted in their surface activation with argon (Ar)-
plasma that allows the radicals formation for subsequent 1,6-hexanediamine immobilization, 
also assisted by plasma treatment. This greener strategy already discussed and evaluated in 
Chapter 5, was once more applied due to its great potential of surface modification saving 
organic solvents and time consuming. 
Hereupon, native and functionalized CP monoliths (bare and magnetic) were characterized in 
terms of morphological, mechanical, magnetic and physico-chemical features. 
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6.3.2. CHARACTERIZATION OF CP MONOLITHS BEFORE AND AFTER TPN-BM COUPLING 
SEM images presented in Fig. 6.3 exhibits bare and magnetic monoliths CP 25:75 monoliths 
before (Fig. 6.3 A, B and C) and after TPN-BM coupling (Fig. 6.3 D, E and F), respectively. 
Native bare and magnetic CP 25:75 monoliths (A and B) exhibit small spherical pores. After 
TPN-BM ligand coupling (D, E) the porous network of both supports is kept as well as their 
homogeneity. Considering the magnetic monolith processed by the additional step (swelling and 
freeze drying process (FD), CP 25:75_M
FD
) (Fig. 6.3 C), it is possible to observe a significant 
increase of porous network, even after its functionalization (CP 25:75_M_TPN-BM
FD
) (F), as the 
homogeneity of the support is maintained. This result comprising CP 25:75_M_TPN-BM
FD
 
monolith suggests that the freeze-drying step added after support swelling can be an optional 
strategy to monitor and redefine monoliths pore size in dry conditions. SEM micrographs of CP 
14:86 monoliths were not considered due to high heterogeneity, low stability and poor 
mechanical properties in dry and wet state exhibited by this support (Table 6.1). 
 
 
Figure 6.3 – SEM images of bare and magnetic chitosan-poly(vinyl alcohol) (CP) monoliths before and 
after functionalization with TPN-BM. Particularly, (A) bare CP monolith, CP 25:75, (B) magnetic CP 
monolith CP 25:75_M and (C) magnetic CP monolith submitted to an additional treatment for opening 
porous network involving swelling and freeze-drying procedures, CP 25:75_M
FD
.  The corresponding SEM 
images obtained after functionalization with TPN-BM are shown in D, E and F respectively: (D) CP 
25:75_TPN-BM, (E) CP 25:75_M_TPN-BM and (F) CP 25:75_M_TPN-BM
FD
. All the images have a 
magnification of 500 and the scale bar in white indicates 10 µm. 
 
Morphological data obtained by SEM is in agreement with the data obtained by (MIP) (Fig. 6.4). 
Fig. 6.4 A compares the pore size distribution of CP monoliths herein prepared (CP 25:75 and 
CP 14:86) and of CP 50:50 prepared by freeze-drying method described in Chapter 2. Clearly, 
the pores architecture of CP monolithic supports prepared from both methods is different. CP 
50:50 reveals a broad pore size diameter (one sharp peak around 10 µm and a larger one 
between 30-60 µm) and a higher mercury intrusion, ≈ 3.5 mL g
-1
, which means greater porosity 
(70%).
82
 Conversely, the mercury intrusion for CP 25:75 and CP 14:86, is around 0.5 mL g
-1
 
which translates a lower porosity value around 40% (Table 6.1), and a decrease in average 
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pore size diameter (between 0.5-10 and 20 µm). These results addressed to the sharper style of 
pore size distributions, justify the improvement of monoliths porous network production, with 
higher control, using the methodology composed by gelation process, water-acetone 
substitution and scCO2 phase-inversion/drying, herein presented. Fig. 6.4 B shows the pore size 
distribution of magnetic CP 25:75 prepared by both strategies: the one previously mentioned 
and another one involving freeze-drying after monoliths swelling (FD). 
 
Figure 6.4 – Distributions of pore size diameter of all chitosan-poly(vinyl alcohol) (CP) monoliths. 
Particularly, (A) represents bare CP monoliths: (●) CP 25:75, (■) CP 14:86 and, (▲) CP 50:50; (B) 
represents magnetic CP monoliths: (Δ) CP 25:75_M and (▲) CP 25:75_M
FD 
and (C) represents CP 
monoliths functionalized with TPN-BM: (○) CP 25:75_TPN-BM and (●) CP 25:75_M_TPN-BM
FD
. 
FD
 means 
that monoliths were submitted to an additional treatment for opening porous network involving swelling and 
freeze-drying procedures. 
 
It is clear the enlargement of pore size diameter of CP 25:75_M
FD
 (around 10 µm in average) 
comparing with CP 25:75_M (around 0.6 µm). Nevertheless, the porosity is similar (Table 6.1) 
for magnetic CP monoliths treated by different strategies. Although the strategy that comprises 
swelling and freeze-drying procedures has allowed a pore size enlargement, the monolith 
volume also increased. Since the porosity translates the quotient between the pore volume and 
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the total volume (support volume plus pore volume),
228
 the volumes ratio was not significantly 
affected, resulting a similar porosity for magnetic CP monoliths treated differently. Fig. 6.4 C 
illustrates the pore size distribution of bare CP monolith after TPN-BM immobilization (CP 
25:75_TPN-BM), and the magnetic one submitted to pores opening method also after TPN-BM 
coupling (CP 25:75_M_TPN-BM
FD
). For CP 25:75_TPN-BM, the porosity as well as the pore 
size diameter decreased, approximately from 43 to 28% and 5 to 0.6 µm, respectively. This was 
expected since the ligand coupling process normally leads to a decrease (Table 6.1) of these 
morphological features.
82,161
 Addressed to this, the value of compression modulus in dry state 
increased significantly, as expected. However, the stiffness of the material in wet state is very 
similar before and after TPN-BM coupling, suggesting that independently of the monolith 
composition, no significant differences are registered upon hydration (Table 6.1). Additionally, 
the post-treatment combining the swelling with further freeze drying process (only applied for 
magnetic monoliths in order to take advantage of their magnetic behaviour), originated 
monoliths (CP 25:75_M
FD
 and CP 25:75_M_TPN-BM
FD
) with pore size diameter around 9±2 
µm, porosities above 50% (53-55%) and a strong mechanical behaviour (around 16.0±2 and 
3.0±0.5 kPa) for CP 25:75_M
FD
 and CP 25:75_M_TPN-BM
FD
, respectively. These values are 
within the range of values that are required for chromatographic supports to enable the 
processing of viscous and crude samples.
140
 
 
Table 6.1 - Morphological and mechanical characterization of bare and magnetic chitosan-poly(vinyl 
alcohol) (CP) monoliths before and after functionalization with ligand TPN-BM. All data was obtained from 
triplicated measurements.
 FD
 means that monoliths were submitted to an additional treatment for opening 
porous network involving swelling and freeze-drying procedures. 
 
Monolith 
Average 
pore size 
diameter
a
 
(µm) 
Porosity
a
 
(%) 
Surface  
area
a
 
(m
2
g
-1 
 
monolith) 
Compressive modulus 
(kPa) 
Dry Wet 
CP 25:75 5±2 43±5 7.4±0.2 8±2 4.0±0.2 
CP 14:86 20±5 39±5 4.2±0.2 1.4±0.2 1.5±0.2 
CP 25:75_TPN-BM 0.6±0.2 28±5 6.2±0.5 22±2.0 2±1 
CP 25:75_M 0.6±0.2 49±5 11.3±0.5 21±2.0 3±1 
CP 25:75_M_TPN-BM 0.9±0.2 28±5 6.2±0.5 2±1 2±1 
CP 25:75_M
FD
 7±2 53±5 1.7±0.2 14±2 2.8±0.5 
CP 25:75_M_TPN-BM
FD
 9±3 55±5 1.2±0.2 17±2 3.2±.0.5 
a
 Determined for dried monoliths by mercury porosimetry analysis. 
 
If the swelling time was extended, probably larger pore sizes could be generated and thus, a 
correlation between both parameters could open new insights for the preparation of different 
starting points of porous structures. 
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In agreement with these morphological and mechanical features are the water fluxes (Fig. 6.5). 
 
Figure 6.5 – Water fluxes of bare and magnetic chitosan-poly(vinyl alcohol) (CP) monoliths before and 
after functionalization with ligand TPN-BM at the absence and presence (represented by bars with strikes) 
of a permanent magnet of 0.5 T. 
FD
 means that monoliths were submitted to an additional treatment for 
opening porous network involving swelling and freeze-drying procedures. 
 
The water fluxes for different CP 25:75 monoliths were measured at the pH conditions applied 
for antibody capture and release, pH 8 and 3, respectively.
11,82,161
 It must be noted that the 
housings used for water flux measurements were different and dependent on the monolith type 
(bare or magnetic). The permanent magnet used to measure the magnetically-assisted water 
fluxes was designed to allocate a housing (column) with 1 cm of diameter (all the calculations 
and details are referred in Chapter 5). However, the monoliths herein produced have 1.5 cm of 
diameter. Thus, the magnetic monolith, CP 25:75_M, was cut to be fitted in a column with 1 cm 
of diameter, which was than inserted in the hole of the permanent magnet. Nevertheless, the 
water flux remained impossible to be measured at the gravitational conditions, due to monolith 
negligible swelling capacity, as there was no available apparatus that could work under 
pressure. Conversely, the magnetic ones, submitted to the additional treatment for opening 
porous network, were tested in a column with 1 cm of inner diameter, after incubation with water 
overnight to improve their swelling behaviour. The column was closed at the bottom to assure 
that the monolith was able to swell and fit to the column walls homogeneously. The water flux 
measurements of bare CP monoliths, before and after TPN-BM coupling, were performed in a 
column with 1.5 cm of diameter, since the bare supports were not evaluated under 
magnetically-assisted conditions. CP 25:75 and CP 25:75_TPN-BM presented similar fluxes at 
pH 8 and 3 (between 3 and 4 L h
-1 
m
-2
) suggesting that, although the differences of pore size 
diameters and porosity values obtained for these two supports, both might have a very well 
interconnected porous network. Predominantly, it is expected that supports with larger pores 
and higher porosity lead to higher fluxes. However, if the pores are interconnected, the water 
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fluxes can be similar and comparable between two distinguished porous networks.
234
 Regarding 
magnetic monoliths, although exhibiting high stiffness and a closed porous network, the flux of 
CP 25:75_M_TPN-BM was possible to be measured (Fig. 6.5). CP 25:75_M_TPN-BM always 
presented higher water flux at pH 8 than at pH 3, either in the absence or in the presence 
(represented in the Fig. 6.5 by bars with sticks) of the magnet. At low pH, chitosan (pKa≈6.5) is 
deprotonated and thus, swells more.
78
 However, as the monolith is fitted into a column, the 
matrix swelling is limited by column dimensions, leading to a water flux reduction. Another and 
fundamental observation is that under a magnetic field (0.5 T), CP 25:75_M_TPN-BM shows 
higher flux values at pH 8 and 3 (9 and 6.5 L h
-1 
m
-2
, respectively) rather than in the absence of 
the magnetic field (5 and 2.5 L h
-1 
m
-2
, respectively). These observations clearly suggest that: 
(1) the monolith is able to respond to a magnetic field of 0.5 T and (2) the MNPs embedded into 
monolith network increase its hydrophilicity and then, the water fluxes. Lastly, the monoliths 
submitted to the swelling and freeze drying post-treatment, CP 25:75_M
FD
, exhibited evidently 
higher water fluxes at both pH conditions studied (approximately 10 L h
-1
 m
-2
), comparing with 
the ones not submitted to pores opening, with further increase when under the action of the 
magnetic field (approximately 13 L h
-1 
m
-2
). Moreover, after TPN-BM coupling, CP 
25:75_M_TPN-BM
FD
 achieved the higher water flux at pH 3 under the presence of the magnet 
(approximately 18 L h
-1 
m
-2
), demonstrating the potential acceleration of antibody recovery in 
downstream processes when using these monoliths in a real application. 
In order to evaluate the magnetic deformation, magnetic CP 25:75 monoliths were placed into a 
permanent magnet of 0.5 T, and the size decrease was monitored in dry and wet conditions 
(Fig. 6.6). 
Non-functionalized magnetic CP monoliths (CP 25:75_M and CP 25:75_M
FD
) in dry state 
exhibited a negligible magnetic deformation (≈ 2%). The stiffness of the supports does not allow 
a significant magnetic deformation, only an attraction to the magnet. Conversely, in wet state, 
these supports are able to deform approximately 12%. In addition, after magnet removal, they 
are able to recover 6% of their initial size, but a total return to the initial position is not 
detectable. Functionalized magnetic CP monoliths (CP 25:75_M_TPN-BM and CP 
25:75_M_TPN-BM
FD
) also did not deform suggestively in dry state. However, in wet state both 
supports reveal higher magnetic deformation (between 16 and 21%, respectively) with the 
capacity to return to their initial position. 
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Figure 6.6 – Magnetic deformation of magnetic chitosan-poly(vinyl alcohol) (CP) monolith, CP 25:75_M, 
magnetic CP monolith submitted to an additional treatment for opening porous network involving swelling 
and freeze-drying procedures, CP 25:75_M
FD
,  and CP 25:75 and CP 25:75_M
FD
 monoliths after 
functionalization with TPN-BM, CP 25:75_M_TPN-BM and CP 25:75_M_TPN-BM
FD
,  respectively,  in dry 
and wet states, at the presence of a permanent magnet of 0.5 T. 
 
The higher magnetic deformation was achieved with the wet magnetic CP monoliths which were 
submitted to the swelling and freeze-drying stages (FD), functionalized with TPN-BM 
(CP25:75_M_TPN-BM
FD
). This result is in agreement with the morphological properties 
previously discussed, since magnetic CP 25:75 monoliths treated with the “pores opening” 
approach presented larger pores, that facilitate the porous network mobility and, consequently, 
greater magnetic deformations are achieved.  
Considering all morphological and mechanical properties as well the ability to respond to 
magnetic stimulus, CP 25:75_M_TPN-BM
FD
 monolith appears as the most promising support for 
the purpose of this study. Thus, in order to evaluate the stability of CP 25:75_M_TPN-BM
FD
 
monolith, regarding MNPs and TPN-BM leaching issues, studies of release profiles over 12 
hours were performed immersing CP monolithic samples in different solvents and in pH buffer 
and CIP solutions (most typically used in bioseparation) (Fig. 6.7). 
MNPs leaching from CP 25:75_M_TPN-BM
FD
 was practically negligible since MNPs release 
after 12h only occurred using HCl (Fig. 6.7 A). Considering other solution conditions, less than 
2% of MNPs were released. This result suggests that CP monoliths fabricated by the strategy 
herein reported can be as much or more robust and stable than the ones produced by freeze-
drying method (Chapter 2, 3 and 5).
82,161
 Considering the TPN-BM leaching (Fig. 6.7 B), also the 
stability of the monolith is evident because the maximum amount of TPN-BM released (9%) 
occurs after 12 h using NaOH and regeneration buffer solutions. Nevertheless, CP 
25:75_M_TPN-BM
FD
 is never exposed more than half an hour to those harsh conditions herein 
tested. 
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Figure 6.7 – Stability evaluation of magnetic chitosan-poly(vinyl alcohol) (CP) monolith submitted to an 
additional treatment for opening porous network involving swelling and freeze-drying procedures, 
functionalized with TPN-BM, CP 25:75_M_TPN-BM
FD
, regarding (A) magnetic nanoparticles (MNPs) and 
(B) TPN-BM leaching, when immersed over 12 h in solutions typically used during cleaning-in-place (CIP) 
procedures, including solutions with pH values of 3, 5, 7, 8 and 11. All data was obtained from duplicated 
measurements with errors ± 3%. 
 
The CP monoliths functionalization strategy was also monitored and evaluated. CP monoliths 
were activated and aminated under plasma treatment for further TPN-BM coupling. Particularly, 
the activation occurs through the radicals generated by argon (Ar)-plasma at the supports 
surface. Thus, the activated monoliths react with the 1,6-hexanediamine which is dragged by 
plasma system. TPN-BM was further immobilized promoting the reaction of the free chlorine 
presented in TPN-BM ligand and free NH2 onto aminated CP monoliths, in DMF batch system. 
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After the functionalization procedure, amines and TPN-BM yields were estimated by Kaiser test 
(see Chapter 2) and by subtracting the initial and final amount of TPN-BM, respectively (Fig. 
6.8). 
 
 
Figure 6.8 – Amines and ligand TPN-BM densities of native and magnetic chitosan-poly(vinyl alcohol) 
(CP) monoliths, CP 25:75 and  CP 25:75_M
FD
 respectively, both produced using the functionalization 
strategy based on plasma technology. 
FD
 refers to monoliths that have undergone further swelling and 
freeze-drying procedures for additional opening of porous network. 
 
Fig. 6.8 exhibits and compares the efficiency of CP monoliths functionalization for two supports 
processed by different methods and thus, exhibiting different morphological properties. CP 
25:75 was not submitted to a porous network opening through swelling and freeze-drying 
procedures after water-acetone substitution and scCO2 drying as CP 25:75_M
FD
 was. 
Therefore, different morphological features were obtained (as previously discussed) and 
consequently different amination and TPN-BM yields were achieved. CP 25:75_M
FD
 presented 
higher values of amination (370±10 µmol NH2 g
-1
 support) and TPN-BM coupling (320±20 µmol 
TPN-BM g
-1
 support) yields, than CP 25:75 (310±40 µmol NH2 g
-1
 support and 290±10 µmol 
NH2 g
-1
 support, respectively). Both monoliths were functionalized following the same 
procedure. Thus, functionalization strategies based on plasma treatment may be more efficient 
for materials modifications if the materials exhibit large pores. Particularly, as larger pores allow 
a better efficiency of argon diffusion, more activated radical groups at the matrix surface are 
enabled, and consequently, higher density of bonded amines and successive ligand couplings 
can be reached. 
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6.3.3. EVALUATION OF TPN-BM FUNCTIONALIZED MONOLITHS FOR ANTIBODY 
PURIFICATION 
To evaluate the adsorption capacities of CP monoliths for IgG, and consequently to estimate the 
affinity parameters involved, partition equilibrium studies were performed in duplicate, and the 
experimental data was fitted according to Langmuir-Freundlich (LF) isotherm. Langmuir-
Freundlich isotherm was the chosen adsorption model because its assumptions fulfils the 
characteristics of CP monoliths-IgG systems: (1) CP monoliths present heterogeneous nature 
(2) that involve unequal binding sites and, (3) at low concentration of IgG, the experimental data 
is not linear which is characteristic of Freundlich model, while for higher IgG concentrations the 
experimental profile of CP monoliths behave as a monolayer adsorption, typical of Langmuir 
model.
139,141,137
 Fig. 6.9 A exhibits the experimental (exp) and theoretical (LF) profiles for 
adsorption of IgG onto CP 25:75 and CP 25_75_M
FD
 before and after TPN-BM coupling. Fig. 
6.9 B shows the different affinity constants (Ka), theoretical maximum capacity (Qmax) and 
Langmuir–Freundlich coefficients (n) that were obtained for each CP monolith, with an error of 
±0.5, ±30 and ±0.1, respectively. Functionalized monoliths, CP 25:75_TPN-BM and CP 
25_75_M_TPNBM
FD
, always offered higher values of Ka, Qmax and n, when compared to the 
non-functionalized ones. This observation suggests the importance of TPN-BM coupling to 
improve the binding capacity of CP monoliths for IgG. Curious is the similar Ka value obtained 
for non-functionalized magnetic monolith, CP 25_75_M
FD
 (1.5×10
4
 M
-1
), comparing with the 
bare one after TPN-BM coupling, CP 25:75_TPN-BM (1.2×10
4 
M
-1
). Although CP 25:75_TPN-
BM present similar Ka value than CP 25_75_M
FD
, the Qmax and n values are higher, 550 mg IgG 
g
-1
 support and 1.8, in comparison with 255 mg IgG g
-1
 support and 1.1 of CP 25_75_M
FD
, 
respectively. Furthermore, calculated Ka values exhibit the same order of magnitude (10
4
), 
usually obtained for similar affinity devices fitted with Langmuir–Freundlich isotherm,
82,139,141
 
indicating a medium affinity interaction, which is considered optimal for bioseparation processes 
while facilitating protein recovery.
6
 
The values of Qmax for CP 25:75_TPN-BM and CP 25_75_M_TPNBM
FD
 were 550 and 515 mg 
IgG g
-1
 support, respectively, which are higher than the ones observed for CP 25:75 and CP 
25_75_M
FD
 (210 and 255 mg IgG g
-1
 support, respectively), and analogous to the values for 
similar functionalized platforms used for the same purposes.
82,136,141,161
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Figure 6.9 – (A) Langmuir–Freundlich adsorption isotherms for bare and magnetic chitosan-poly(vinyl 
alcohol) (CP) monoliths before, CP 25:75 and CP 25_75_M
FD
, and after TPN-BM immobilization (CP 
25:75_TPN-BM and CP 25_75_M_TPNBM
FD
 and (B) summary of the estimated affinity parameters of  
Langmuir–Freundlich isotherms for bare and magnetic chitosan-poly(vinyl alcohol) (CP) monoliths before 
and after TPN-BM immobilization. 
FD
 refers to monoliths that have undergone further swelling and freeze-
drying procedures for additional opening of porous network. 
 
The n is normally employed as an empirical coefficient that represents the type and the extent 
of cooperativity presented in the binding interaction. Therefore, n>1 demonstrates good binding 
capacity (positive cooperativity between protein and adsorbent) and a heterogeneous feature of 
adsorption. Conversely, n=1 and n<1 indicate purely independent non interacting sites and 
negative cooperativity, respectively. Thus, for CP 25:75_TPN-BM and CP 25_75_M_TPNBM
FD 
the n values are closer to 2, meaning a positive cooperativity in binding (attractive forces due to 
lateral interactions) and a heterogeneous nature of protein adsorption, while for CP 25:75 and 
CP 25_75_M
FD
, n values are between 0 and 1 suggesting a poor or inexistent cooperativity. 
Summing up, CP monoliths functionalized with TPN-BM showed higher affinity parameters than 
those non-functionalized, result obtained from an accurate approximation of the fitting of 
experimental data with LF isotherm. The sigmoidal behaviour at low IgG concentration and a 
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linear profile at higher IgG concentrations of experimental data explain the use of LF isotherms 
as an indicated model to explain the adsorption phenomena of CP monoliths-IgG systems. 
In order to estimate the dynamic binding capacity of CP monoliths, breakthrough curves were 
performed using bare and magnetic CP monoliths before and after TPN-BM coupling: CP 25:75 
(control), CP 25:75_TPN-BM, CP 25:75_M
FD
 (control) and CP 25:75_M_TPN-BM
FD
 (Fig. 6.10). 
 
Figure 6.10 – Breakthrough profiles for human IgG upon chitosan-poly(vinyl alcohol) (CP) 25:75 
monoliths: (A) bare and (B) magnetic, before and after TPN-BM coupling. Bare CP monoliths before and 
after TPN-BM coupling, CP 25:75 and CP 25:75_TPN-BM respectively, were tested in a column with 1.5 
cm of diameter and thus, in the absence of a permanent magnet (A) while magnetic CP monoliths before 
and after TPN-BM coupling, CP 25:75_M
FD
 and CP 25:75_M_TPN-BM
FD
 respectively, were tested in a 
column with 1 cm of diameter and under magnetic elution conditions of 0.5 T (B). 
FD
 refers to monoliths 
that have undergone further swelling and freeze-drying procedures for additional opening of porous 
network. 
Bare CP monoliths with or without TPN-BM coupling, were placed in a larger column (1.5 cm of 
diameter) since they did not need to be cast in a column with 1 cm of diameter to fit in the hole 
of the permanent magnet, to be tested under magnetically-assisted conditions as magnetic 
monoliths needed. Therefore, both tested conditions, for bare and magnetic supports, are not 
directly comparable since the swelling degree of each support, and consequently the porous 
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network availability, is different due to the restrictions of column dimensions. Thus, the profiles 
of CP monoliths observed in Fig. 6.10 led to different amounts of IgG bound and eluted (Table 
6.2) since they must be considered independent systems. 
 
Table 6.2 - Binding and elution dynamic capacities of chitosan-poly(vinyl alcohol) monoliths, CP 25:75 and 
CP 25:75_M
FD
, before and after TPN-BM coupling, CP 25:75_TPN-BM and CP 25:75_M_TPN-BM
FD
, 
respectively; the values were obtained from the breakthrough profiles for human IgG. 
 
Monolith 
hIgG Bound 
(m IgG g
-1
 support) 
% hIgG eluted 
(m IgG Eluted  g
-1
 support) 
CP 25:75 15 ± 5 63 ± 5 
CP 25:75_TPN-BM 55 ± 5 58 ± 5 
CP 25:75_M
FD
 7 ± 2 32 ± 5 
CP 25:75_M_TPN-BM
FD
 32 ± 4 65 ± 10 
 
Non-functionalized CP monoliths always exhibit lower binding capacities (15±5 and 7±2 mg IgG 
per gram of monolith for CP 25:75 and CP 25:75_M
FD
, respectively) comparing with the 
functionalized ones (55±5 and 32±4 mg IgG per gram of monolith for CP 25:75_TPN-BM and 
CP 25:75_M_TPN-BM
FD
, respectively). Thus, the high values of IgG binding revealed by CP 
monoliths modified with TPN-BM prove the fundamental role of TPN-BM to recognize, and 
consequently, to retain the IgG. In addition, also the IgG recovery is inferior for non-
functionalized monoliths comparing to those TPN-BM-functionalized. The percentages of 
recovery for both functionalized supports, CP 25:75_TPN-BM and CP 25:75_M_TPN-BM
FD
 is 
around 60%. Before the monoliths insertion in each housing, CP 25:75_M_TPN-BM
FD 
displayed 
a larger porous network than CP 25:75_TPN-BM which could enable high efficiency in IgG 
capture and release. However, to take advantage of the magnet behaviour, CP 25:75_M_TPN-
BM
FD
 was fitted in smaller column (to be allocated in the hole of the magnet) that in some way 
restricts the monolith swelling. Consequently, the advantages of the magnetically-assisted 
elution of IgG were attenuated. Nevertheless, it should be underlined that the magnetically-
assisted elution was faster (less than 1 minute) comparing with the typical one employed for CP 
25:75_TPN-BM (two minutes), which from an operational point of view, turn the 
chromatographic process less time consuming. 
 
6.3.4. REPRODUCIBILITY AND OPTIMIZATION OF TPN-BM FUNCTIONALIZED CP 
MONOLITHS FOR ANTIBODY PURIFICATION 
The performance reproducibility of CP 25:75_TPN-BM and CP 25:75_M_TPN-BM
FD
 was 
evaluated over cycles using pure solution of IgG (Fig. 6.11 A and B, respectively). 
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Figure 6.11 – Evaluation of chromatographic performance of TPN-BM functionalized chitosan-poly(vinyl 
alcohol) (CP) monoliths: (A) CP 25:75_TPN-BM and (B) CP 25:75_M_TPN-BM
FD
. 
FD
 refers   that have 
undergone further swelling and freeze-drying procedures for additional opening of porous network. The 
chromatographic procedures (bind, elution and regeneration steps) were performed consecutively along 
three cycles at a gravitational flow rate. 
 
CP 25:75_TPN-BM monolithic platforms over cycles (Fig. 6.11 A) exhibit a periodic behaviour 
suggesting that the binding, elution and regeneration profiles are constant during each tested 
cycle (55, 42 and 8 mg IgG per gram of monolith, respectively). Conversely, for CP 
25:75_M_TPN-BM
FD
 this periodicity is not so evident. Over cycles, some amount of IgG (20%) 
was physically entrapped into porous network avoiding an outstanding performance of the 
support during its operation time as it is observed in Fig 6.11 B. Thus, it is the CP 25:75_TPN-
BM (Fig. 6.11 A) that revealed better binding and elution profiles, being in agreement with 
breakthrough curves previously discussed. It should be remembered that CP 25:75_TPN-BM 
was casted in a larger column due to no need to be tested under magnetically-assisted elution. 
Therefore, the support was able to swell easily facilitating the availability of TPN-BM 
(immobilized onto supports) to interact with IgG. 
The optimization performed for magnetic CP monoliths, which involved an additional treatment 
for opening porous network comprising swelling and freeze-drying procedures (CP 
25:75_M_TPN-BM
FD
), was attenuated by the column dimensions that is able to be allocated in 
the magnet to perform magnetically-assisted elution. Due to this, the experimental data 
obtained for CP 25:75_M_TPN-BM
FD
 suggest that under tested operation conditions (smaller 
columns and gravitational flux) its reusability is not completely assured. Nevertheless, these 
preliminary results also indicate that with a different permanent magnet, designed to allocate a 
larger column, certainly better performances and greater binding and elution capacities could be 
achieved, instead of the maximum 25 and 15 mg of IgG g
-1
support, respectively, as herein 
demonstrated. In addition, it is important to mention that all chromatographic assays were 
performed using a piston in the regeneration step to force the expulsion of IgG imprisoned 
physically to the support. Still, 5% of IgG remained in the supports between cycles, possibly due 
to the absence of fixed and constant operation parameters such as pressure and flow rate.  
In order to give a step further concerning the possible potential of CP monolithic platforms as 
promising devices for antibody purification, CP 25:75, CP 25:75_TPN-BM and CP 
25:75_M_TPN-BM
FD
 were tested with two different crude extracts: (1) one containing a single 
CHAPTER 6: POROUS CHITOSAN-BASED MONOLITHS PREPARED FROM THE BEST 
COMBINATION OF SUSTAINABLE MATERIALS AND TECHNIQUES 
123 
  
chain fragment, scFv, produced in Pichia Pastoris (approximately 10 mg of total protein per 
millilitre) and (2) another containing monoclonal antibodies (mAbs) produced by CHO cells 
(approximately 2 mg of total protein per millilitre). Once again, CP 25:75 and CP 25:75_TPN-BM 
were tested in a larger column (1.5 cm of diameter since their elution profiles are not dependent 
on a magnetic field, Fig. 6.12 A and B). Conversely, CP 25:75_M_TPN-BM
FD
 was evaluated 
casted in a column with 1 cm of diameter due to the magnetically-assisted elution (Fig. 6.12 C). 
CP 25:75_M monoliths were not tested due to difficulties in measuring their fluxes under 
gravitational conditions as previously mentioned. 
 
Figure 6.12 – Images of gravitational chromatographic apparatus employed for bare and magnetic 
chitosan-poly(vinyl alcohol) (CP) monoliths before, CP 25:75 (A), and after TPN-BM coupling, CP 
25:75_TPN-BM (B) and CP 25:75_M_TPN-BM
FD
 (C). A and B are performed in the absence of a 
permanent magnet and C in the presence of a permanent magnet of 0.5 T. 
FD
 refers to monoliths that have 
undergone further swelling and freeze-drying procedures for additional opening of porous network. 
 
 
SDS-page gels resulting from the chromatographic experiments with two different crude extracts 
using CP monoliths are presented in Fig. 6.13. Fig. 6.13 A, C and D correspond to CP 25:75, 
CP 25:75_TPN-BM and CP 25:75_M_TPN-BM
FD
 monoliths tested with mAbs crude extract and, 
accordingly, Fig. 6.13 B, D and E correspond to the same supports but using scFv crude 
samples. CP 25:75, which works as a control, shows in the first elution (E1 in Fig. 6.13 A) two 
bands corresponding to mAbs fractions. These results show unspecific retention of mAbs on the 
monoliths network. For scFv (Fig. 6.13 B) native CP 25:75 show no protein binding to the 
support and also no protein in the elution lanes. Fig. 6.13 C and D reveals the CP25:75_TPN-
BM ability in mAbs and scFv purification, respectively, and for both cases, it is not observed 
again, mAbs or scFv fractions in elution lanes. This result can be explained by the blocking that 
might occur when crude extracts with larger biomolecules are being permeated, through CP 
25:75_TPN-BM monolith operating under gravitational conditions.  
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Figure 6.13 –The acrylamide gels from SDS-PAGE performed with the fractions collected during the mAbs 
(A, C, E) and scFv purification (B, D, F) using bare and magnetic chitosan-poly(vinyl alcohol) (CP) 
monoliths before and after TPN-BM coupling: (A, B) CP 25:75, (C, D) CP 25:75_TPN-BM and (E, F) CP 
25:75_M_TPN-BM
FD
; 
FD
 refers to monoliths have undergone further swelling and freeze-drying procedures 
for additional opening porous network; lane M corresponds to the molecular weight marker, lane LD 
represents the loading, lane FT is the flowthrough, lane W1, W2 and W3 corresponds to the washes 
(phosphate buffer (50 mM, pH 8.0)), and lane E1, E2, E3 and E4 are the elution fractions (sodium citrate 
buffer (50 mM, pH 3.0)). 
 
Interesting is the CP 25:75_M_TPN-BM
FD
 elution behaviour for mAbs (E) and scFv purification 
(F). Conversely to CP 25:75 and CP 25:75_TPN-BM, in first, second and third elutions (Fig. 
6.13 E, E1, E2, E3), mAbs fractions are evident, although with limited purity: 75% in the first one 
while in the others two (E1 and E2) present 97% purity. Similar profile is exhibited when the 
same support purifies scFv (Fig. 6.13 F, E1, E2, E3). These results clearly suggest two 
important points: (1) in fact, the magnetically-assisted elution is crucial to help the exclusion of 
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mAbs and scFv from the porous network of monolithic platform, however, (2) this support is not 
able to capture and elute mAbs and scFv selectively and with low non-specific adsorption 
background, since in the elution lanes other proteins are presented.  
Fig. 6.14 represents quantitatively the capacity of CP 25:75_M_TPN-BM
FD
 in binding, elution 
and regeneration stages considering the total protein concentration. The elution is higher for 
scFv crude extract (10 mg total protein per millilitre considering 1 gram of support) comparing to 
mAbs crude extract in which the amount of total protein is lower (7 mg total protein per millilitre 
considering 1 gram of support). Since the SDS-PAGE gel correspondent of mAbs purification is 
slightly pure that the one related to scFv, although both present low selectivity, it is possible to 
infer that mAbs are more abundant in the elution fractions, collected during chromatographic 
procedures, than scFv. Thus, although mAbs are larger than scFv, which in a first glance could 
be an unfavourable point for an efficient operation of CP monoliths with a close porous 
networks, CP 25:75_M_TPN-BM
FD
 revealed an encouraging performance for mAbs purification 
(cross information from Fig. 6.13 E and F and Fig. 6.14), rather than scFv (40% of purity). 
 
 
Figure 6.14 – Performance of binding, elution and regeneration of TPN-BM functionalized magnetic 
chitosan-poly(vinyl alcohol) (CP) monoliths submitted to an additional treatment for opening porous 
network involving swelling and freeze-drying procedures, CP 25:75_M_TPN-BM
FD
, using two different 
crude extracts: one contain only the single chain fractions (scFv) and another one containing monoclonal 
antibodies (mAbs). 
 
Probably, this suggestive preference for mAbs purification instead of scFv is not related only 
with the porous network, which in fact is restricted due to column dimensions, but also with the 
type of interactions that are established between the target molecule and TPN-BM immobilized 
onto monoliths. It was found and mentioned in Chapter 4 that TPN-BM revealed a pH 
dependence especially for Fc domain of IgG. However, in opposition to mAbs, the scFv extract 
only comprises part of the Fab domain which, also based on the knowledge acquired from the 
studies described in Chapter 4, establishes preferentially hydrophobic interactions (not pH 
dependent) with TPN-BM. Thus, this fact helps to explain why the elution lanes of scFv crude 
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extract (Fig. 6.13 F) are slightly more contaminated than the lanes correspondent to mAbs 
extract (including Fab and Fc domains). Probably, for CP 25:75_M_TPN-BMFD_mAbs system, 
the elution, despite being of low selectivity considering all porous structure constraints, might 
have been executed by a pH dependence. 
Regarding the regeneration step, in both cases, it was not 100% efficient since these supports 
still retain 15-20% of total protein. Once more, the operation of CP 25:75_M_TPN-BM
FD
 under 
pressure will be desired in order to assure not only an effective CIP procedure, but also an 
effective and established operation mode. In addition, a slight increase in porous network, 
namely pore size diameter, could also be a promising solution. 
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6.4. CONCLUDING REMARKS 
In the present study, microporous monoliths composed by different ratios of chitosan and 
poly(vinyl alcohol) (CP) with and without embedded magnetic nanoparticles (MNPs), were 
successfully prepared by using a combination between gelation and supercritical CO2 (scCO2) 
assisted processes. A second approach for CP monoliths porous network opening at dry state 
was performed, and consisted in creating a new porous network starting point, based on 
swelling and freeze-drying methods. Both strategies generated different structures with distinct 
morphological, mechanical, magnetic and physico-chemical properties. CP monoliths were 
further modified using plasma treatment (firstly argon (Ar) plasma generated the radicals and 
secondly, the 1,6-hexanediamine dragged by the plasma system reacted with activated CP 
monoliths, aminating them) for further coupling of TPN-BM, a triazine-based affinity ligand. After 
CP monoliths functionalization, the supports were again characterized and tested as affinity 
chromatographic platforms. CP 25:75 monoliths, with and without MNPs embedded, prepared 
by both methods, and after TPN-BM coupling (CP 25:75_TPN-BM and CP 25:75_M_TPN-
BM
FD
) exhibited a promising affinity behaviour towards IgG which com,prises acceptable 
estimated affinity parameters and encouraging binding capacities (55 and 32 mg IgG g
-1
 
support, respectively). However, some optimizations regarding the pore size diameter of 
monoliths and their operation mode should be considered to improve the preliminary affinity 
profile herein demonstrated. Particularly, considering the pore size, other casting solution 
concentrations should be tested and the high pressure parameters varied. In addition, and 
considering the second strategy of porous network opening, the swelling time should also be 
enlarged in order to promote higher water uptake degrees, and consequently to generate new 
porous network starting points comprising larger pores. Considering the operation mode: i) for 
an appropriate gravitational condition, a new permanent magnet should be designed to allocate 
larger columns to allow magnetically-assisted operations without restrictions of monoliths 
swelling and expansion; ii) under pressure operations, the ideal should be to test these supports 
in appropriate equipment (e.g. AKTA) in order to define the optimum process parameters 
(pressures and flow rates). Nevertheless, the obtained results suggest a good beginning to use 
CP monoliths herein prepared as affinity chromatographic platforms, especially CP 
25:75_M_TPN-BM
FD
 which was able to bind approximately 25 mg of total protein and to elute 
selectivity 50% of mAbs with 98% of purity, when tested with crude samples (mAbs crude 
extracts). The methods herein proposed to generate CP monoliths combined with the 
functionalization strategy based on plasma technology, revealed to be a robust and efficient 
solution. Furthermore, they can be used not only for other bioseparation purposes but also for 
many other applications regarding tissue engineering, drug delivery and cell growth where the 
preparation of well-defined 3D structures is crucial. 
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CHAPTER 7 
EVALUATION OF GREEN CHEMISTRY IMPACT 
 
 
 
 
SUMMARY 
 
On this chapter, the greenness of two strategies performed in this thesis was evaluated: (1) the 
synthesis of biomimetic ligand TPN-BM and (2) the monoliths functionalization strategy based 
on plasma treatment. This evaluation was perfrmed following green chemistry metrics. The 
calculations revealed that both alternative routes revealed maximum atom economy (AE), mass 
productively (MP), carbon efficiency (CE) and reaction mass efficiency (RME) values while 
those obtained for E-factor and mass intensity (MI) were minimized.  
Overall, this chapter shows the green impact of these two strategies herein developed and 
consequently, the most important contributions for the development of sustainable practises. 
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7.1. INTRODUCTION 
7.1.1 GREEN CHEMISTRY AND GREEN ENGINEERING 
During the last decade, chemists and engineers have made a strong effort to reverse the 
negative publicity associated to chemistry regarding ecological and social points of view.
235
 
Normally, chemical industries generate large amount of waste which was becoming increasingly 
expensive to industry but also to environment.
236
 Thus, these associated costs started working 
as an important driving force for important and significant changes in science and industry to 
achieve economic, environmental and social benefits.  As a result of this, new topics such as 
“green chemistry” and “green engineering” started appearing to alert people for the reactions 
optimization considering materials and energy usage, waste reduction from all sources, and 
overall cost minimization.
237
 This remarkable change in the world of chemistry was 
accomplished by the new European chemicals legislation REACH, the Registration Evaluation 
and Authorization of Chemicals, which has become probably the most important chemicals 
legislation we have ever seen.
238
 Moreover, this “green philosophy” also aims the minimization 
of toxicity and hazards, and the maximization of safety practices in the design of chemical 
reactions, products and processes, to operate under a safe chemical code. Based on this, 12 
principles of green chemistry and green engineering (Table 7.1) introduced by Paul Anastas 
and John Warner in 1998 were established to guide chemists and engineers in laboratories or 
industries in how to develop greener and sustainable products or processes.
235,239
 
More recently, these 12 principles of green chemistry and green engineering were summarized 
into the more suitable and impressive acronym, PRODUCTIVELY and IMPROVEMENTS, 
respectively (Fig. 7.1).
235,236
 
Although some minds outside Europe still look to REACH in a threatening way due to possible 
restructuration and investments that it can oblige, it is not surprising that it has been applied to 
numerous industry sectors.
238
 From aerospace, automobile, cosmetics, electronics, energy, 
household products, pharmaceutical, agriculture, there are hundreds of examples of successful 
applications of award winning, economically competitive technologies.
236
 This green revolution 
in the chemistry world has stimulated all creative ability, which is one of the most famous 
features of the chemistry field; researchers and engineers have to find out new and sustainable 
strategies to redesign processes and products considering all the stages of their life cycle.
240
 
Therefore, in order to measure the “greenness” of processes some metrics were created as well 
as basic tools to access the life cycle of a product or process.
151,237,241
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Table 7.1 – 12 Principles of Green Chemistry.
235
 
Principle Description 
1. Inherent Rather Than 
Circumstantial 
All materials and energy inputs and outputs to be as 
inherently non-hazardous as possible. 
2. Prevention Instead of 
Treatment 
It is better to prevent waste than to treat or clean up waste 
after it is formed. 
3. Design for Separation 
Separation and purification operations should be designed to 
minimize energy consumption and materials use. 
4. Maximize Efficiency 
Products, processes, and systems designed to maximize 
mass, energy, space, and time efficiency. 
5. Output-Pulled Versus 
Input-Pushed 
Products, processes, and systems should be "output pulled" 
rather than "input pushed" through the use of energy and 
materials. 
6. Conserve Complexity 
Embedded entropy and complexity must be viewed as an 
investment when making design choices on recycle, reuse, or 
beneficial disposition. 
7. Durability Rather Than 
Immortality 
Targeted durability, not immortality, should be a design goal. 
8. Meet Need, Minimize 
Excess 
Design for unnecessary capacity or capability (e.g., "one size 
fits all") solutions should be considered a design flaw. 
9. Minimize Material Diversity 
Material diversity in multicomponent products should be 
minimized to promote disassembly and value retention. 
10. Integrate Material and 
Energy Flows 
Design of products, processes, and systems must include 
integration and interconnectivity with available energy and 
materials flows. 
11. Design for Commercial 
"Afterlife" 
Products, processes, and systems should be designed for 
performance in a commercial "afterlife”. 
12. Renewable Rather Than 
Depleting 
Material and energy inputs should be renewable rather than 
depleting. 
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Figure 7.1 - Schematic representation of the meaning of IMPROVEMENT and PRODUCTIVELY from the 
green chemistry point of view.
242
  
 
7.1.1.1. GREEN METRICS 
In order to access how much a process is sustainable or not, some green metrics were 
established and further translated in mass indicators. The different mass indicators are: atom 
economy (AE), E-factor, mass intensity (MI), mass productivity (MP), carbon efficiency (CE) and 
reaction mass efficiency (RME). Also the energetic intensity can be calculated.
235,237,243
 
Atom economy (AE) aims to calculate how much of the reactants persist in the final product 
(equation 7.1). 
    
∑                               
∑                                
 
                 Equation 7.1 
  
Its calculation involves key assumptions such as: to ignore the reaction yield and molar excess 
of reactants and it does not take into account with the solvents and reagents. For a generic 
reaction A + B → C, AE can be calculated according to equation 7.2: 
 
    
                         
                                                   
 
          Equation 7.2 
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For a generic synthetic process involving multisteps: 
A + B → C (1) 
C + D → E (2)  
E + F → G (3) 
AE is calculated according to equation 7.3: 
    
            
                                                  
 
Equation 7.3 
 
Since the calculation of AE disregards the intermediates, because they are formed and 
immediately consumed. The greener is a process, the greater is AE. 
E-factor is another mass indicator which is related to the waste that is produced from the 
beginning to the end of a process. Since it is calculated from the quotient between the kg of 
waste that is produced to obtain a kg of product (equation 7.4), it is desirable that E-factor could 
be as low as possible because it means that few wastes are created. 
 
          
               
          
 
          Equation 7.4 
For this evaluation it is extremely important to define precisely what is considered as “waste” 
and divided it in different categories since depending on its nature (e.g: organic, inorganic, 
solid). For each type of waste, different treatments can be applied and consequently the overall 
greenness of the process must be re-evaluated. The value of E-factor is limited and it does not 
take into account the nature and the environmental impact of the generated waste. In order to 
achieve a more accurate prediction, the E-factor can be multiplied by an environmentally 
hazardous quotient, Q. Thus, Q depends on the species involved in the reactions and, based on 
this, a computer program has been developed (EATOS: environmental assessment tool for 
organic synthesis). The deliverables of this program can be used to compare and improve 
chemical reactions.
237
 
Mass intensity is another indicator given by the quotient between the total mass that is 
produced in a process and the mass of the product, taking into account the yield and 
stoichiometry (equation 7.5). 
 
    
                                                
                    
 
          Equation 7.5 
Regarding the total mass, this metric includes everything that is employed in a process or 
process step such as: reactants, reagents, catalysts, solvents, acids, bases, extractions, 
crystallisations, among others. The water is not considered due to its no significant 
environmental impact.  
CHAPTER 7: EVALUATION OF GREEN CHEMISTRY IMPACT 
134 
 
It can also be possible to correlate MI with E-factor through the following equation (equation 
7.6): 
               
              Equation 7.6 
In addition, by expressing MI as a percentage, it appears in a similar form to an effective mass 
yield and atom economy designated by mass productivity (equation 7.7). 
 
     
 
  
     
    Equation 7.7 
Carbon efficiency (CE) allows determining the amount of carbon present in the reactants that 
are incorporated into the final product and, it is expressed in percentage (equation 7.8). This 
calculation considers the yield and stoichiometry of reactants and products. 
 
     
                                 
                                                 
     
             Equation 7.8 
The last green metric is designated by reaction mass efficiency (RME) and it is defined as the 
percentage of the mass of reactants that remain in the final product. Basically, it is very similar 
to the yield, and considers the stoichiometry of reactants (equation 7.9) 
 
      
               
                     
     
             Equation 7.9 
For an accurate evaluation, all metrics should be taken into account to achieve a global 
overview of a process. 
 
7.1.2. LIFE CYCLE ASSESSMENT (LCA) 
Life cycle assessment (LCA) is a technique to assess the environmental aspects and potential 
impacts associated with a product, process, or service, by: (1) performing a list of relevant 
energy and material inputs and environmental releases, (2) evaluating the potential 
environmental impacts regarding inputs and releases, and (3) understanding the results to help 
in a more informed and precise decision.
21,244
 Thus, a LCA of a product or process includes four 
stages: (1) raw material acquisition, (2) manufacturing, (3) use/reuse/maintenance, and (4) 
recycle/waste management. In these 4 stages, important aspects must be considered for an 
accurate analysis (Fig. 7.2). 
LCA is the only pillar that has been standardized to date (ISO 2006a, b). UNEP (2009) has 
published guidelines for social LCAs and is currently developing methodological sheets for 
impact subcategories.
238
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Figure 7.2 - Schematic representation of a typical diagram of LCA.
244
 
 
During the last two decades a special attention has been given to this technique and different 
LCA studies regarding pharmaceuticals,
5,245 
polymers,
246,247
 food,
248
 biodiesel,
249,250
 textiles,
251
 
and pesticides
252
 have been developed. Concerning pharmaceutical manufacturing companies, 
which are the scenario that includes the problematic of this thesis, there is an increasing 
pressure to ensure that information, and data about their processes are accurate and 
reproducible. However, the current environmental regulations (e.g. for eco‐products) are not yet 
specifically oriented to be applied to pharmaceutical products (including biopharmaceutical ones 
involving mAbs) and processes. Moreover, no standard methods are available to guide 
companies in the integration and evaluation of sustainability. Thus, the evaluation of industrial 
processes is normally based on metrics or indicators, depending on the company environmental 
and sustainability goals.
5,245,253
 
Regarding pharmaceutical and biopharmaceutical products or processes, very few LCA studies 
can be found in the literature. This might be due to three main reasons: (1) difficulties in 
measuring the inputs and outputs data, (2) lack of information and methodologies to evaluate 
the environmental impacts of some chemical compounds used, and (3) the need for protecting 
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the intellectual property.
5
 The limited studies available for biotechnological processes 
recommend that the most effective way for increasing the process environmental performance 
is by optimizing material and energy efficiency.
5,245,254
 
Generally, pharmaceutical processes are divided in two main processing stages. The first one is 
related to the active pharmaceutical ingredients (API) production and the second to the final 
drug formulation that includes the API (see Fig. 7.3).
5
 
 
 
Figure 7.3 - Schematic representation of the two main processing stages of pharmaceutical processes: 
primary processing (A) and second processing (B).
5
 
 
The most challenging step considering all process is the downstream stage which comprises 
cell harvesting, protein concentration, and final purification. This step, although already 
established and optimized, involves the use of a large amount of solvents, materials, energy 
and time consuming. Thus, after an exhaustive study about all pharmaceutical process a model 
of LCA was designed based on 8 indicators which are described in Table 7.2.
5
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Table 7.2 – LCA tool to perform sustainability evaluations of pharmaceutical processes based on indicators.
5
 
  
 
This recent LCA tool specifically designed for pharmaceutical processes, in particular the 
biotechnological based ones, is still under development, but its results are already being used in 
the design and implementation of a biopharmaceutical API production process with the 
perspective that in a near future could be extended to enlarge the system boundary.
5
 
Indicator Unit Description 
Energy intensity MJ/vial* 
Total energy consumed in the 
production of one vial. 
Process material intensity kg/vial 
Total amount of non-renewable 
resources needed to obtain a 
unit mass of product. 
Process water intensity L/via 
Total amount of water required to 
obtain a unit mass of product. 
Potential chemical risk - 
Potential risk to human health 
associated with manipulation, 
storage, and use of hazardous 
chemical compounds. 
Carbon footprint kg CO2-eq/ vial 
Potential contribution of different 
greenhouse gas emissions (e.g. 
CO2, CH4, N2O) to global 
warming. 
Freshwater aquatic toxicity kg 1,4-dichlorobenzene - eq/vial 
Measures the impact of 
substances emitted to the 
aquatic environment during 
manufacture activities. 
Net cash flow generated €/vial 
A measure of the company's 
financial health. 
Direct employment persons/ vial 
Number of persons involved in 
the pharmaceutical product 
manufacture per unit of product. 
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Since this thesis aims to develop sustainable functional polymeric platforms to employ in 
downstream stages of biopharmaceutical processes, this study pretends to evaluate the 
greenness of two strategies developed in this thesis: (1) the synthesis of biomimetic ligand 
TPN-BM and (2) the monoliths functionalization strategy based on plasma treatment.  
The remaining steps reported in this thesis were not evaluated according to green metrics or 
LCA due to the high complexity of each one as well as the absence of data in the literature to 
support and to compare the results. 
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7.2. CASE STUDY 1: EVALUTION OF TPN-BM LIGAND SYNTHESIS 
In this case study, it is intended to determine how much is sustainable the TPN-BM synthesis 
reported in Chapter 3.
161
 The TPN-BM synthesis came up with the need of solubility 
improvement of ligand 22/8 also known as artificial Protein A.
11
 Once established this objective, 
the synthesis was projected and conducted following some principles of green chemistry as 
previously described. However, in order to evaluate in a more quantitative way the “greenness” 
of the synthetic procedure, green metrics were applied. 
Fig. 7.4 exhibits a schematic representation of the chemical synthetic route followed for the 
preparation of ligand 22/8 (A) and the alternative one, ligand TPN-BM (B). 
 
 
 
Figure 7.4 - Schematic representation of chemical synthetic route followed for the preparation of (A) ligand 
22/8: (i) 3-aminophenol, NaHCO3, acetone, water, 0 ºC, 2h; (ii) 4-amino-1-naphthol hydrochloride, 
NaHCO3, acetone, water,  45 ºC, 5h,  and (B) ligand TPN-BM: (i) resorcinol, DIPEA, dry THF, 0 ºC, 2h; (ii) 
1,4-dihydroxynaphthalen, DIPEA, dry THF, 0 ºC, 2h. DIPEA= diisopropylethylamine. 
 
The two synthetic routes are similar however, the reactants and the solvents involved as well as 
the synthesis conditions are different (the details of reactions are mentioned in Chapters 2 and 
3). Mass indicators such as AE, E-factor, MI, MP, CE and RME were applied to both synthesis 
and the results are presented in Table 7.3. 
 
Table 7.3 – Mass indicators for ligands 22/8 and TPN-BM. 
 
Ligand AE (%) E-factor MI MP (%) CE (%) RME (%) 
22/8
82,88
 77 40 30 2.4 60 46 
TPN-BM
161
 84 2.9 3.3 26 76 74 
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Accordingly to all values resulted from mass indicators, it is clearly visible that better values 
were obtained for ligand TPN-BM synthesis. Particularly, AE, MP, CE and RME are mass 
indicators which should be maximized, since they translate in general the idea that all reactants 
employed in a process are converted into the final product. Thus, the waste represented by E-
factor and the MI that gives an overview of all reaction intervenients (reactants, solvents, 
catalysts, etc) must be minimized.
235
 Considering this reasoning, ligand TPN-BM represents not 
only  (Chapter 3) an efficient experimental solution
161
 but also a sustainable alternative 
considering their improved mass indicator values compared  to those of ligand 22/8.
82,88
  
Summing up, in TPN-BM synthesis, it was possible to improve AE and CE in 10%, E-factor, MI 
and RME in approximately 30% and MP in 20%. In addition, it is important to highlight the 
obtained values are in the range values of other chemistries.
237
 
In order to compare and to rank both synthesis, a qualitative estimation resulted from the 
quantitative evaluation above presented together with the details described in Chapter 3 (table 
7.4), can be performed (Table 7.5). 
 
Table 7.4 – Comparison of ligand 22/8 and ligand TPN-BM synthesis.
161
  
 
Process Parameters Ligand 22/8 TPN-BM Green Chemistry Principles 
Solvents involved 6 4 Safer solvents 
Temperatures (ºC) 0-45 0 Energy efficiency 
Purification Steps 6 4 Design for separation 
Time consumption (h) 7 4 Time saving 
Mass Productivity (%) 2.4 26 Atom economy 
 
Table 7.5 is divided in 4 categories in which: (1) the environment involves all mass indicators 
and life cycle-emissions, (2) the safety comprises care consideration about process, materials 
and exposure controls, (3) the efficiency covers the yield, conversion, purity, number of unit 
operations, processing time and operability and (4) the energy includes energy requirements 
considering cooling, heating and electricity. The colours also represent different scenarios: 
green denotes alternatives with significant advantages, red means alternatives with significant 
disadvantages and yellow suggests alternatives that do not exhibit significant advantages or 
disadvantages. 
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Table 7.5 – Qualitative evaluation of ligand 22/8 and ligand TPN-BM synthesis. The colours represent 
different scenarios: green denotes alternatives with significant advantages, red means alternatives with 
significant disadvantages and yellow suggests alternatives that do not exhibit significant advantages or 
disadvantages. 
 
Ligand Environment Safety Efficiency Energy 
22/8
82,88
  
    
TPN-BM
161
 
    
 
Thus, observing Table 7.5 it is obvious that TPN-BM synthesis offers great advantages to ligand 
22/8 synthesis considering all main topics involved in the evaluation of the process.  
20 years ago, ligand 22/8 was produced as a template to mimic Protein A. Based on the 
biomimetic approach, this attempt was already in that time an application of green chemistry 
early before the concept was coined.
21
 However, the time is always changing and challenging 
scientists to improve and to optimize processes, and ligand TPN-BM is an example of this effort 
as well as being a more efficient biomimetic solution with improved solubility than ligand 22/8, 
was synthesised following a more sustainable procedure. 
 
 
7.3 CASE STUDY 2: EVALUATION OF PLASMA TREATMENT AS A METHOD FOR 
SURFACES MODIFICATION 
To create a functional support, the first step that is normally taken involves the introduction of 
amines onto materials surface for subsequent functionalization. 
Herein it is intended to evaluate two methods of monoliths functionalization (monoliths of 
chitosan and polyvinyl alcohol, CP): (1) traditional one: performing epoxy-activation followed by 
the amination procedure
82
 (reported in the Chapters 2 and 3) and (2) an alternative one 
(reported in Chapter 5): using plasma treatment for one step activation and amination (Fig. 7.5). 
 
 
 
Figure 7.5 - Schematic representation of two methods of materials functionalization: (1) traditional one: 
performing epoxy-activation followed by the amination procedure and (2) the alternative one: using plasma 
treatment for one single step of activation and amination. 
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Both functionalization strategies, the traditional and the one involving plasma treatment, are 
composed by two steps where the first one regards the introduction of two different reactive 
chemical species, epoxy rings and radicals, respectively. The amination step is common in both 
functionalization routes but it is performed at different conditions, since the alternative one 
occurs under the plasma chamber. This new approach involves different reagents, time and 
energy consumptions, therefore mass indicators were applied and the different metrics were 
compared (Table 7.6). 
 
Table 7.6 – Mass indicators for both strategies of monoliths functionalization: traditional and induced by 
plasma treatment. 
 
Strategy AE (%) E-factor MI MP (%) CE (%) RME (%) 
Traditional
82
 56 296 297 0.3 0.1 0.7 
Plasma 99 0.1 1.1 95 77 77 
 
It is known that immobilization strategies on solid supports require time, excess of reagents and 
that the steric hindrance prevails. Therefore it is urgent to overcome these drawbacks creating 
new strategies of immobilization which should be kept in mind not only their efficiency but also 
their sustainability. Hereupon, and considering the mass indicator values for both 
functionalization strategies, it is clear that the one based on plasma treatment revealed to be 
more efficient than the traditional route of surfaces modification. Although plasma technique is 
fast, it allowed to maximize all mass indicators at least in 2-fold, contributing for the greenness 
of the functionalization process. The amount of Argon used to radical’s formation was not 
accounted because its use belongs to a transient step to enable the amination step. 
Nevertheless, it is possible to assume that all radicals formed, reacted efficiently due to higher 
estimated values of green metrics in amination step. 
In an overview, considering environment, safety, efficiency and energy impacts of both 
functionalization routes, a qualitative analysis was also performed. In Table 7.7, the colours 
represent different scenarios; green - significant advantages, red - alternatives with significant 
disadvantages and yellow - alternatives that do not exhibit significant advantages or 
disadvantages. 
 
Table 7.7 – Qualitative evaluation of both strategies of monoliths functionalization: traditional and induced 
by plasma treatment. The colours represent different scenarios: green denotes alternative with significant 
advantages, red means alternatives with significant disadvantages and yellow suggests alternatives that 
do not exhibit significant advantages or disadvantages. 
 
Strategy Environment Safety Efficiency Energy 
Traditional
82
 
    
Plasma 
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The methodology with plasma treatment as a tool for the surface modification represents an 
efficient and sustainable alternative. Particularly, in less time (30 minutes) it is possible to 
achieve higher amines density (330 µmol NH2 g
-1
 support) minimizing the environmental impact, 
while the traditional route involving more organic species required 13 hours to achieve an amine 
density of 226 µmol NH2 g
-1
 support. Moreover, to obtain 226 µmol NH2 g
-1
 support through the 
traditional strategy, the amount of reactants involved is much higher becoming this 
functionalization route uninteresting from the green chemistry and economic point of views. 
Plasma treatment being a solvent free technique justify in this way why it has been increasingly 
studied and been a focus of high attention in the field of surfaces modification. 
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7.4 CONCLUDING REMARKS 
The future of green chemistry is as broad as the future of chemistry as a whole, and it is 
therefore difficult to predict. Just as chemistry has always been a journey rather than a 
conclusion, green chemistry is also based on the statement that continual improvement, 
discovery, and innovation is the path towards a more sustainable world. Therefore, it is very 
important to make researchers and manufactures aware of this, because although the growing 
of green chemistry acceptance, there is still a friction that avoids its total agreement.  
It is understandable that it is impossible to reduce all the waste involved in an entire process, to 
obtain only yields of 100% or even to reduce totally the organic solvents of a process step. 
However, it is incomprehensible that scientists and industrial engineers have no consciousness 
and care about the environment when designing and implementing new processes at 
laboratory, pilot or industrial scales. Therefore, it is urgent to invert this, and try to act always, in 
a sustainable way to reduce the use of toxic compounds and feed-stocks, by-products, solvents, 
waste and energy consumptions. Thus, this work led to the development of greener synthetic 
route comprising the design: (1) of new strategies for the synthesis of biomimetic ligands and 
(2) the new routes for the functionalization of polymeric platforms used to purify antibodies. The 
results obtained from mass indicators demonstrate that the alternative strategies followed in this 
thesis fulfil the requirements of green chemistry. Particularly, the alternative synthesis of the 
biomimetic ligand as well as the functionalization strategy based on plasma treatment enabled 
the significant reduction of waste and solvents used and, at the same time, the increase of 
reaction yields, atom economy, mass productivity and carbon efficiency. Therefore, this study 
clearly shows that the main goals of a process can be maintained even improving its 
sustainability.  
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CHAPTER 8: CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
 
8.1 CONCLUDING REMARKS 
Up to now, polymeric monoliths are known as the more recent and fashionable generation of 
chromatographic supports. However, more than trendy, they are effective 3D porous supports 
due to their very-well organized and interconnected porous network which enables the faster 
permeation of both viscous fluids and large biomolecules. These main features have been 
attracting high attention in the chromatography world, especially for antibody and virus 
purification. Monoliths have been prepared mainly using synthetic monomers processed via 
radical, cationic and anionic polymerizations. Although highly robust, most of these polymeric 
monoliths need extensive cleaning protocols to prepare them for contact with biological 
samples. Additionally, the functionalization strategies employed for ligand attachment involve 
numerous steps and toxic chemicals. 
 
In order to minimize costs and the environmental impact, monoliths produced mainly from 
natural polymeric resources (chitosan, agarose and dextran) blended with low contents of 
synthetic polymers (PVA or acrylate species) were investigated as potential chromatographic 
platforms to intensify antibody purification processes. The main benefit of this approach 
comprises the fact that biopolymers were not chemically modified but, physically entrapped in 
the chemical network already established between the synthetic polymers. The idea was to 
improve the mechanical stability of the natural monoliths without compromising their potential of 
biodegradability and disposability.  
 
The freeze drying processes as well as supercritical fluid technology are techniques that have 
been widely used to generate porous structures in which the pore control is crucial, e.g., tissue 
engineering and drug delivery. Aware of the same requirement, these methodologies were 
successfully applied for natural-based monoliths preparation, and generated distinguished 3D 
structures for bioseparation purposes. Thus, the combination of these two strategies offered the 
creation of a panoply of porous supports with different pore size ranges and mechanical 
properties, in cleanable and rigorous modes, comparing with intensive chemical steps normally 
established.  
 
For the sake of monolithic platforms optimization regarding antibody purification purposes, 
efficiency and time processing, natural monoliths were embedded with magnetic nanoparticles 
(MNPs) to confer them a magnetic responsive behaviour. Two great advantages attached to the 
magnetically-assisted elution were found: (1) the amount of protein was higher (15% more) 
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operating under magnetic conditions and (2) the time for antibody elution was reduced to half, 
which greatly decreases protein damage under the drastic pH conditions employed in the 
recovery step. This strongly reinforces the important role of MNPs entrapped in the monoliths 
network to operate faster under antibody purification processes. 
 
Plasma technology, known as an organic solvent free technique, also demonstrated to be an 
alternative and powerful strategy to compete with the traditional organic functionalization routes. 
The main contributions of this methodology comprised: (1) the reduction of functionalization 
procedure in 12 hours and (2) the use of organic species to half, and (3) an increase of the 
amines and ligands densities in 2-fold (confirmed by XPS, a highly sensitive technique), in 
comparison to the “old-style” (epoxyactivaction and amination). In fact, there are not many 
techniques with the same demonstrated efficiency. Thus, more than design for sustainability, 
that was always kept in mind during this project, the successful modification strategy of 
monoliths was evident, and opens new insights, not only for antibody purification purposes, but 
for enzymes immobilization or small protein couplings. 
 
The redesign of antibody chromatographic processes was also extended to the affinity ligands. 
The new artificial Protein A, ligand TPN-BM, came up as a greener and practical solution to 
upgrade the selectivity of monoliths for antibody purification. Its synthesis, based on green 
chemistry principles, highly contributed for the reduction of organic solvents, time and energy 
consumptions. Furthermore, the reaction yields, mass productively and carbon efficiency, were 
higher when compared with known chemical routes applied for biomimetic ligand synthesis. 
Thus, TPN-BM, more than a biomimetic approach, that by itself is already a sustainable 
solution, it is doubtless a workable and reproducible Protein A substitute. This strong affinity 
behaviour for antibody recognition was confirmed by in silico studies through automated 
molecular docking and MD simulations. These studies allowed to validate experimental affinity 
constants, and to explain the ON/OFF mechanism observed for this affinity pair at binding (pH 
7) and elution (pH 3) conditions (see Table 8.1). Moreover, the computational findings were 
similar to the ones discovered for the natural affinity ligand most used in affinity antibody 
purification methods. Thus, all these statements highlight the great evolution achieved in affinity 
ligand design, and the potential of TPN-BM monolithic platforms as strong competitors to 
established Protein A-agarose beads.  
 
Remarkably, all the findings of this thesis enabled to make a real progress, since a step further 
in the green chemistry and in the affinity chromatography was achieved. 
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Table 8.1 – Comparison of binding and elution capacities of natural-based monoliths produced in this 
thesis as well as the purity of mAbs purified from crude samples. 
 
Monolith 
Protein bound  
(mg IgG g
-1
 support) 
Protein eluted  
(mg IgG g
-1
 support) 
Purity of purified 
mAbs (%) 
CP_22/8 150±15 138±5 98 
CG_22/8 26±8 16±5 n.t 
CP_TPN-BM 160±10 140±10 98 
CG_TPN-BM 60±5 24±5 n.t 
CHT_M_TPN-BM 100±10 80±10 n.t 
CP_M_TPN-BM 120±10 105±10 98 
AA_M_TPN-BM 103±10 83±10 97 
DXT_M_TPN-BM 80±7 23±5 n.t 
CP 25:75_TPN-BM 55±5 35±5 n.t 
CP 25:75_M_TPN-BM
FD
 32±5 19±5 75 
n.t.: not tested 
 
 
8.2. FUTURE PERSPECTIVES 
In nature, monolith is known as a single large block of stone employed in architecture/sculpture, 
which needs of continuum improvements, to be admired and remembered as a marker of 
history. In science, as in Nature, this block requires to be carved towards a better performance 
in different applications. 
 
This thesis fulfilled some gaps in the field of monoliths applied in antibody purification, 
particularly in view of monoliths composition, preparation and functionalization with biomimetic 
ligands prepared by green chemistry approaches. Still, there is scope for improvement 
regarding mechanical stability and pore homogeneity. ScCO2 technology is a promising tool to 
achieve higher control of pores according to their use for analytical or industrial requests. This 
tuning will affect and consequently improve, the efficiency of antibodies binding, since 
homogeneous networks with a controlled pore size will generate better platforms for ligand 
attachment, and antibody capture. Also, these monoliths should be tested not only under 
gravitational conditions but under pressure using specific equipment, as AKTA. Moreover, the 
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scale up of these supports is still limited and therefore this is an area that must be addressed to 
monoliths optimization in order to definitely push monolith applicability to industry. 
 
Nevertheless, the possible acceptance by the industry of the strategies herein presented is 
probably far away. Nowadays, the industry is formatted preferentially to design products for a 
life time, and not always assuring its biodegradability or disposability. Only with a change of 
mind-set will it be possible to spread the potential of these affinity monoliths, moving from the 
research bench to sustainable large-scale chromatographic processes and other engineering 
applications. 
 
However, the true is, as Paul Anastas reinforces in all his papers,
21,151,235,239
 the green chemistry 
and practices are more than a stylish philosophy; it is a state of spirit for which chemists and 
engineers must be aware when they develop or optimize products or processes. 
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